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ABSTRACT OF THE DISSERTATION 
Identification of the Molecular Basis of Morphological Variation in Avian Beaks 
by 
Kara Elizabeth Powder 
Doctor of Philosophy in Biology and Biomedical Sciences 
(Molecular Genetics and Genomics) 
Washington University in St. Louis, 2009 
Professor Michael Lovett, Thesis Advisor 
 Vertebrates, particularly birds, show extremely variable species-specific 
morphology in craniofacial structures.   Cranial neural crest cells give rise to all 
the cartilage and bone of the face, and transplantation experiments have shown 
that these cells contain species-specific patterning information.  First, I employed 
custom cross-species microarrays to analyze the spectrum of developmental 
signaling pathway and transcription factor gene expression changes in neural 
crest cells of the developing beaks for the chicken, duck, and quail, both before 
and after morphological variation is evident. I found that neural crest cells have 
established a species-specific gene expression profile that predates 
morphological variation. In addition to expression changes in the Bmp and 
Calmodulin pathways, previously associated with morphological variation in 
Darwin’s finches, I observed dramatic changes in a number of Wnt signaling 
components in the broad-billed duck. 
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 Second, given that deletion of the microRNA processing gene DICER in 
neural crest cells results in loss of nearly all facial structures, I utilized high-
throughput sequencing to describe the microRNAs that are expressed and/or 
differentially expressed among the same neural crest samples used for the 
microarray analysis. In remarkable contrast to relatively unchanged pattern of 
transcription factor gene expression, microRNA expression is highly dynamic 
during stages when avians acquire species-specific morphology.  The microRNA 
expression profiles also suggest that the transition from multipotent, proliferative 
neural crest cells into cells differentiating to form the tissues of the face may be 
delayed in the duck relative to the chicken and quail.  This prolonged period of 
proliferation in duck neural crest may contribute to the increase in beak size and 
width of the adult duck bill versus the chicken beak.   
Finally, I illustrate examples of how these genomic data sets can initiate 
new avenues of investigation and testable hypotheses.  I found that the Wnt 
pathway acts upstream of the Bmp pathway and induces regional changes in 
growth of the developing beak.  I also correlate changes in expression of miR-
222 in the frontonasal prominence with alterations in protein (but not mRNA) 
levels of one of its target genes, the cell cycle regulator p27(KIP1).  I then 
identified seven mature microRNAs that appear to be specific to the avian 
lineage.  Using PCR, I confirmed that two of these, miR-2954 and miR-2954*, are 
conserved across the avian lineage, from ratites to songbirds. 
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CHAPTER 1 
Origins of Craniofacial Morphological Variation 
 2 
In On the Origins of Species Charles Darwin observed how populations 
evolve through adaptations and natural selection to generate the “endless forms” 
found in nature (Darwin 1859).  Since then, the fields of evolution and 
development have been trying to understand the genetic and molecular 
mechanisms that underlie these morphological variations.  King and Wilson’s 
seminal paper in 1975 observed that the proteins of chimpanzees and humans 
are too similar to explain their organismal differences, and thus many of the 
morphological differences are likely to be due to changes in gene regulation 
(King and Wilson 1975).  This raises the question, what types of genes influence 
species-specific morphologies? The two largest classes of trans-acting regulatory 
molecules are transcription factors (TFs) and microRNAs (miRNAs), which 
control protein levels of hundreds of target genes through specific and 
combinatorial activation and repression (Hobert 2008).  In addition, specific 
signaling pathways such as the fibroblast growth factor (Fgf), Hedgehog, Notch, 
transforming growth factor β/Bone morphogenetic protein (TGFβ/BMP), and Wnt 
signaling networks serve crucial roles in animal development--from body 
patterning to organogenesis and cell-fate specification (Gilbert Scott F. 2003a)--
and modulations in these pathways may contribute to morphological variations 
(Pires-daSilva and Sommer 2003). 
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Regulatory sources of species-specific morphologies  
It appears unlikely that morphological variation is due to the exploitation of 
entirely novel genes or genetic networks, but rather by ”tinkering” (Jacob 1977) 
with  existing developmental programs (Carroll S.B. 2005, Gilbert S. F. 2003b). 
Indeed, the TF and signaling pathway spectrums are largely conserved from 
sponges to humans (Larroux et al. 2008, Nichols et al. 2006), though cis 
regulatory regions have gained remarkable complexity over this same time 
period (Levine M. and Tjian 2003).  Intriguingly, microRNAs appear to have been 
continuously added during the metazoan lineage (Grimson et al. 2008, Heimberg 
et al. 2008, Hertel et al. 2006, Prochnik et al. 2007, Sempere et al. 2006, 
Wheeler et al. 2009), with increased rates of acquisition at the advent of 
bilaterians, vertebrates, and eutherian animals (Heimberg et al. 2008, Hertel et 
al. 2006, Wheeler et al. 2009).  However, closely related organisms (e.g. 
Darwin’s finches or Drosophila species) that have undergone micro-evolutionary 
changes seem to have predominantly the same microRNAs (Tang et al. 2010 
and unpublished data), though their targets may have evolved (Clop et al. 2006, 
Nozawa et al. 2010).  So, if the arsenal of regulatory genes is largely the same, 
what is the regulatory source of species-specific morphologies? 
Developmental regulatory genes such as TFs, miRNAs, and signaling 
pathways can be modified in multiple ways to alter the shape and organization of 
animal bodies (Gilbert S. F. 2003b).  First, the regulatory gene itself may be 
mutated within its protein-coding regions.  For instance, the homeobox (Hox) 
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transcription factor Ultrabithorax (Ubx) has undergone changes in at least two 
regions in the C-terminus of the protein in insects, but not in arthropods, that 
render it able to repress the Distalless (Dll) gene and thus repress abdominal 
limb formation (Galant and Carroll 2002, Ronshaugen et al. 2002). Also, the 
Melanocortin-1-receptor (MC1R) gene has been mutated at different locations in 
various lineages to control melanism in birds, cats, and mice (Eizirik et al. 2003, 
Nachman et al. 2003, Theron et al. 2001).  Despite these clear examples of 
mutations within protein-coding domains, adaptive mutations affecting 
morphology are more likely to occur in cis regulatory elements of genes to 
prevent deleterious pleiotropic effects (Carroll S.B. 2005, Carroll S. B. 2008).  
Pleiotropy is largely avoided in the above cases as the changes between insects 
and arthropods in Ubx occur outside of its DNA-binding homeodomain and other 
motifs that are essential for its functions during body patterning in both species 
(Galant and Carroll 2002, Ronshaugen et al. 2002), and MC1R expression 
appears to be restricted to very specific cell types like melanocytes (Carroll S. B. 
2008).  
 Current theories (Carroll S.B. 2005, Gilbert S. F. 2003b, Parsons and 
Albertson 2009) suggest that the predominant source of species-specific 
morphological forms is subtle quantitative, temporal, and/or spatial alterations in 
gene expression.  These modulations occur through differences in cis regulation, 
via DNA changes (e.g. creation or ablation of TF binding sites) or epigenetic 
modification (e.g. DNA methylation or histone acetylation and methylation) of 
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promoter, enhancer, or insulator elements (Gibney and Nolan 2010, Levine M. 
and Tjian 2003).  First, gene expression can be repressed or enhanced in one 
species or another.  For instance, increased expression levels of the ebony gene 
underlies differential body color in Drosophila species (Wittkopp et al. 2003).  
Second, there may be differences in the timing of gene expression 
(heterochrony).  This occurs between direct and indirect developing sea urchins, 
which skip or include a larval stage, respectively, based on the timing of wnt-5 
expression (Ferkowicz and Raff 2001).  Third, species may have altered the 
location of gene expression (heterotopy) to affect species-specific morphologies.  
An example of this is how the duck has webbed feet: while the expression of the 
GREMLIN gene is localized to the digits of a chicken limb bud, its expression is 
expanded to include the interdigital mesoderm of ducks, which ultimately 
represses apoptosis of the interdigital web (Merino et al. 1999). 
  
Craniofacial complex as a model system 
I have focused on species-specific craniofacial morphologies for three 
reasons.  First, vertebrates (and particularly birds) exhibit an extraordinary 
degree of natural facial variation, and these variations correlate with adaptive 
radiations to exploit new ecological niches.  Second, despite the morphological 
differences in adult facial structures, vertebrates have conserved craniofacial 
morphologies during embryonic development (Figure 1-1).  From this “phylotypic 
stage” (Slack et al. 1993) structures then diverge through changes in gene 
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expression and the delineation of discrete regions of responsiveness in the facial 
primordial (Abzhanov et al. 2004, Abzhanov et al. 2006, Brugmann et al. 2006b, 
Brugmann et al. 2010, Brugmann et al. 2007, Wu P. et al. 2004, Wu P. et al. 
2006).  The identification of this closely similar stage of craniofacial 
morphogenesis allows for the analysis of the molecular and genetic signals that 
drive subsequent morphological changes, as well as manipulation of facial 
primordia prior to the occurrence of differential structures.  Third, given the 
conservation of the molecular genetic “toolkit” that is used to build the face 
across vertebrates, insights gained from work in evolutionary models can benefit 
human health.  For instance, expression of the gene BMP4 was first correlated 
with beak depth in Darwin’s finches (see below) (Abzhanov et al. 2004), and was 
subsequently associated with cleft lip in both humans and mice (Liu et al. 2005, 
Suzuki et al. 2009).   Thus, it is likely that genes which contribute to natural 
morphological variation will be a valuable source of candidate genes to study 
human craniofacial abnormalities, which account for approximately one third of 
congenital defects (Dixon et al. 2011). 
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Figure 1-1: Embryonic and skeletal fate of cranial neural crest cells in vertebrates, 
modified from Santagati and Rijli (2003).  (A) Schematic drawings depicting neural crest 
migration from the diencephalon, mesencephalon, and rhombomeres to embryonic pharyngeal 
arches.  The diagram is representative of chick, mouse, and human embryos, although the neural 
crest migratory pathways differ slightly in different species (Kulesa et al. 2004).  (B) The 
primordial embryonic facial structures populated by neural crest cells are highly conserved across 
vertebrates. (C) Contribution of neural crest cells to skull of humans, mice, and birds.  AN, 
angular bone; AR, articular bone; BA, basihyal; CB, ceratobranchial; CO, columella; DE, dentary 
bone; di, diencephalon; EB, epibranchial; EN, entoglossum; FNP, frontonasal process; HY, hyoid 
bone; IS, interorbital septum; JU, jugal bone; man, mandibular prominence; max, maxillary 
prominence; mes, mesencephalon; MX, maxillary bone; NA, nasal bone; NC, nasal capsule; 
PA1–PA3, pharyngeal arches 1–3; PL, palatine bone; PM, premaxillary bone; QU, quadrate; RP, 
retroarticular process; R1–R7, rhombomeres 1–7; SO, scleral ossicles; ZY, zygomatic bone.  
Embryo images in (B) courtesy of Dr. S. Brugmann (chick and mouse) and Dr. K. Sulik (human). 
 
 
Avians as a model organism 
The wide range of different adult bill shapes in birds, coupled with the 
evolutionary conservation of vertebrate facial development, makes avians an 
ideal model system for exploring the genetic differences that specify facial 
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variation.  In addition, eggs for a number of species are widely available, and the 
developing embryo is easily accessible for in vivo (in ovo) manipulations.  For 
these reasons, many of the classic studies on neural crest initiation, migration, 
patterning, and contribution to the adult face were studied in avian systems 
(Kontges and Lumsden 1996, Lumsden et al. 1991, Noden 1978, 1983, Tosney 
1982).  Much of this was possible due to the ability to make quail-chicken 
chimeras and reliably mark donor and host cells (Kontges and Lumsden 1996, Le 
Douarin 2004, 2008, Noden 1978, 1983).  The chicken, quail, and, more recently, 
the duck, are the most common experimental avian systems due to their 
availability.  The chicken and quail are closely related, with the last common 
ancestor 38.8 ± 1.3 million years ago (MYA).  The duck is more diverged, at 89.8 
± 7.0 MYA.  By comparison, these three species are 104.2 ± 2.8 million years 
diverged from nearly all other birds, including Darwin’s finches (van Tuinen and 
Hedges 2001).  However, when comparing divergent species one must be 
cautious in assigning functional relevance.  That is, what changes are causative 
in changing beak shape, and what changes are artifacts of comparing different 
genera?  Yet, importantly, nearly all birds in the order Galliformes, including the 
chicken, quail, pheasant, grouse and turkey, have narrow, conical beaks while 
the duck, goose, swan, and other members of the order Anseriformes have a 
broad, flat bill. 
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Developmental origins of the beak  
Craniofacial development begins with neural crest (NC) initiation in the 
neural folds of the forebrain and hindbrain, at the interface between the 
presumptive neural ectoderm and surface ectoderm.  Soon before neural tube 
closure, NC is specified through the integration of Bmp, Fgf, and Wnt signaling 
(Knecht and Bronner-Fraser 2002, Sauka-Spengler and Bronner-Fraser 2008).  
At the 5-6 somite stage--approximately Hamburger-Hamilton stage 9 (HH9) 
(Hamburger and Hamilton 1951)—NC cells undergo an epithelial-to-
mesenchymal transition and delaminate from the neural folds (Sauka-Spengler 
and Bronner-Fraser 2008, Tosney 1982).  Via interactions between Eph receptor 
tyrosine kinases and their Ephrin ligands (Mellott and Burke 2008), NC cells from 
the diencephalon and mesencephalon migrate as a sheet to populate the 
frontonasal prominence (FNP) and NC cells from the mesencephalon and 
rhombomeres migrate in stereotypical streams to populate the pharyngeal, or 
branchial, arches (schematized in Figure 1-1A) (Lumsden et al. 1991).  By HH14-
HH15, the embryonic facial structures have been populated by NC (Figure 1-1B) 
(Lumsden et al. 1991), which ultimately form all of the cartilage and bones of the 
face (Figure 1-1C) (Kontges and Lumsden 1996). 
 One of these embryonic structures, the frontonasal prominence (FNP, 
Figure 1-1A-B), is of particular importance in vertebrate craniofacial variance.  
This structure forms the forehead and middle of the nose in humans and is the 
predominant source of the upper beak in avians (Figure 1-1C) (Kontges and 
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Lumsden 1996, Noden 1978).  In addition, the skeletal elements most 
responsible for variation in length and width of the upper beak (prenasal cartilage 
and premaxilla, respectively) (Richman and Lee 2003) are derived from the FNP, 
implicating this prominence in determination of diversity in avian beaks.  As 
analyzed visually and quantitatively by multivariate analysis, the frontonasal 
prominences of chickens, ducks, and quails exhibit a maximum degree of 
morphological similarity at HH20 (Figure 1-2, the phylotypic stage, as noted 
above), but have become morphologically distinct and developed different growth 
trajectories by HH25 (Brugmann et al. 2010).  These differences in growth 
eventually give rise to species-specific morphologies (e.g., narrower beaks in 
chick and quail embryos vs. broader bills in duck embryos) (Brugmann et al. 
2010). 
 
 
Figure 1-2: Morphological progression of the developing beak of the chick, quail, and duck 
(Brugmann et al. 2010).  (A-C) The frontonasal prominence (f, red box) is highly similar in HH20 
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chick, quail and duck embryos. (D-I) At HH22 and HH23 the frontonasal (f) prominence remains 
indistinguishable between species. (J-L) At HH25 the frontonasal prominence (dotted red line) is 
morphologically distinct between species. While the frontonasal prominence of the chick and quail 
appears as rectangular projections, the frontonasal prominence of the duck has bilaterally 
symmetrical bulges.  (M-O) At HH27 the morphological differences between the beaks and bill 
are exacerbated and can be used to identify species.  White scale bar denotes 500 µm and black 
scale bar denotes 1 mm.  e, eye; f, frontonasal prominence; mn, mandibular prominence; mx, 
maxillary prominence.  
 
Hox patterning of the face 
 Frontonasal prominence (FNP) and first pharyngeal arch (PA1) derivatives 
are the principal components of the upper and lower face, respectively, while 
derivatives of the second and third pharyngeal arches (PA2 and PA3) have only 
minor contributions to the facial skeleton of vertebrates (Figure 1-1C).  In 
addition, PA2 or PA3 neural crest transplanted to PA1 cannot form PA1 
derivatives, but transplanted PA1 neural crest can form PA2 derivatives (Figure 
1-3D-E) (Couly et al. 1998).   This distinction between pharyngeal arches has 
been shown to be due to differences in homeobox A2 (HOXA2) gene expression 
(Figure 1-3).  This gene is expressed in PA2 and PA3, but not in regions that 
contribute to the face  (Figure 1-3A) (Hunt et al. 1991).  Loss of HOXA2 
expression in the second arch results in a homeotic transformation, with the 
second arch taking on a first arch fate and developing into duplicate maxillary 
and mandibular structures (Figure 1-3B) (Gendron-Maguire et al. 1993, Rijli et al. 
1993).  Conversely, over-expression of HOXA2 in PA1 causes this arch to take 
on a second arch fate and the loss of first arch derivatives (Figure 1-3C) (Creuzet 
et al. 2002, Grammatopoulos et al. 2000).   Further work showed that PA1 crest 
is competent for Hox gene expression, but this expression is repressed by 
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fibroblast growth factor 8 (FGF8) expression from the isthmus region at the 
border between the midbrain and rhombomere 1 (Irving and Mason 2000).  
Furthermore, transplantation of the isthmus or over-expression of FGF8 in the 
second arch phenocopies loss of HOXA2 expression and results in duplications 
of PA1 derivatives (Figure 1-3B) (Irving and Mason 2000, Noden 1983, Trainor et 
al. 2002).  Together, these experiments show that a lack of HOXA2 expression is 
critical for jaw formation.  Interestingly, the loss of HOXA2 expression in the first 
arch may have been a critical step in evolution of the vertebrate face, as jawless 
lampreys retain Hox expression in PA1 (Figure 1-3F) (Cohn 2002). 
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Figure 1-3: Hox patterning in the face (Brugmann et al. 2006a).  (A) HOXA2 expression 
distinguishes pharyngeal arches that form the face (PA1) from those that cannot (PA2-PA4). (B) 
Loss of HOXA2 expression in the second arch (PA2) via gene knock-out or FGF8 expression 
causes PA2 to adopt first arch fates. (C) Ectopic expression of HOXA2 in PA1 results in these 
cells adopting second arch fates. (D) Transplanted Hox-negative cells can form Hox-positive 
derivates.  (E) However, Hox-positive cells transplanted to PA1 cannot form the jaw.  (F) Jawless 
organisms such as lampreys retain Hox expression in PA1. fb, forebrain; mb, midbrain; mes, 
mesencephalon; PA1–PA3, pharyngeal arches 1–3; r1–r7, rhombomeres 1–7. 
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Tissue control of facial patterning 
 The frontonasal prominence and the pharyngeal arches consist of a 
mesenchymal core--neural crest cells only in the FNP (Tapadia et al. 2005), and 
predominantly neural crest cells in other structures--surrounded by epithelia, and 
reciprocal interactions between these tissues provide patterning beyond anterior-
posterior patterning by HOXA2 (Brugmann et al. 2006a). Both the endoderm and 
facial ectoderm provide patterning and positioning information to neural crest 
cells to induce them to form the cartilage and bones of the face (Couly et al. 
2002, Hu et al. 2003).  For instance, a small region of facial ectoderm, termed the 
FEZ (frontonasal ectodermal zone), consists of juxtaposed expression domains 
of fibroblast growth factor 8 (FGF8) and sonic hedgehog (SHH) and demarcates 
the dorsoventral axis of the upper beak.  Ectopic transplantation of the FEZ 
initiates reprogramming of the underlying neural crest, resulting in duplications of 
the upper and lower beak, whose polarity is entirely dependent on the orientation 
of the FEZ (Hu et al. 2003).  However, the experiments detailed below 
demonstrate that while neural crest cells receive positional information from the 
endoderm and facial ectoderm, they integrate this with the species-specific 
patterning information they contain. 
 
Neural crest cells and species-specific patterning 
Reciprocal transplantations of neural crest cells of the presumptive beak 
(midbrain and rhombomeres 1 and 2) between ducks and quails have shown that 
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neural crest cells inherently possess directions for species-specific facial 
development (Schneider and Helms 2003, Tucker and Lumsden 2004). 
Transplantation of quail neural crest cells onto a duck host (quck) resulted in a 
quail beak on a duck body (Figure 1-4C), while duck neural crest cells 
transplanted onto a quail host (duail) develop into a duck-like bill (Figure 1-4D).  
This indicates that populations of cranial neural crest cells are able to maintain 
their own molecular programs.  In addition, neural crest cells are able to alter 
gene expression patterns in non-neural crest host tissues, for instance the egg 
tooth (“et” in Figure 1-4).  This structure is epidermal in origin and used by the 
bird to crack the egg during hatching; it is thick and rounded in the quail and the 
quck (Figure 1-4F,G), while it is flat and leathery in the duck and duail (Figure 1-
4E,H) (Schneider and Helms 2003).  Overall, these experiments suggest that 
transplanted neural crest cells receive positional clues from the ectoderm and 
epithelia instructing them to make a beak, and they reply by producing their own 
type of beak. While they have revealed a cellular origin for species-specific facial 
morphology, they left unanswered how that patterning information was encoded.  
 16 
 
Figure 1-4: Cranial neural crest cells contain species-specific patterning information, 
adapted from Schneider and Helms (2003).  (A) The duck has a broad, flat bill.  (B) The quail 
has a narrower, conical bill. (C) Quail neural crest cells generate quail-like beaks in duck hosts. 
(D) Duck neural crest cells generate duck-like beaks in quail hosts.  (E-H) Sagittal sections of 
embryos from A-D.  White scale bar denotes 2 mm (A-D) and black scale bar denotes 1 mm (E-
H).  ey, orbital region; d, dentary; et, egg tooth; Mk, Meckel’s cartilage; nc, nasal capsule; np, 
nasal passage; pm, premaxilla; pp, prenasal process; v, trigeminal sensory neurons.  
 
Species-specific differences in craniofacial form 
 Recently, a number of studies have addressed the molecular basis of 
species-specificity in craniofacial structures.  Quantitative trait loci (QTLs) that 
underlie craniofacial variation have been identified in mice (Cheverud et al. 2004, 
Ehrich et al. 2003) and baboons (Sherwood et al. 2008).  In addition, many 
studies have centered on a small, East African fish known as the cichlid.  In Lake 
Malawi alone, over 500 unique species of this fish have evolved in the past 1-2 
million years (Kocher 2004); diversification of jaw structures contributed 
significantly to this adaptive radiation (Danley and Kocher 2001).  Between 1 and 
11 QTLs account for variability in different parts of the cichlid head, including  the 
dentary, premaxilla, and mandible (Albertson et al. 2003, Albertson et al. 2005).  
Bone morphogenetic protein 4 (bmp4) has emerged as one likely candidate 
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gene.  This gene underlies one of the QTL peaks (Albertson et al. 2005), exhibits 
increased amino acid substitutions in its pro-domain (Terai et al. 2002), and 
increases cartilage formation in the jaw when over-expressed in zebrafish 
(Albertson et al. 2005).  Further, cDNA microarray approaches identified two 
additional genes, cichlid metalloproteinase 1 (cimp1) and a homolog of 
microfibril-associated glycoprotein 4 (magp4), that are differentially expressed 
between cichlid jaws and may contribute to diversity via alterations in the 
extracellular matrix (Kijimoto et al. 2005, Kobayashi et al. 2006). 
 BMP4 has also received considerable attention based on studies in 
Darwin’s finches, a set of 14 closely related birds that have become a classic 
example of adaptive evolution. BMP4 is expressed at earlier stages and over a 
larger domain in the mesenchyme of finches with broad beaks (e.g. ground 
finches such as Geospiza magnirostris) than those with narrower beaks (e.g. 
cactus finches such as Geospiza scandens) (Figure 1-5) (Abzhanov et al. 2004). 
Using a cDNA microarray, it was found that broader beaks also express 
increased levels of transforming growth factor beta receptor II (TGFBR2), the 
Wnt inhibitor dickkopf homolog 3 (DKK3), and β-catenin (CTNNB1) (Mallarino et 
al. 2011), while calmodulin 1 (CALM1) expression associates with a narrower 
beak shape (Figure 1-5) (Abzhanov et al. 2006). Further, BMP4 has increased 
expression in the wide-billed duck compared to the conical beak of the chicken, 
and correlates with differential regions of proliferation to influence depth, width, 
and curvature of the beak (Wu P. et al. 2004, Wu P. et al. 2006).  While these 
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studies implicate Calmodulin, TGFβ, and Wnt signaling in differential facial 
shapes and provide valuable insight into the molecular basis of morphological 
variation, we are only just beginning to identify the gene expression changes that 
control species-specificity of cranial neural crest cells.  Additionally, these studies 
were conducted after morphological variation is evident (Abzhanov et al. 2004, 
Abzhanov et al. 2006, Brugmann et al. 2010, Wu P. et al. 2004, Wu P. et al. 
2006) and did not resolve what upstream regulators might be responsible for 
regulating differential β-catenin, BMP4, Calmodulin, DKK3, and TGFBR2 
expression. 
 
Figure 1-5: Species-specific gene expression patterns in Darwin’s finches, modified from 
Abzhanov et al. (2004) and Mallarino et al. (2011).  The ground finch (e.g. Geospiza 
magnirostris) shows earlier and broader expression of BMP4, TGFBR2, β-catenin, and DKK3 and 
develops a broad beak, whereas the cactus finch (e.g. Geospiza scandens) shows increased 
expression of Calmodulin and develops an elongated beak. pmx, premaxilla; pnc, prenasal 
cartilage. 
 
microRNAs in facial development 
 An additional level of gene regulation is controlled by microRNAs 
(miRNAs), 19-25 nucleotide-long RNAs that affect gene expression via mRNA 
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degradation or translational inhibition.  These short RNAs have been implicated 
in a wide range of regulatory roles in development and differentiation, including 
cellular proliferation, migration, differentiation, apoptosis, and epithelial-
mesenchymal transitions (all of which also occur in the developing face) (Stefani 
and Slack 2008). Like transcription factors, miRNAs regulate hundreds of target 
genes, and they do so by specifically (but imperfectly) binding the 3’ UTR of gene 
transcripts (Hobert 2008).  miRNAs are thought to function during development to 
confer robustness by repressing leaky transcription (Hornstein and Shomron 
2006), fine tuning gene expression levels to optimal ranges (Cohen et al. 2006, 
Hornstein and Shomron 2006, Wu C. I. et al. 2009), sharpening spatial and 
temporal expression patterns (Levine E. et al. 2007), and acting as a “clean-up” 
mechanism to avoid formation of a mixed developmental fate (Giraldez et al. 
2006).  Intriguingly, miRNAs may have a role in species-specific diversification as 
well.  While humans (Chen and Rajewsky 2006) and mice (Hiard et al. 2010) 
show negative selection against mutations that destroy conserved miRNA 
binding sites, the morphologically divergent cichlids of Lake Malawi have 
increased levels of polymorphism in predicted miRNA binding sites within 3’ 
UTRs (Loh et al. 2011).  However, the divergence times within these lineages 
vary drastically-- approximately 370,000 years for humans (Noonan et al. 2006), 
23 million years for mice (Adkins et al. 2001), and 1-2 million years for cichlids 
(Kocher 2004). 
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 MicroRNAs also appear to be essential for normal facial development.  
Conditional knockout of the miRNA processing gene Dicer1 in Wnt1-expressing 
tissues (which include the neural crest [NC]) results in severe craniofacial 
malformations in mice due to nearly complete ablation of all crest-derived facial 
bones (Figure 1-6) (Huang et al. 2010, Zehir et al. 2010). Importantly, NC cells 
migrate normally in these Dicer mutant animals, demonstrating that miRNAs are 
likely necessary for neural crest survival and differentiation (Zehir et al. 2010).  
To date, only one miRNA has been correlated with a known function in facial 
development.  miR-140 negatively regulates platelet derived growth factor 
receptor alpha (pdgfra) during palatogenesis in zebrafish, and loss of this miRNA 
causes cleft palate due a defect in NC migration (Eberhart et al. 2008).  Recently, 
a single nucleotide polymorphism (SNP) that affects the processing of miR-140 
has been identified in human cases of nonsyndromic cleft palate (Li et al. 2010), 
reinforcing how insights gained from model systems can be readily translated to 
human biology.  While some of the microRNAs expressed during facial 
development are known (Eberhart et al. 2008, Mukhopadhyay et al. 2010), the 
potential roles of microRNAs in facial development and species-specific facial 
variation are largely unknown.  
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Figure 1-6.  Loss of microRNAs result in dramatic craniofacial malformations, adapted 
from Huang et al. (2010).   (A-B) Compared to control mice (A), mice with conditional knock-out 
(CKO) of DICER in neural crest cells (B) have severe facial abnormalities.  (C-F) Embryos from 
(A-B) stained with Alizarin Red and Alcian Blue.  Scale bar denotes 2 mm. a, atlas; as, 
alisphenoid; bo, basioccipital; bs, basisphenoid; d, mandible; e, exoccipital; f, frontal; ip, 
interparietal; n, nasal; nc, nasal capsule; o, otic capsule; p, parietal; pl, palatine; ps, presphenoid; 
px, premaxilla; s, supraoccipital; x, maxilla.  
 
 
Future directions 
 Craniofacial abnormalities are among the most common birth defects, 
accounting for approximately one third of congenital abnormalities (Dixon et al. 
2011).  Targeted mutagenesis in animal models such as the mouse have 
provided important information on the effects of single genes in defects such as 
cleft lip and/or palate and craniofacial development in general.  However, we still 
lack a comprehensive description of the spectrum of molecular genetic players, 
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including microRNAs, in vertebrate facial development.  We also have only a 
very rudimentary description of the genes and pathways that underlie species-
specific variation in facial structures.  Using custom, cross-species microarrays, I 
first identified the set of transcription factors and developmental signaling 
pathways that differ in neural crest cells of the embryonic upper beak in chickens, 
quails, and ducks. I then conducted unbiased deep sequencing to 
comprehensively analyze the microRNA transcriptome of the samples, in the first 
large-scale evaluation of miRNA expression in the duck and quail, and the first 
investigation of the role of miRNAs in species-specific facial development.  
Finally, I functionally analyzed differentially expressed mRNA and miRNA genes 
through viral over-expression and Western blots.  I further evaluated the 
application of these data sets as candidate genes to investigate human 
craniofacial abnormalities.  Understanding the molecular mechanisms that 
control natural craniofacial variation in the avian beak enhances our insights into 
variations that underlie adaptive evolution, and may serve as a novel source of 
candidate genes for studies of mammalian craniofacial development. 
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CHAPTER 2 
Microarray Gene Expression Profiles of Chicken,  
Quail, and Duck Frontonasal Neural Crest Cells 
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Introduction 
Both mammals and birds exhibit remarkable morphological variation in 
craniofacial structures, particularly in those derived from the frontonasal 
prominence (FNP), the structure that forms the upper beak of the bird (Figure 1-
1) (Kontges and Lumsden 1996, Noden 1978).  Cranial neural crest (NC) cells of 
the FNP give rise to the facial bones and cartilage in both species (Kontges and 
Lumsden 1996, Noden 1978), and have been shown in avians to contain 
molecular information that regulates species-specific facial variation (Schneider 
and Helms 2003, Tucker and Lumsden 2004).  However, these studies did not 
resolve how that patterning information was actually encoded.  Subsequent 
studies in birds (Abzhanov et al. 2004, Abzhanov et al. 2006, Mallarino et al. 
2011, Wu et al. 2004, Wu et al. 2006) and fish (Albertson et al. 2005, Terai et al. 
2002) identified two genes involved in regulating species-specific growth of facial 
prominences.  BMP4 has increased expression levels in Darwin’s finches with 
broad beaks (Abzhanov et al. 2004), while CALM1 is up-regulated in finches that 
exhibit an elongated beak morphology (Abzhanov et al. 2006).  While these 
studies demonstrated that modulations in these genes can alter beak 
morphology, they were conducted after morphological variation is evident and did 
not clarify whether these genes are initiating morphological changes or whether 
their expression is simply changing in response to an upstream mediator.    
Therefore, I sought to identify the set of transcription factors and signaling 
molecules that differ during embryonic development of the avian face in three 
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bird species (chicken, quail, and duck) that exhibit very different facial 
adaptations than Darwin’s finches.  My objective was to identify early mediators 
of species-specific craniofacial morphology, at stages prior to morphological 
variation and differential BMP4 and CALM1 expression, and to identify a set of 
genes that may play major roles in driving vertebrate facial development and 
evolution.   
 For this study, our collaborators first determined when the chicken, quail, 
and duck begin to demonstrate species-specific morphological differences 
(Brugmann et al. 2010).  Based on these results, I was able to restrict my studies 
to the embryonic period preceding (HH20) and following (HH25) morphological 
variation (Figure 1-2), and to the relevant cellular population (the FNP neural 
crest).  I used custom, cross-species microarrays (Hawkins et al. 2003, Hawkins 
et al. 2007, Messina et al. 2004) to identify the developmental signaling pathway 
and transcription factor gene expression changes that differ between cranial 
neural crest cells in the developing beaks of chickens, quails, and ducks.  
Through a combination of DNA sequencing and BLAST comparisons of known 
chicken, quail, and duck gene sequences, I determined that sequence 
divergence is likely not a major source of error in my microarray data.  I verified a 
number of changes in gene expression using RNA in situ hybridization and 
reverse transcription PCR (RT-PCR).  Finally, I analyzed gene expression 
changes in duck and chicken wing buds and hearts to analyze the specificity of 
the gene expression changes I identified in the developing face.  
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RESULTS 
Cross-species microarray analysis  
 To identify the differences in expression that may be responsible for the 
morphological variation between the species, I measured changes in gene 
expression among frontonasal neural crest samples from three birds (chickens, 
quails, and ducks) at two different developmental stages. Our collaborators 
micro-dissected frontonasal neural crest samples both before (HH20) and after 
(HH25) morphological distinctions between the species are evident (Brugmann et 
al. 2010).  Commercially available chicken microarray gene chips (e.g. 
Affymetrix) are not suitable for cross-species comparisons, given that they 
require 100% conservation across probes or are designed to the 3’ UTR of 
genes, which have high divergence rates.  Therefore, I utilized a custom, cross-
species microarray platform (Hawkins et al. 2007, Messina et al. 2004). In all, 
expression changes were measured for approximately 2,400 genes, 
encompassing nearly all known or predicted transcription factors (TFs) (Messina 
et al. 2004) and developmental signaling pathways (see Materials and 
Methods). 
For each species, the early (HH20) was compared to the later (HH25) 
developmental stage.  Stage-matched comparisons were also performed for 
each pair of bird species at both HH20 and HH25. A minimum of four 
separate microarray hybridizations (two comparisons and two dye switches) were 
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conducted for each comparison; for interspecies comparisons, six to nine 
microarrays were analyzed. A total of 55 array comparisons were conducted for 
this study.   All microarray analysis is described in Materials and Methods.     To 
assess the similarity and quality of replicate microarray experiments, I performed 
unsupervised hierarchical clustering using the dChip software package (Figure 2-
1).   This analysis showed that replicate microarray chips show a high degree of 
data reproducibility.  For instance, all microarray comparisons of chicken versus 
quail samples were most similar to each other than they were to any other 
microarray comparisons. 
 
 
Figure 2-1: Unsupervised hierarchical clustering of microarray comparisons.    All 55 
microarray comparisons are across the top, connected by a tree representing the similarity of 
their gene expression patterns.  A small sample of genes interrogated is shown on the right. 
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Differential gene expression among frontonasal neural crest of three avian 
species 
 I detected 232 differentially expressed genes in any two-species 
comparison at either developmental stage (>2-fold change and p-values<0.05; 
see Figure 2-2 for examples and Table 2-1 for a complete listing).  This number 
is almost certainly an underestimate since it includes only those genes that have 
clearly identifiable orthologs in the Gallus gallus genome (International Chicken 
Genome Sequencing Consortium 2004).  Unfortunately, it appears that 
approximately 10% of chicken orthologs are still missing from the published 
genomic DNA sequence (Hawkins et al. 2003, International Chicken Genome 
Sequencing Consortium 2004).  For example, the Wnt10b microarray probe, 
designed from the mouse Wnt10b gene, reported a >20-fold increase in 
transcript levels in duck versus chicken, or duck versus quail, NC cells.   
However, we could not computationally identify a clear Wnt10b ortholog in the 
chicken genome and thus filtered out data of that type.  The 102 genes with 
unclear orthologs in the Gallus gallus genome are listed in Table 2-2, but not 
discussed in the sections below.   Note that full gene names not listed in text or 
Tables 2-1 and 2-2 can be found at NCBI GEO 
(http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE11099. 
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Figure 2-2: Examples of differentially expressed genes.  Average relative fold change at 
HH20 and HH25 between frontonasal neural crest cells of chickens, quails, and ducks for 
components of (A) Wnt signaling, (B) the TGF-beta/BMP family, (C) FGF pathway, (D) genes 
previously implicated in craniofacial development, and (E) miscellaneous genes of interest. Fold 
changes are expressed as duck relative to chicken or quail, where genes with a negative fold 
change are expressed at lower levels in the duck versus either chicken or quail.  For a complete 
listing of genes, see Table 2-1. 
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AEBP2 AE(adipocyte enhancer) -binding protein 2 XM_416415 -2.39 
1.7E-
03 -2.14 
3.3E-
04 0.00 0.00 0.00 0.00 -1.55 
2.6E-
04 -1.60 
1.5E-
04 
ALDH3A2 aldehyde dehydrogenase 3 family, member A2 
NM_001006
223 0.00 0.00 0.00 0.00 -1.71 
5.2E-
04 -1.38 
2.0E-
04 1.97 
1.0E-
04 1.95 
1.8E-
03 
AMOT angiomotin XM_420309 0.59 0.012 0.67 0.012 -0.44 2.1E-03 -0.79 
2.5E-
03 1.07 
5.0E-
04 1.12 
5.1E-
04 
ANAPC2 anaphase-promoting complex subunit 2 XM_415533 0.24 0.079 0.39 
1.7E-
03 -0.45 0.021 -0.08 0.52 0.74 
1.3E-
03 1.15 
7.6E-
05 
ARC 
activity-regulated 
cytoskeleton-associated 
protein 
NM_204432 -0.82 0.24 -1.14 6.9E-03 -1.14 
6.8E-
03 -0.25 0.59 -0.05 0.89 -0.91 
9.5E-
04 
ARNT2 aryl-hydrocarbon receptor nuclear translocator 2 XM_413854 -2.13 
5.8E-
03 -1.60 
1.4E-
04 -1.83 
1.3E-
03 -1.71 
1.1E-
03 -0.45 0.025 -0.35 0.031 
ASCL1 achaete-scute complex (Drosophila) homolog-like 1 U01339 -1.01 
5.7E-
04 -0.94 
1.0E-
03 0.05 0.74 0.37 0.017 -1.09 
4.0E-
03 -1.20 0.015 
ATF7 activating transcription factor 7 XR_026691 -1.61 
3.3E-
04 -1.34 
8.2E-
04 -0.36 0.28 -0.65 
7.6E-
03 -0.81 
8.9E-
03 -0.77 0.010 
BANP BTG3 associated nuclear protein XM_414196 -2.34 
5.6E-
04 -1.89 
1.5E-
07 -2.68 
1.4E-
05 -2.68 
7.7E-
07 -0.25 0.057 1.05 
1.8E-
03 
BATF basic leucine zipper transcription factor, ATF-like XM_421279 1.49 0.016 1.15 
3.7E-
03 0.91 0.015 1.25 0.011 0.26 0.41 -0.61 
8.8E-
03 
BC052269 zinc finger and BTB domain containing 46 (ZBTB46) XM_417431 -1.59 
6.3E-
04 -1.36 
2.5E-
05 -0.87 0.054 -0.86 
4.6E-
04 -1.03 
1.8E-
04 -0.75 
1.7E-
03 
BC052625 zinc finger protein ZNF467 XM_001235894 0.79 
9.2E-
04 0.68 
1.5E-
04 1.23 
2.2E-
06 1.04 
3.0E-
04 0.00 0.00 0.00 0.00 
BCL6B 
B-cell CLL/lymphoma 6, 
member B (zinc finger 
protein) 
NM_001012
930 -1.70 
8.4E-
06 -1.05 
6.5E-
07 -0.31 0.12 0.28 0.29 -1.36 
3.7E-
03 -1.00 
1.7E-
03 
Bmp10 bone morphogenetic protein 10 XM_417667 -0.88 0.24 -0.87 0.47 -1.53 0.033 -1.33 0.067 0.43 0.51 -0.18 0.73 
Bmp2 bone morphogenetic protein 2 NM_204358 -0.67 0.12 -0.26 0.37 -1.85 
2.6E-
05 -2.54 
1.1E-
08 1.44 
7.9E-
03 1.41 
7.6E-
05 
Bmp9 bone morphogenetic protein 9 NM_205432 -0.01 0.93 0.06 0.51 -0.88 
2.8E-
03 -1.08 
5.4E-
04 0.81 
4.8E-
04 0.80 
1.8E-
04 
Bmpr1a bone morphogenetic protein receptor, type 1A NM_205357 -1.10 
6.5E-
04 -0.33 0.042 0.77 0.15 0.42 0.17 -1.30 
2.4E-
05 -0.73 0.010 
BRD3 bromodomain-containing 3 XM_425330 0.00 0.00 0.00 0.00 -2.71 1.7E-05 -3.07 
4.8E-
05 2.33 
1.5E-
03 2.48 
3.9E-
04 
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BRD9 bromodomain containing 9 XM_418893 2.38 6.1E-05 2.26 
2.1E-
05 3.21 
4.5E-
07 2.94 
7.1E-
05 -1.15 
4.2E-
03 -1.13 
8.8E-
04 
BS69 adenovirus 5 E1A binding protein (ZMYND11) XM_418557 1.40 
6.1E-
04 0.51 0.053 0.45 0.16 0.37 
6.9E-
03 -0.52 0.20 0.05 0.83 
BTF3L2 basic transcription factor 3 XM_423823 1.49 4.9E-04 1.46 
3.6E-
04 1.07 
7.9E-
03 1.02 
1.3E-
04 0.46 0.066 0.75 
8.6E-
03 
BTK 
Bruton 
agammaglobulinemia 
tyrosine kinase 
NM_204233 2.70 6.6E-04 1.96 
2.9E-
06 2.05 
1.7E-
06 1.82 
1.2E-
04 0.11 0.73 0.04 0.81 
C3IP1 kelch-like 12 (Drosophila) (KLJL12) XM_419251 3.40 
2.2E-
06 3.23 
2.8E-
07 3.55 
1.6E-
05 2.75 
4.8E-
04 0.00 0.00 0.00 0.00 
CALM2 
calmodulin 2 
(phosphorylase kinase, 
delta) 
NM_205005 -1.39 3.7E-04 -1.00 
7.0E-
04 -2.26 
4.6E-
05 -2.02 
5.5E-
06 1.58 
2.6E-
03 1.54 
2.0E-
05 
CBFA2T3 
core-binding factor, runt 
domain, alpha subunit 2; 
translocated to, 3 
NM_001030
580 0.00 0.00 0.00 0.00 -1.85 0.038 -1.98 
1.4E-
05 2.91 
8.7E-
03 1.25 0.033 
CCNB2 G2/mitotic-specific cyclin B2 NM_001004369 -0.67 
4.6E-
03 -0.81 
6.4E-
04 0.46 
2.7E-
03 0.52 0.017 -1.07 
5.3E-
04 -1.33 
2.7E-
03 
CCND2_H
uman G1/S-specific cyclin D2 NM_204213 -1.26 
2.0E-
03 -1.35 
7.7E-
04 0.01 0.97 -0.34 0.022 -1.10 
6.6E-
03 -0.96 
2.3E-
03 
CDC2 cell division control protein 2 NM_205314 -0.81 0.17 -1.39 3.1E-05 0.05 0.90 0.01 0.91 -0.47 0.037 -1.00 
8.4E-
04 
CDK5 cyclin-dependent kinase 5 CR353821 0.56 0.019 0.63 4.8E-04 -0.04 0.79 -0.45 
5.7E-
03 0.57 
7.5E-
03 1.00 
1.9E-
04 
CDKN2C_
Chick 
cyclin-dependent kinase 6 
inhibitor (P18-INK6), cyclin-
dependent kinase 4 inhibitor 
C (P18-INK4C) 
XM_426660 -0.83 1.7E-04 -0.69 
1.8E-
03 1.01 
3.0E-
03 0.72 
3.6E-
04 -1.62 
3.8E-
06 -1.51 
2.2E-
04 
CDKN3 cyclin-dependent kinase inhibitor 3 BX933305 0.68 
8.9E-
03 0.41 0.014 -0.72 0.16 -0.82 
4.7E-
03 1.12 
7.3E-
03 1.30 
1.5E-
03 
CITED2 
Cbp/p300-interacting 
transactivator, with Glu/Asp-
rich carboxy-terminal 
domain, 2 
NM_206844 0.31 0.25 0.63 2.4E-03 1.16 0.039 1.04 
6.2E-
03 -0.12 0.76 0.10 0.63 
CKS1B 
cyclin-dependent kinases 
regulatory subunit 1 (CKS-1) 
(SID1334) (PNAS-16 / 
PNAS-143) 
NM_001112
806 0.52 
6.2E-
03 1.15 
8.4E-
07 0.56 
2.7E-
03 0.50 
1.5E-
05 -0.07 0.47 0.29 
2.4E-
03 
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Cks2 cyclin-dependent kinases regulatory subunit 2 (CKS-2) 
XM_0012319
66 -1.26 
2.0E-
03 2.41 
3.4E-
05 2.45 
2.8E-
08 2.51 
9.2E-
07 0.04 0.91 0.07 0.78 
COL5A1 collagen, type V, alpha 1 U39621 -0.78 0.14 0.11 0.43 -1.34 8.9E-06 -0.59 0.12 1.01 0.11 1.10 0.012 
CREB3L2 cAMP responsive element binding protein 3-like 2 XM_416356 0.84 
6.8E-
03 0.86 
1.1E-
04 1.31 
1.2E-
05 1.09 
1.3E-
04 -0.44 0.081 -0.24 0.10 
CREBL2 cAMP responsive element binding protein-like 2 
XM_0012313
05 -3.04 
1.7E-
04 -2.44 
8.4E-
07 -1.63 
4.4E-
03 -1.69 
2.1E-
04 -1.98 
1.1E-
03 -1.24 
1.9E-
03 
CRIP1 cysteine-rich protein 1 (intestinal) BX934543 -1.11 0.040 -1.19 
9.7E-
04 -0.25 0.052 -0.66 0.074 -1.10 
2.3E-
03 -0.48 
3.1E-
03 
DKK2 dickkopf homolog 2 XM_420494 4.48 1.8E-03 3.65 0.023 4.37 0.045 4.53 
6.4E-
04 0.00 0.00 0.00 0.00 
E2F4 E2F transcription factor 4, p107/p130-binding 
XM_0012319
47 -1.87 
1.4E-
05 -1.43 
8.6E-
07 -0.03 0.89 -0.55 
4.2E-
03 -0.98 0.041 -0.86 
1.7E-
04 
EED embryonic ectoderm development 
NM_001031
376 0.30 0.40 -0.10 0.58 -0.72 
4.6E-
03 -0.72 0.015 1.24 
2.9E-
03 0.39 0.17 
EGR2 early growth response 2 AF291747 0.24 0.39 0.43 0.010 -1.94 4.0E-05 -2.50 
3.4E-
07 1.61 
6.7E-
04 1.93 
2.7E-
04 
ELL elongation factor RNA polymerase II 
NM_001012
847 1.85 0.054 1.67 0.082 3.17 
9.7E-
05 3.53 
5.9E-
03 -1.32 0.017 -1.90 
5.2E-
04 
EOMES eomesodermin (Xenopus laevis) homolog XM_426003 0.32 0.40 0.66 0.022 -0.30 0.58 -1.02 0.017 1.56 0.064 1.74 
2.0E-
04 
ETS2 
v-ets avian erythroblastosis 
virus E26 oncogene 
homolog 2 
NM_205312 0.04 0.82 -0.39 4.6E-03 -1.53 
2.6E-
04 -1.01 
9.4E-
03 0.77 0.037 0.84 
2.0E-
04 
ETV4 
ets variant gene 4 (E1A 
enhancer-binding protein, 
E1AF) 
XM_418106 -1.09 3.4E-03 -0.17 0.21 0.31 0.045 -0.50 
7.8E-
05 -1.20 
2.1E-
05 0.11 0.43 
EVI1 ecotropic viral integration site 1 XM_422804 1.13 
8.9E-
03 0.65 
7.6E-
04 1.73 
3.4E-
04 1.93 
1.3E-
04 -0.68 0.011 -1.03 
9.3E-
04 
FBI1 
HIV-1 inducer of short 
transcripts binding protein; 
lymphoma related factor 
NM_204680 2.13 8.7E-05 2.24 
6.2E-
07 2.07 
3.6E-
07 1.69 
1.9E-
04 0.30 0.40 0.36 0.080 
Fgf10 fibroblast growth factor 10 NM_204696 1.04 2.3E-04 0.83 
6.5E-
05 0.86 
3.3E-
03 0.65 0.019 0.29 
2.7E-
03 -0.05 0.49 
Fgf13 fibroblast growth factor 13 
NM_001001
743 
XM_420238 
1.35 0.020 1.18 6.3E-03 1.75 
3.3E-
03 1.83 
1.4E-
06 -0.14 0.46 -0.19 0.29 
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Fgf16 fibroblast growth factor 16 NM_001044650 2.53 
2.4E-
05 2.51 
1.3E-
06 2.65 
1.8E-
08 2.97 
2.5E-
09 0.00 0.00 0.00 0.00 
Fgf2 fibroblast growth factor 2 NM_205433 0.46 0.022 0.09 0.53 -1.16 8.4E-03 -0.94 0.014 1.85 
2.2E-
03 1.71 
4.6E-
04 
Fgf4 fibroblast growth factor 4 NM_001031546 -0.27 0.078 -0.31 
6.1E-
05 -1.89 
8.9E-
04 -1.96 
1.1E-
03 1.28 
3.8E-
03 1.21 
7.6E-
03 
Fgf7 fibroblast growth factor 7 NM_001012525 1.23 
1.0E-
03 0.73 
8.1E-
05 -0.39 0.21 0.25 0.16 1.70 
8.3E-
05 0.67 
5.2E-
04 
Fgf9 fibroblast growth factor 9 NM_204399 -0.98 1.1E-04 -0.89 
1.3E-
05 -2.64 
2.0E-
07 -2.24 
3.2E-
05 1.02 
7.9E-
05 1.41 
7.4E-
05 
Fgfr2 fibroblast growth factor receptor 2 NM_205319 0.19 0.26 -0.61 
2.9E-
05 -0.68 
5.5E-
03 -1.18 
1.6E-
04 1.09 
3.4E-
04 0.63 0.025 
FLJ10895 cyclin J (CCNJ) XM_421691 1.00 1.1E-03 0.75 
7.3E-
05 0.98 
7.1E-
05 1.04 0.021 -0.25 0.15 -0.40 0.10 
FLJ11040 mitochondrial Rho 1 (MIRO-1) 
NM_001006
208 -0.18 0.24 0.04 0.66 -1.40 
5.0E-
06 -1.50 
2.5E-
04 1.33 0.052 1.72 
1.1E-
03 
FLJ11078 kelch-like 26 (Drosophila) (KLJL26) XM_418239 3.15 
1.9E-
05 3.25 
6.6E-
08 2.14 
8.8E-
09 2.37 
1.5E-
05 1.08 0.018 1.39 
2.7E-
03 
FLJ12517 jumonji domain containing 4 (JMJD4) 
NM_001030
959 2.30 
2.5E-
04 2.02 
9.3E-
06 2.91 
1.0E-
05 3.12 
5.5E-
06 -1.01 0.026 -0.94 0.010 
FLJ36155 GLIS family zinc finger 1 (GLIS1) XM_422485 0.50 
3.4E-
03 0.33 0.021 -0.78 
2.1E-
04 -1.24 
2.5E-
05 1.27 
8.8E-
05 1.62 
6.6E-
04 
FMR2 fragile X mental retardation 2 XR_027199 0.14 0.48 0.00 1.00 -1.51 
3.0E-
04 -1.92 
3.1E-
03 0.97 0.038 2.04 0.023 
FOXC2 forkhead box C2 (MFH-1, mesenchyme forkhead 1) NM_205138 1.01 0.014 0.95 
5.8E-
07 1.74 
1.0E-
05 1.54 
6.6E-
07 -0.68 0.18 -0.25 0.087 
FOXO3A forkhead box O3A XM_001234495 -1.05 0.016 -1.24 
1.6E-
04 -0.23 0.31 -0.16 0.65 -0.47 0.19 -1.27 
1.7E-
03 
FREQ frequenin homolog (Drosophila) NM_205377 -0.86 
7.9E-
03 -0.37 
2.7E-
03 0.65 
2.5E-
03 0.78 
7.6E-
04 -1.32 
9.7E-
05 -1.19 
7.1E-
05 
Fzd1 frizzled homolog 1 NM_001030337 4.65 
2.6E-
06 4.18 
1.1E-
08 3.96 
2.7E-
07 4.29 
7.2E-
07 0.00 0.00 0.00 0.00 
Fzd3 frizzled homolog 3 XM_420029 -0.74 2.0E-03 -1.64 
5.7E-
06 -0.20 0.39 -0.04 0.85 -0.11 0.79 -1.34 
3.1E-
03 
Fzd5 frizzled homolog 5 AF463494 -1.13 3.8E-04 -0.66 
4.2E-
04 -0.67 
1.7E-
03 -0.71 
1.3E-
04 -0.07 0.67 0.06 0.28 
Fzd7 frizzled homolog 7 NM_204221 -1.59 1.3E-03 -1.04 
7.1E-
05 -1.58 
1.0E-
05 -1.69 
8.9E-
04 0.29 0.057 0.68 
2.0E-
03 
 
 
 42 
ProbeID Description 
NCBI 
Accession 
Chick D
C
 H
H
20
 
A
ve
 F
ol
d 
D
C
 H
H
20
 
P-
Va
lu
e 
D
C
 H
H
25
 
A
ve
 F
ol
d 
D
C
 H
H
25
 
P-
va
lu
e 
D
Q
 H
H
20
 
A
ve
 F
ol
d 
D
Q
 H
H
20
 
P-
va
lu
e 
D
Q
 H
H
25
 
A
ve
 F
ol
d 
D
Q
 H
25
 
P-
va
lu
e 
Q
C
 H
H
20
 
A
ve
 F
ol
d 
Q
C
 H
H
20
 
P-
va
lu
e 
Q
C
 H
H
25
 
A
ve
 F
ol
d 
Q
C
 H
H
25
 
P-
va
lu
e 
GATA6 GATA-binding protein 6 NM_205420 -0.90 0.072 -1.07 5.5E-04 -0.16 0.59 -0.55 0.092 -0.18 0.58 -1.12 
9.3E-
04 
gCDH23 cadherin-related 23 protein (otocadherin) XM_421595 0.02 0.96 0.08 0.19 -0.77 0.010 -0.88 
2.5E-
03 0.78 0.038 1.01 
4.3E-
03 
gCLDN14 claudin 14 XM_425552 -1.30 0.020 -0.48 0.011 -0.90 0.012 -1.15 1.6E-03 0.11 0.53 0.68 0.028 
GCN5L2 
GCN5 (general control of 
amino-acid synthesis, yeast, 
homolog)-like 2 
NM_204329 0.23 0.051 0.02 0.95 1.97 1.2E-04 1.97 0.020 -1.31 
8.1E-
04 -1.21 0.037 
gCREB3 cAMP responsive element binding protein 3 XM_425893 -1.11 0.022 -0.55 0.12 -0.50 0.095 -0.56 0.065 -0.25 0.45 -0.03 0.91 
gGJB5 gap junction protein, beta 5 (connexin 31.1) XM_425784 1.02 
5.8E-
03 1.47 
1.0E-
04 1.18 0.045 1.21 
8.4E-
03 0.00 0.00 0.00 0.00 
gHES1 hairy and enhancer of split 1 NM_204472 1.28 2.8E-03 1.50 
7.5E-
05 1.17 
9.7E-
04 1.06 
2.4E-
03 0.40 0.047 0.57 
2.7E-
03 
gHES5 hairy and enhancer of split 5 NM_001012695 -1.21 0.027 -0.79 
8.6E-
03 -0.67 0.091 -0.65 0.088 -0.59 0.086 -0.36 0.25 
gID3 inhibitor of DNA binding 3 NM_204589 -0.35 0.14 0.16 0.015 -0.89 0.025 -1.04 0.010 0.88 7.0E-03 0.92 
4.7E-
03 
gID4 inhibitor of DNA binding 4 NM_204282 -1.06 0.029 -0.39 0.32 -0.47 0.25 -0.23 0.27 -0.49 0.22 -0.18 0.34 
gMADH1 
mothers against 
decapentaplegic homolog 1 
(SMAD1) 
XM_420428 -0.26 0.55 0.29 0.37 2.36 8.0E-03 2.66 
3.9E-
04 -2.17 
1.6E-
03 -2.26 
1.0E-
03 
gNog noggin NM_204123 0.46 3.2E-03 0.66 
2.6E-
05 -1.78 
1.7E-
04 -1.89 
2.7E-
05 2.41 
1.8E-
04 2.42 
5.9E-
06 
gNUP153 nucleoporin 153kDa XM_418937 -5.11 7.7E-04 -5.17 
2.0E-
03 0.00 0.00 0.00 0.00 -4.66 
1.8E-
03 -5.19 
3.0E-
05 
gOSR2 odd-skipped related 2 XM_001234796 -2.20 
1.6E-
03 -1.52 
9.4E-
04 -0.61 
6.2E-
03 -0.72 
2.4E-
03 -1.58 
1.4E-
03 -1.41 
8.3E-
03 
GPA33 glycoprotein A33 (transmembrane) XM_416656 -0.88 
5.1E-
04 -1.14 
3.6E-
06 -0.68 0.26 -0.78 
4.9E-
03 -0.89 0.15 -0.08 0.65 
gPAX1 paired box gene 1 U22046 -1.49 0.028 -1.26 1.8E-05 0.41 0.11 0.29 0.12 -1.57 
7.8E-
03 -1.72 
1.2E-
03 
gPAX9 paired box gene 9 NM_204912 -1.74 0.011 -1.16 5.1E-04 0.25 0.23 0.09 0.66 -1.65 
2.3E-
03 -1.35 
1.3E-
03 
gPOU4F3 POU domain, class 4, transcription factor 3 NM_204759 -1.25 0.019 -1.31 
7.3E-
04 -0.49 0.064 -0.70 0.010 -0.55 0.023 -0.63 0.059 
GPRC5C G protein-coupled receptor, family C, group 5 member C XM_425386 -0.91 
5.1E-
03 -0.55 0.010 -1.11 
5.1E-
04 -1.21 
3.2E-
05 0.37 0.40 0.38 0.10 
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GTF3C1 
general transcription factor 
IIIC, polypeptide 1 (alpha 
subunit, 220kD ) 
XR_027220 2.80 2.4E-04 2.15 
3.0E-
05 2.31 
6.5E-
05 2.21 
1.1E-
04 0.00 0.00 0.00 0.00 
gTGFB3 transforming growth factor, beta 3 NM_205454 -1.32 0.14 -0.68 0.11 -1.91 0.030 -2.19 0.017 0.77 0.21 1.18 0.065 
HAND1 heart and neural crest derivatives expressed 1 NM_204965 -1.18 
5.9E-
04 -1.14 
2.6E-
03 0.35 0.18 0.19 0.27 -1.05 
1.1E-
04 -1.46 
7.7E-
05 
HEY1 hairy/enhancer-of-split related with YRPW motif 1 XM_425926 -1.34 0.036 -1.06 
8.4E-
04 -2.08 
5.2E-
05 -2.84 
1.3E-
03 0.13 0.52 0.55 
2.4E-
03 
HIC1 hypermethylated in cancer 1 NM_205236 -1.21 2.9E-05 -1.11 
7.0E-
07 -0.51 0.15 -0.33 0.28 -0.61 0.041 -0.79 
7.1E-
05 
HMG1 high-mobility group box 1 (HMGB1) NM_204902 0.24 0.13 0.47 
1.9E-
03 -0.39 
9.3E-
03 -0.31 0.14 1.27 0.029 0.92 
3.0E-
03 
HMG20A high-mobility group 20A NM_001030394 -0.25 0.048 -0.34 0.017 0.58 
2.6E-
03 0.70 
2.5E-
04 -0.60 
2.0E-
04 -1.26 
2.4E-
03 
HMGIC high mobility group AT-hook 2 (HMGA2) NM_205001 -1.42 
2.2E-
03 -0.84 
1.4E-
03 0.77 
3.9E-
04 0.71 0.072 -1.10 0.026 -1.50 
1.1E-
04 
HNF1A transcription factor 1, hepatic 
NM_001030
668 -0.41 0.18 0.00 0.99 0.47 0.067 0.32 0.059 -1.06 
7.3E-
03 -0.34 0.048 
HNF4A hepatocyte nuclear factor 4, alpha 
NM_001030
855 0.00 0.00 0.00 0.00 -2.19 
2.5E-
07 -2.32 
2.3E-
06 1.32 0.021 2.27 
1.7E-
03 
HOX11 T-cell leukemia, homeobox 1 (TLX1) NM_205015 1.47 0.020 1.00 0.032 1.20 
6.7E-
03 1.33 
1.5E-
03 0.44 0.23 -0.38 0.38 
HOXA3 homeobox A3 NM_204548 0.45 0.42 0.28 0.51 0.58 0.21 1.03 0.021 -0.56 0.37 -0.46 0.24 
HOXB6 homeobox B6 BX931212 -1.74 6.0E-04 -1.18 
2.5E-
06 0.12 0.52 -0.17 0.51 -1.25 
6.3E-
03 -1.06 
4.3E-
03 
HRIHFB21
22 
TRIO and F-actin binding 
protein (TRIOBP or TARA) XM_416272 -1.55 0.022 -1.16 
3.4E-
03 -0.10 0.68 -0.03 0.88 -1.55 0.080 -1.94 
4.0E-
03 
HSHPX5 msh homeobox 2 NM_204559 -1.67 5.2E-04 -1.29 
2.9E-
04 -1.23 
1.4E-
03 -1.25 0.030 -0.74 
6.7E-
03 -0.03 0.88 
HSPC063 zinc finger and BTB domain containing 44 (ZBTB44) XM_417873 1.63 
3.0E-
03 1.61 
1.2E-
03 2.07 0.013 2.58 
6.1E-
04 -0.22 0.34 -0.68 
7.3E-
03 
HSPX153 
NK1 transcription factor 
related, locus 1 (Drosophila) 
(NKX1-1) 
XM_0012348
91 -1.50 0.022 -2.16 
9.0E-
03 -0.94 0.027 -0.90 0.046 -0.71 0.25 -0.82 0.13 
IGFBP3 insulin-like growth factor binding protein 3 EF624351 -0.34 0.57 -0.77 
4.9E-
03 -0.35 0.020 -0.08 0.59 -1.65 0.037 -0.42 0.16 
IRLB DENN/MADD domain containing 4A (DENND4A) XM_413911 -1.28 
1.4E-
03 -0.81 
4.1E-
04 -1.45 
4.2E-
04 -1.93 
6.1E-
05 0.44 0.029 0.85 0.014 
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IRX2 iroquois homeobox protein 2 NM_001030336 3.64 
8.8E-
05 2.91 
2.3E-
05 2.51 
1.2E-
05 2.93 
2.1E-
05 0.83 
1.5E-
03 0.96 
4.7E-
04 
Jag2 jagged 2 XM_001235688 -3.55 
2.9E-
06 -3.21 
1.0E-
06 0.40 
3.0E-
03 0.23 0.14 -3.19 
1.1E-
06 -3.42 
9.5E-
06 
JUN v-jun avian sarcoma virus 17 oncogene homolog 
NM_001031
289 -0.26 0.38 -0.12 0.47 1.02 0.024 1.20 
8.9E-
04 -0.73 0.071 -0.60 0.079 
KCNN2 
potassium 
intermediate/small 
conductance calcium-
activated channel, subfamily 
N, member 2 
NM_204798 0.94 8.8E-04 0.47 
9.0E-
03 0.69 0.026 1.14 
7.6E-
04 0.40 0.23 -0.15 0.40 
KIAA0130 
thyroid hormone receptor-
associated protein, 100 kDa 
(TRAP100) 
NM_001031
363 -1.34 0.039 -1.09 
1.3E-
03 -1.52 
7.7E-
05 -1.36 
2.0E-
04 0.43 0.021 0.53 0.060 
KIAA0161 
ubiquitin conjugating 
enzyme 7 interacting protein 
4 (UBCE7IP4) 
XM_419938 -0.36 0.37 0.06 0.74 1.75 0.073 1.01 0.018 -1.28 0.019 -1.94 8.7E-03 
KIAA0669 
TSC22 domain family, 
member 2 (TSC22D2 or 
TILZ4) 
CR522985 2.15 1.5E-04 2.41 
3.5E-
07 1.69 
2.8E-
03 2.63 
6.4E-
05 1.29 0.055 0.61 0.14 
KIAA0952 BTB (POZ) domain containing 3 (BTBD3) XM_425262 1.77 
1.2E-
04 1.61 
4.7E-
05 1.82 
1.2E-
03 1.44 
2.8E-
05 0.89 
3.9E-
04 0.76 
3.2E-
03 
KIAA1076 SET domain containing 1B (SETD1B) 
NM_001030
661 -1.00 
3.4E-
04 -0.67 
3.6E-
05 -1.12 
6.3E-
05 -1.54 
1.4E-
04 0.33 
1.9E-
03 1.38 
1.8E-
05 
KIAA1172 
splicing factor, 
arginine/serine-rich 15 
(SFRS15) (pre-mRNA 
splicing SR protein rA4) 
NM_001012
822 0.58 0.22 0.43 0.075 1.20 
1.8E-
04 0.71 0.058 -0.15 0.63 -0.59 0.054 
KIAA1190 zinc finger and BTB domain containing 47 (ZBTB47) XM_425959 -0.28 0.27 0.65 
2.1E-
04 1.01 
1.6E-
03 1.04 
6.2E-
06 -0.17 0.82 -0.24 0.089 
KIAA1388 zinc finger protein ZNF319 XM_425100 -1.13 2.0E-04 -1.10 
1.5E-
05 -1.33 
9.9E-
09 -1.43 
3.4E-
05 0.31 0.17 0.45 0.026 
KLF13 Kruppel-like factor 13 XM_425065 1.79 9.3E-03 2.98 
2.9E-
03 2.62 
2.9E-
08 2.73 
1.1E-
04 0.00 0.00 0.00 0.00 
KRT12 keratin 12 (Meesmann corneal dystrophy) XM_425874 -1.58 0.012 -1.84 
2.2E-
07 -0.02 0.89 0.02 0.84 -1.67 
8.5E-
05 -1.80 
3.1E-
04 
Lfng lunatic fringe gene homolog NM_204948 1.37 4.7E-03 1.23 
5.8E-
04 1.55 
8.6E-
04 0.82 0.074 -0.21 0.23 0.47 0.10 
LMO1 LIM domain only 1 (rhombotin 1) XM_420991 -0.95 
1.0E-
03 -0.69 
7.9E-
04 -0.22 0.26 -0.06 0.75 -1.25 
2.3E-
05 -0.53 
6.9E-
03 
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LOC15248
5 zinc finger protein ZNF827 XM_420430 -1.61 
3.9E-
03 -2.48 
1.1E-
05 0.11 0.79 -0.53 0.079 -1.99 
4.9E-
05 -2.26 
3.1E-
05 
LOC16885
0 zinc finger protein ZNF800 XM_415991 -0.70 
5.2E-
04 -0.72 
3.7E-
03 0.14 0.45 0.46 0.10 -1.11 
7.9E-
03 -1.08 
4.8E-
03 
LOC51580 
recombining binding protein 
suppressor of hairless 
(Drosophila) (RBPSUH) 
XM_420752 1.78 5.4E-04 2.75 
5.7E-
08 2.59 
2.1E-
05 2.08 
8.8E-
06 -0.03 0.94 0.43 0.039 
LOC51652 
vacuolar protein sorting 24 
homolog (S. cerevisiae) 
(VPS24) 
XM_420858 -0.44 0.23 -0.62 0.012 -2.66 1.2E-03 -1.59 
1.6E-
03 1.12 0.023 1.63 
3.8E-
03 
LOC90322 chromobox homolog 7 (CBX7) XR_027064 -0.73 
8.4E-
03 -1.15 
8.1E-
04 0.15 0.17 0.10 0.54 -1.14 
2.8E-
04 -1.21 
2.1E-
04 
LRP5 low density lipoprotein receptor-related protein 5 
NM_001012
897 2.24 
1.6E-
04 1.95 
8.4E-
07 2.97 
1.2E-
05 2.68 
2.9E-
08 -0.83 0.010 -0.44 0.019 
LRP6 Low-density lipoprotein receptor-related protein 6 XM_417286 -1.14 0.027 -0.39 0.12 0.09 0.65 0.15 0.47 -0.50 0.17 -0.77 0.017 
LZTR1 leucine-zipper-like transcriptional regulator, 1 XM_419246 1.13 
3.4E-
04 0.67 0.018 1.07 0.025 0.80 0.039 0.65 0.021 0.19 0.45 
LZTS1 leucine zipper, putative tumor suppressor 1 XM_428882 1.25 0.024 0.84 0.028 1.46 
7.6E-
03 1.39 
1.3E-
04 -0.63 0.12 -0.01 0.95 
MADH2 
mothers against 
decapentaplegic homolog 2 
(SMAD2) 
NM_204561 -2.57 2.7E-05 -2.83 
9.2E-
07 0.00 0.00 0.00 0.00 -3.57 
8.8E-
04 -3.89 
4.5E-
04 
MAFK 
v-maf musculoaponeurotic 
fibrosarcoma oncogene 
family, protein K (avian) 
NM_204756 0.91 6.3E-03 0.57 
2.7E-
03 1.00 
5.3E-
03 1.20 0.044 -0.42 0.12 -0.47 0.17 
mAPC adenomatosis polyposis coli XM_001233410 2.08 0.046 2.26 
1.6E-
03 1.60 0.057 2.40 0.040 0.25 0.32 0.38 0.12 
MEF2A 
MADS box transcription 
enhancer factor 2, 
polypeptide A (myocyte 
enhancer factor 2A) 
AJ010072 2.41 0.020 3.06 5.2E-04 1.92 0.030 2.14 0.010 0.43 0.042 0.69 0.025 
Mfng manic fringe homolog XM_416278 -0.53 1.5E-03 -0.39 
4.3E-
03 0.25 0.017 0.34 0.018 -1.21 
1.6E-
05 -1.02 
5.9E-
03 
MGC1563
1 
retina and anterior neural 
fold homeobox like 1 
(RAXL1) 
NM_204104 2.47 5.6E-03 2.13 
5.5E-
06 0.89 0.052 0.79 
7.7E-
03 1.22 
2.6E-
06 1.15 
8.1E-
06 
MGC1673
3 
integrator complex subunit 4 
(INST4) XM_417220 3.84 
2.7E-
04 3.45 
2.0E-
06 3.53 
1.2E-
06 3.11 
1.5E-
03 0.00 0.00 0.00 0.00 
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MID2 midline 2 XM_420134 -2.65 2.5E-05 -2.99 
2.1E-
07 0.48 0.088 1.06 
6.6E-
03 -4.44 
9.0E-
07 -5.28 0.023 
MLLT1 
myeloid/lymphoid or mixed-
lineage leukemia (trithorax 
(Drosophila) homolog); 
translocated to, 1 
XM_418209 0.30 0.049 0.50 9.9E-04 -1.03 
2.0E-
04 -1.63 
6.4E-
05 1.41 
7.7E-
04 2.11 
6.3E-
04 
MLLT6 
myeloid/lymphoid or mixed-
lineage leukemia (trithorax 
(Drosophila) homolog); 
translocated to 6 
XM_418117 -1.83 4.8E-04 -1.50 
4.4E-
07 -0.44 0.19 -0.97 
1.0E-
04 -1.04 0.011 -0.53 0.019 
MLLT7 forkhead box O4 (FOXO4) XM_426261 3.39 0.023 2.70 2.9E-05 2.02 
2.3E-
04 2.82 
5.0E-
07 0.00 0.00 0.00 0.00 
MORF 
MYST histone 
acetyltransferase 
(monocytic leukemia) 4 
(MYST4) 
XM_421609 1.17 3.8E-03 0.45 0.19 -0.03 0.92 0.04 0.91 0.88 0.060 0.79 
3.7E-
03 
MORF4 mortality factor 4 like 1 (MORF4L1) 
NM_001037
173 0.39 
3.1E-
03 0.26 0.017 -0.34 0.16 -0.49 0.025 1.05 
6.9E-
04 0.69 
2.4E-
03 
mOSR1 odd-skipped related 1 XM_419967 -0.30 0.38 0.50 0.11 2.64 1.4E-03 2.59 
4.7E-
04 -2.43 
2.4E-
03 -2.49 
4.9E-
04 
mPAXIP1L 
transcription activation 
domain interacting protein 1 
like 
XM_418546 -0.03 0.82 0.38 0.20 1.45 0.023 1.98 7.6E-04 -1.37 0.019 -1.61 
3.3E-
03 
MYCBP c-myc binding protein BX933751 0.68 9.0E-03 0.82 0.026 -1.08 0.013 -0.35 0.23 0.96 0.023 0.83 
2.0E-
04 
MYH11 myosin, heavy polypeptide 11, smooth muscle NM_205274 -1.34 
8.1E-
04 -1.08 
9.9E-
04 -1.61 
3.1E-
05 -1.97 
1.1E-
04 -0.16 0.63 0.48 0.33 
MYNN myoneurin XM_001233289 4.30 
1.0E-
04 3.36 
1.9E-
05 3.83 
5.8E-
07 4.76 
2.3E-
06 0.14 0.27 -0.59 
2.9E-
03 
NAB1 NGFI-A binding protein 1 (EGR1 binding protein 1) NM_204268 1.83 
4.8E-
04 1.36 
1.9E-
05 0.46 0.13 0.57 0.039 1.13 
1.8E-
03 1.87 
5.0E-
04 
NCOR2 nuclear receptor co-repressor 2 XM_415107 1.33 
1.6E-
03 1.64 
4.4E-
06 0.98 
1.5E-
04 0.44 0.012 0.71 0.41 0.97 
1.4E-
03 
NFE2L2 nuclear factor (erythroid-derived 2)-like 2 NM_205117 2.71 
2.5E-
06 2.53 
2.7E-
04 1.98 
6.8E-
05 1.78 
1.3E-
04 0.52 0.29 0.73 
2.6E-
03 
NKX6-2 NK6 transcription factor related, locus 2 (Drosophila) XM_421832 -0.99 0.037 -0.30 0.19 -1.38 
9.4E-
03 -1.64 
3.8E-
03 0.38 0.015 0.88 
3.7E-
03 
NKX6A NK6 transcription factor related, locus 1 (Drosophila) AF102991 1.31 0.18 1.02 
2.5E-
04 1.40 
9.6E-
04 1.16 
1.8E-
03 -0.01 0.97 -0.35 0.047 
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Notch2 Notch gene homolog 2 XM_001233595 0.11 0.60 0.46 0.13 -1.26 
5.6E-
05 -1.62 
1.9E-
05 1.02 
1.3E-
03 1.17 
4.9E-
05 
NR1I3 nuclear receptor subfamily 1, group I, member 3 NM_204702 -0.83 0.011 -0.61 
6.1E-
03 -1.58 
4.9E-
04 -1.65 
7.6E-
05 0.82 0.026 1.56 0.020 
NR3C2 nuclear receptor subfamily 3, group C, member 2 XM_420437 0.00 0.00 0.00 0.00 -2.68 
1.3E-
08 -3.36 
3.6E-
07 2.69 
1.4E-
04 3.16 
7.0E-
06 
OCT11 
POU domain, class 2, 
transcription factor 3 
(POU2F3) 
XM_425799 0.05 0.90 0.03 0.86 -2.31 2.5E-05 -2.09 
3.3E-
04 2.19 
1.4E-
04 2.79 0.018 
p21_Chick cyclin-dependent kinase inhibitor 1 NM_204396 -1.42 
2.1E-
04 -1.08 
8.7E-
07 -0.31 0.011 -0.09 0.32 -1.04 
1.3E-
05 -0.81 
2.1E-
04 
p27KIP1_
Chick 
cyclin-dependent kinase 
inhibitor 1B NM_204256 0.38 0.044 1.04 
5.9E-
06 -1.20 
9.5E-
07 -1.28 
3.5E-
06 1.63 
2.1E-
04 2.26 
5.5E-
06 
p57KIP2_
Chick 
cyclin-dependent kinase 
inhibitor 1C BM489375 -0.18 0.27 0.10 0.16 -0.98 
4.9E-
06 -1.34 
3.9E-
05 0.78 
2.3E-
03 1.46 
6.8E-
05 
PCMT1 
protein-L-isoaspartate (D-
aspartate) O-
methyltransferase 
NM_001031
525 0.73 0.16 -0.57 0.079 -3.67 
7.2E-
06 -2.91 
1.0E-
04 3.49 
6.0E-
08 2.47 
1.6E-
03 
PCQAP 
PC2 (positive cofactor 2, 
multiprotein complex) 
glutamine/Q-rich-associated 
protein 
XM_415235 0.28 0.39 0.22 0.33 -0.34 0.21 -0.40 0.36 1.28 0.017 1.23 5.2E-03 
PDEF 
SAM pointed domain 
containing ets transcription 
factor (SPDEF) 
XM_425831 -0.43 6.7E-03 -0.20 0.079 0.13 0.22 0.52 0.055 -1.14 0.023 -1.37 0.067 
PFDN5 prefoldin 5 BX931362 4.70 1.4E-04 4.08 
7.4E-
08 4.02 
9.0E-
07 4.91 
7.7E-
06 0.00 0.00 0.00 0.00 
PFKL phosphofructokinase, liver XM_001232620 2.90 
7.8E-
05 2.25 
3.4E-
05 2.45 
2.0E-
06 2.37 
9.1E-
05 -0.11 0.34 0.58 0.10 
PHF16 PHD finger protein 16 XM_416870 -2.07 5.7E-05 -1.78 
3.4E-
07 -1.51 
3.6E-
07 -1.82 
6.2E-
06 -0.45 
5.9E-
03 -0.33 
5.2E-
03 
PITX2 paired-like homeodomain transcription factor 2 AF077092 -1.55 
1.6E-
03 -1.56 
1.8E-
04 -0.33 0.33 -0.86 
5.0E-
03 -0.54 0.043 -1.42 
2.1E-
03 
PLTP phospholipid transfer protein XM_425722 -1.67 5.4E-03 -1.40 
4.9E-
03 0.00 0.65 0.90 0.014 -1.62 0.026 -2.30 
8.1E-
03 
POU1F1 POU domain, class 1, transcription factor 1 NM_204319 1.35 0.020 1.33 
2.2E-
05 -2.18 
2.4E-
06 -2.37 
1.6E-
05 3.89 
8.3E-
04 3.60 
3.2E-
05 
PPARA peroxisome proliferative activated receptor, alpha 
XM_0012361
11 -1.23 
8.5E-
03 -0.83 
2.3E-
04 -1.02 
1.9E-
03 -1.24 
4.4E-
05 0.10 0.77 0.55 0.17 
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PPARBP 
peroxisome proliferator 
activated receptor binding 
protein 
XM_418125 1.25 7.3E-04 1.54 
7.0E-
05 1.18 
5.3E-
04 0.65 
1.4E-
03 -0.13 0.63 0.31 0.22 
PRDM12 PR domain containing 12 XM_415465 -1.64 0.12 -0.71 0.086 -0.63 0.27 -1.32 8.2E-03 0.42 0.52 0.10 0.72 
PRDM5 PR domain containing 5 XM_420628 -0.20 0.50 0.05 0.68 -1.49 4.6E-05 -2.44 
1.8E-
05 1.42 0.023 1.15 
2.6E-
03 
PSIP1 PC4 and SFRS1 interacting protein 1 
NM_001031
610 1.17 
7.2E-
03 -0.27 0.075 0.94 
3.0E-
03 1.67 
1.2E-
04 -0.11 0.72 -2.12 
1.7E-
04 
PSMB4 
proteasome (prosome, 
macropain) subunit, beta 
type, 4 
XM_427542 0.00 0.00 0.00 0.00 -2.73 3.9E-05 -3.30 
4.4E-
08 2.37 
5.1E-
04 2.01 
3.3E-
05 
Ptch2 patched homolog 2 AF409095 -0.11 0.12 -0.31 6.9E-03 -1.30 
5.1E-
04 -1.27 
9.2E-
04 1.30 
1.2E-
03 0.93 
1.4E-
03 
PTTG1IP pituitary tumor-transforming 1 interacting protein XM_422649 -0.80 
2.6E-
03 -0.63 
6.2E-
05 -1.40 
2.3E-
03 -1.05 
3.5E-
05 0.50 0.12 0.45 0.031 
R32184_3 
chromosome 19 open 
reading frame 6 (C19orf6) 
(aka aspecific BCL2 ARE-
binding protein 1) 
XM_418222 -0.07 0.75 -0.21 0.031 1.24 2.4E-03 1.58 
1.0E-
03 -1.24 
4.9E-
03 -1.17 0.022 
RAI15 
retinoic acid induced 15 
(aka SMYD family member 
5) 
NM_001012
894 -0.42 0.094 -0.18 0.29 -1.09 
4.0E-
04 -1.07 
1.5E-
04 0.83 
4.8E-
03 1.01 
3.6E-
03 
RALGDS ral guanine nucleotide dissociation stimulator XM_425331 -0.84 0.039 -1.20 
2.2E-
05 -0.23 0.73 1.08 
3.2E-
03 -1.37 
1.2E-
03 -1.95 
1.7E-
04 
RAX retina and anterior neural fold homeobox 
XM_0012321
18 -0.08 0.54 0.34 0.065 1.69 
1.5E-
06 1.58 
4.9E-
05 -1.49 
8.8E-
05 -1.60 
2.9E-
04 
RBBP5 retinoblastoma binding protein 5 
NM_001030
914 -0.52 0.45 -1.14 0.010 -0.11 0.70 0.17 0.57 -0.55 0.31 -1.46 
7.5E-
04 
RELB 
v-rel reticuloendotheliosis 
viral oncogene homolog B, 
nuclear factor of kappa light 
polypeptide gene enhancer 
in B-cells 3 (avian) 
AF029260 -1.28 5.0E-04 -0.55 
9.2E-
03 -0.51 0.078 -0.85 
8.4E-
05 0.14 0.59 0.17 0.25 
RGC32 response gene to complement 32 XM_417029 0.26 0.24 0.12 0.48 1.50 
2.0E-
04 0.90 
8.5E-
05 -1.31 
7.1E-
04 -1.02 
1.2E-
04 
RIPX rap2 interacting protein x XM_001233433 -1.87 
3.2E-
05 -1.50 
1.1E-
06 -1.21 
1.7E-
05 -1.22 
4.1E-
04 -0.59 0.034 -0.54 0.015 
RNF24 ring finger protein 24 CR385827 0.23 0.31 0.10 0.69 -0.72 0.011 -1.26 6.4E-04 0.80 0.056 1.30 0.023 
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RREB1 ras responsive element binding protein 1 NM_205049 -1.97 0.13 -0.30 
3.5E-
03 0.99 
3.5E-
03 0.77 
3.7E-
03 -1.23 
1.5E-
04 -1.04 0.013 
Rxrg retinoid X receptor gamma NM_205294 -0.85 6.1E-04 -0.46 0.066 0.07 0.79 -0.10 0.70 -1.42 
2.3E-
05 -0.86 
4.6E-
03 
SAFB scaffold attachment factor B XM_423726 -0.02 0.96 0.23 0.31 -1.11 1.3E-05 -0.79 0.31 0.19 0.73 0.40 0.53 
SATB2 SATB family member 2 XM_421919 -0.64 0.011 -0.58 2.4E-04 0.82 
2.6E-
04 0.10 0.61 -1.28 
8.2E-
06 -0.77 
2.1E-
04 
SCA2 
spinocerebellar ataxia 2 
(olivopontocerebellar ataxia 
2, autosomal dominant, 
ataxin 2) 
XM_415169 -1.15 5.0E-06 -0.34 
5.0E-
03 0.05 0.77 -0.46 0.017 -1.50 
1.2E-
04 -0.25 
3.8E-
03 
SCML4 sex comb on midleg-like 4 XM_426184 0.59 9.3E-04 0.74 
1.9E-
04 0.83 0.012 1.14 
4.2E-
05 -0.24 0.045 -0.17 0.19 
SFRS8 
splicing factor, 
arginine/serine-rich 8 
(suppressor-of-white-
apricot, Drosophila) 
XM_415093 -0.83 0.087 -0.94 0.042 -1.28 3.5E-04 -2.18 
1.1E-
06 0.14 0.56 0.68 0.051 
SIAH2 seven in absentia homolog 2 (Drosophila) XM_426719 -0.38 0.28 -0.78 
9.9E-
05 -1.15 0.011 -1.24 
6.2E-
03 1.20 0.024 1.14 
1.5E-
03 
SMARCA2 
SWI/SNF related, matrix 
associated, actin dependent 
regulator of chromatin, 
subfamily a, member 2 
NM_205139 0.11 0.26 -0.31 0.053 -1.44 7.3E-04 -1.66 
1.8E-
03 2.08 
1.5E-
03 1.53 
5.6E-
03 
SMARCA4 
SWI/SNF related, matrix 
associated, actin dependent 
regulator of chromatin, 
subfamily a, member 4 
NM_205059 1.10 7.1E-04 0.80 
1.8E-
03 0.53 0.081 0.92 
8.4E-
03 0.39 0.25 0.08 0.44 
SMARCC1 
SWI/SNF related, matrix 
associated, actin dependent 
regulator of chromatin, 
subfamily c, member 1 
XR_026888 -0.19 0.35 0.14 0.17 -1.40 1.3E-03 -1.30 
4.2E-
03 0.59 
7.1E-
03 1.08 
8.3E-
05 
SNAPC4 
small nuclear RNA 
activating complex, 
polypeptide 4, 190kDa 
XM_415416 1.86 2.3E-03 1.38 
3.5E-
03 1.76 
3.0E-
03 3.06 
1.9E-
04 -0.51 0.21 -1.38 
1.0E-
03 
SNAPC5 
small nuclear RNA 
activating complex, 
polypeptide 5, 19kDa 
NM_001007
829 2.24 
1.2E-
03 1.94 
4.0E-
06 0.83 0.011 1.01 
3.1E-
03 0.95 
9.4E-
03 1.15 
4.4E-
04 
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SOX10 SRY (sex determining region Y)-box 10 AJ245601 2.56 
9.1E-
03 1.36 
3.0E-
04 2.48 0.012 2.35 0.063 0.04 0.94 -0.63 0.013 
SOX7 SRY (sex determining region Y)-box 7 
XM_0012346
27 2.20 
1.0E-
03 1.92 
4.6E-
04 -0.56 
1.3E-
03 -0.55 
9.9E-
05 2.76 
8.9E-
07 3.02 
4.2E-
06 
SREBF1 sterol regulatory element binding transcription factor 1 AY029224 -0.74 0.27 0.04 0.76 0.04 0.87 -1.04 
6.2E-
04 0.84 0.093 1.03 
6.3E-
03 
SRF 
serum response factor (c-
fos serum response 
element-binding 
transcription factor) 
U50596 -0.11 0.27 0.06 0.43 -1.28 7.2E-04 -1.79 
4.4E-
03 1.24 
5.1E-
05 1.38 
1.4E-
05 
STOML1 stomatin (EBP72)-like 1 XR_026998 0.63 0.023 0.67 3.2E-03 2.22 
1.0E-
05 2.31 
4.1E-
06 -1.46 
2.4E-
03 -1.94 
4.0E-
04 
SUPT4H1 suppressor of Ty 4 homolog (S.cerevisiae) unknown 0.37 0.040 1.08 
1.5E-
03 1.80 
1.8E-
04 2.07 
2.6E-
04 -0.75 0.18 -0.93 
6.7E-
03 
TAF2C2 
TAF4b RNA polymerase II, 
TATA box binding protein 
(TBP)-associated factor, 
105kDa 
XM_419170 -0.19 0.77 -0.38 2.1E-03 -2.02 
6.3E-
06 -1.88 
1.3E-
04 1.94 
4.8E-
04 1.52 
7.5E-
04 
TAF3 
TAF3 RNA polymerase II, 
TATA box binding protein 
(TBP)-associated factor, 
140kDa 
NM_001030
841 3.02 
5.8E-
04 3.29 
1.7E-
08 2.40 
1.9E-
04 2.89 
2.5E-
04 0.00 0.00 0.00 0.00 
TBX2 T-box 2 XM_001235320 1.52 
6.7E-
03 1.52 
1.0E-
05 0.16 0.63 0.52 0.018 0.90 0.13 1.18 0.020 
TBX20 T-box 20 NM_204144 3.55 1.7E-03 3.72 
5.3E-
03 3.79 
9.8E-
04 3.52 
1.1E-
04 -0.22 0.31 -0.12 0.70 
TCEB1 
transcription elongation 
factor B (SIII), polypeptide 1 
(15kDa, elongin C) 
CR390316 -0.01 0.93 -0.41 2.9E-03 -0.37 0.079 -0.66 0.020 0.04 0.76 1.04 
1.9E-
03 
TCF20 transcription factor 20 (AR1) XM_416218 -3.36 3.5E-05 -2.64 
4.4E-
04 0.00 0.00 0.00 0.00 -2.79 
3.4E-
04 -3.29 
6.8E-
06 
TCF7 transcription factor 7 (T-cell specific, HMG-box) NM_204547 -2.44 
2.6E-
03 -1.86 
2.1E-
05 0.55 0.15 0.70 0.023 -1.91 0.039 -2.24 
2.2E-
03 
TGFB2 transforming growth factor, beta 2 
NM_001031
045 -2.53 
7.5E-
03 -2.36 
3.3E-
07 -1.39 
1.7E-
03 -1.21 
1.6E-
05 -0.43 0.086 -0.95 
2.5E-
04 
THBS3 thrombospondin 3 L81165 1.15 4.7E-03 0.35 0.12 1.39 0.010 1.06 
6.9E-
04 -0.46 0.076 -0.25 0.27 
TIEG2 TGFB inducible early growth response 2 XM_419947 -0.50 0.23 -0.69 
3.0E-
04 -0.77 0.027 -1.04 
1.4E-
03 0.11 0.73 0.73 
1.9E-
03 
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TNRC12 E1A binding protein p400 (EP400) 
XM_0012348
19 -1.45 
7.3E-
04 -1.21 
4.8E-
04 0.45 0.14 0.27 0.19 -1.75 
2.5E-
03 -1.77 
3.0E-
05 
TNRC15 trinucleotide repeat containing 15 XM_422565 1.27 
2.2E-
03 1.42 
7.4E-
04 1.36 
2.9E-
04 1.24 
1.9E-
05 -0.37 0.030 -0.22 0.13 
TRAF4 TNF receptor-associated factor 4 XR_027121 -0.13 0.27 -0.21 0.19 -0.95 
6.7E-
04 -0.92 
6.9E-
03 0.97 
2.2E-
03 1.10 
1.8E-
03 
TRAF5 TNF receptor-associated factor 5 NM_204219 -1.25 
2.5E-
04 -1.13 
4.5E-
04 0.00 0.97 0.48 0.085 -1.23 
1.3E-
03 -1.36 
1.5E-
03 
TRIM9 tripartite motif-containing 9 XM_421468 2.13 1.2E-05 1.65 
9.0E-
04 1.42 
1.8E-
03 1.56 
3.1E-
04 0.72 
1.8E-
03 0.26 0.12 
TRIP11 thyroid hormone receptor interactor 11 XM_421324 2.27 
2.1E-
04 2.41 
1.3E-
05 1.86 
6.1E-
03 1.52 
6.4E-
04 2.00 0.016 1.35 0.16 
WHSC1 Wolf-Hirschhorn syndrome candidate 1 XM_420839 1.50 
9.2E-
04 1.64 
2.5E-
05 1.63 
1.0E-
03 1.84 
5.3E-
03 0.66 0.052 0.35 0.30 
Wnt1 wingless-related MMTV integration site 1 AY753286 4.68 
8.5E-
07 4.24 
7.2E-
06 4.17 
1.8E-
08 4.48 
2.4E-
07 -0.73 0.031 -0.30 0.18 
Wnt11 wingless-related MMTV integration site 11 NM_204784 -1.63 
1.8E-
04 -1.64 
6.2E-
05 -1.00 
2.6E-
03 -0.84 
3.7E-
03 -0.93 
7.9E-
04 -0.81 
7.5E-
03 
Wnt5b wingless-related MMTV integration site 5B 
NM_001037
269 -1.34 
3.8E-
03 -0.83 0.28 -1.24 0.24 -0.19 0.43 -0.65 0.22 -0.11 0.69 
Wnt6 wingless-related MMTV integration site 6 
NM_001007
594 -1.32 
2.3E-
05 -0.97 
3.1E-
05 -0.29 
2.8E-
03 0.04 0.46 -1.09 
5.7E-
05 -1.18 
2.0E-
04 
ZBTB2 zinc finger and BTB domain containing 2 
NM_001031
070 0.55 0.028 0.25 0.084 1.02 
1.3E-
03 1.53 
4.9E-
04 -0.27 0.10 -0.93 
1.3E-
04 
ZFP276 zinc finger protein 276 homolog XM_414213 0.45 
7.5E-
04 -0.32 
7.0E-
05 -1.93 
2.0E-
06 -2.01 
6.6E-
05 2.21 
4.8E-
05 1.15 
3.1E-
04 
ZFPM1 zinc finger protein, multitype 1 (FOG1) XM_414197 -0.04 0.84 -0.05 0.75 -0.61 0.12 -1.52 
6.4E-
04 1.04 
6.0E-
04 1.70 
5.0E-
05 
ZNF384 zinc finger protein 384 NM_001079496 0.20 0.28 0.21 0.093 1.48 
4.1E-
03 0.96 
4.4E-
03 -1.03 
9.3E-
04 -0.56 0.054 
Table 2-1: Genes differentially expressed among stage-matched chicken, quail, and duck samples.  Average fold changes and p-
vales for genes differentially expressed between staged-matched chicken, quail, and duck at HH20 and HH25. Fold changes are log2 
scale, with expression in duck relative to chicken or quail (or in quail relative to chicken).  For example, a negative number is expressed at 
a lower level in the duck versus chicken.  Highlighted comparisons pass >2-fold change and p-values<0.05 criteria. Comparisons which 
were below threshold expression levels in both samples are listed with a fold change and p-value of “0.00.”  ave, average; DC, 
duck/chicken comparison; DQ, duck/quail comparison; QC, quail/chicken comparison 
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AB075831 zinc finger protein ZNF526 0.98 2.3E-04 1.15 
1.0E-
06 1.12 
5.4E-
05 0.87 
5.2E-
05 -0.34 0.044 0.29 
5.0E-
03 
ABT1 activator of basal transcription 1 -1.43 1.3E-03 -1.21 0.015 -0.41 0.30 -0.69 
2.9E-
04 -1.27 
2.3E-
03 -1.11 0.031 
AI022870 catalytic subunit of DNA polymerase zeta 3.02 
8.2E-
05 2.63 
1.0E-
06 2.45 
1.8E-
07 2.48 
4.1E-
07 0.34 0.044 0.44 
2.7E-
03 
AK128361 zinc finger protein ZNF615 -1.16 3.9E-04 -1.30 
2.5E-
06 -1.35 
7.9E-
06 -1.33 
2.3E-
05 0.83 
7.7E-
04 0.06 0.65 
ATF5 activating transcription factor 5 -0.47 0.014 -0.59 9.0E-03 -1.17 
2.1E-
03 -0.89 
7.2E-
03 1.01 
9.1E-
03 0.56 0.020 
BRD4 bromodomain-containing 4 -1.20 3.4E-03 -0.38 0.020 0.22 0.47 -0.15 0.38 -1.28 
3.4E-
04 -0.60 
4.1E-
03 
C5orf7 jumonji domain containing 1B (JMJD1B) -1.45 0.011 -1.16 
1.3E-
03 -0.41 0.064 -0.33 0.40 -1.25 
6.4E-
03 -1.45 
9.8E-
04 
CCNB1 G2/mitotic-specific cyclin B1 -0.69 2.0E-03 -1.17 
1.3E-
03 -0.26 0.45 0.02 0.95 -0.44 
7.8E-
03 -1.00 0.015 
CDKN2D cyclin-dependent kinase 4 inhibitor D (P19-INK4D) 0.53 0.013 0.60 
2.9E-
04 -0.24 0.13 -0.68 
1.4E-
03 0.68 
6.7E-
03 1.27 
8.4E-
06 
CG9879 CG9879 (fly) homolog -0.83 0.021 -1.13 7.9E-04 -0.49 0.032 -0.45 
4.8E-
03 -0.52 0.036 -0.78 
8.6E-
03 
CITED1 
Cbp/p300-interacting transactivator, 
with Glu/Asp-rich carboxy-terminal 
domain, 1 
1.26 0.050 0.92 0.16 1.58 0.036 2.04 5.8E-03 0.46 0.12 0.03 0.93 
CL469780 zinc finger protein ZNF364 2.36 0.013 2.34 8.5E-05 1.44 
4.1E-
03 2.43 
3.0E-
05 0.34 0.27 0.33 0.17 
CNNM1 cyclin M1 0.20 0.40 0.07 0.48 -1.11 3.7E-05 -0.63 
3.8E-
03 1.24 
2.0E-
04 1.02 
4.6E-
04 
CREBL1 cAMP responsive element binding protein-like 1 0.00 0.00 0.00 0.00 -1.67 
9.6E-
05 -1.66 0.021 1.70 
2.1E-
03 1.36 
5.6E-
04 
DKFZp564D0472 hypothetical protein -0.85 0.12 -0.17 0.58 -0.36 0.52 -0.80 0.19 0.77 5.9E-03 1.41 
6.4E-
04 
DKFZp686B0797 zinc finger protein ZNF568 0.51 2.9E-03 0.52 
2.2E-
04 0.85 
1.3E-
07 1.04 
1.0E-
05 -0.27 0.022 -0.63 
6.8E-
04 
DUX1-DUX3-
DUX5 
double homeobox genes 1, 3, and 5 
(probe common to all) 0.37 0.14 0.48 
5.3E-
04 -1.61 
2.2E-
05 -1.99 
2.6E-
03 2.21 
1.4E-
05 1.72 
8.1E-
04 
DUX4 double homeobox, 4 1.11 6.2E-03 0.73 
9.0E-
03 1.58 
5.0E-
04 1.59 0.020 -0.39 0.24 -0.37 
8.1E-
04 
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EVX2 even-skipped homeo box homolog 2 4.29 4.5E-05 4.01 
3.3E-
06 4.61 
1.1E-
07 4.37 
2.8E-
08 0.00 0.00 0.00 0.00 
Fgf11 fibroblast growth factor 11 -1.30 1.0E-04 -0.52 
3.3E-
03 -0.56 0.013 -0.43 0.14 -0.48 0.011 0.35 
9.2E-
03 
Fgf17 fibroblast growth factor 17 -1.29 0.015 -0.36 0.031 -1.36 3.1E-06 -1.62 
2.1E-
06 0.67 
2.9E-
03 1.21 
6.2E-
05 
Fgf5 fibroblast growth factor 5 -0.46 0.10 -1.00 0.011 -1.10 0.10 -0.89 0.077 0.43 0.41 -1.27 0.012 
Fgfr4 fibroblast growth factor receptor 4 -1.32 4.5E-04 -1.45 
3.9E-
05 -0.38 0.053 -0.07 0.82 -1.14 0.010 -1.11 
2.5E-
03 
FLJ10469 zinc finger protein ZNF334 4.92 4.6E-05 4.73 
2.7E-
06 3.24 
1.7E-
03 4.43 
1.2E-
04 0.17 0.55 -0.56 0.024 
FLJ12586 zinc finger protein ZNF329 -0.13 0.39 -0.14 0.22 -1.58 3.3E-04 -1.36 
9.2E-
04 1.90 
7.2E-
04 1.27 
2.8E-
03 
FLJ13265 cyclin N-terminal domain containing 2 (CNTD2) 1.28 
3.5E-
04 0.99 
2.3E-
04 -0.15 0.077 -0.17 0.021 1.33 
1.0E-
05 1.29 
1.2E-
06 
FLJ14297 ATP-binding cassette, sub-family A (ABC1), member 10 (ABCA10) -1.96 
3.8E-
03 -1.16 
4.5E-
04 0.55 0.033 0.35 0.013 -1.72 
6.1E-
04 -2.04 
5.3E-
05 
FLJ14779 zinc finger protein ZNF566 0.08 0.88 -0.19 0.14 -1.67 2.3E-03 -1.47 
5.9E-
03 1.39 
1.4E-
03 0.78 0.022 
FLJ22059 zinc finger protein ZNF574 -0.13 0.73 -0.62 0.012 -0.72 6.1E-03 -1.23 
1.0E-
03 0.51 0.064 0.42 0.11 
FLJ22301 zinc finger protein ZNF672 0.00 0.00 0.00 0.00 -2.07 1.2E-05 -2.14 
2.1E-
03 1.26 
7.8E-
03 2.09 
8.5E-
05 
FLJ23233 zinc finger protein ZNF419 -0.89 0.012 -0.66 1.3E-03 -1.33 
2.5E-
04 -1.21 
3.0E-
03 0.49 0.012 0.44 0.12 
FLJ30726 zinc finger protein 3 homolog (mouse) (ZFP3) -0.58 
6.2E-
03 -0.69 
7.2E-
04 0.42 
9.1E-
03 0.60 
3.3E-
03 -0.97 
2.6E-
04 -1.57 
6.8E-
04 
FLJ31295 zinc finger protein ZNF641 -2.41 4.3E-04 -2.02 
5.0E-
05 -3.41 
2.1E-
06 -3.49 
1.7E-
07 1.50 0.047 1.77 
1.4E-
03 
FLJ32191 zinc finger protein ZNF420 -0.57 0.026 0.16 0.37 -0.81 3.0E-05 -0.84 
1.2E-
04 0.54 0.019 1.09 
2.0E-
05 
FLJ34231 zinc finger protein 62 homolog (mouse) (ZFP62) 0.24 0.19 0.68 
3.3E-
05 -0.38 0.14 -0.90 
8.0E-
03 0.98 
3.7E-
04 1.30 
5.0E-
06 
FLJ35863 zinc finger protein ZNF383 -1.28 1.4E-05 -0.73 0.011 0.09 0.82 0.07 0.62 -0.57 0.070 -0.61 0.092 
FLJ36666 chromosome 19 open reading frame 25 (C19orf25) -1.83 
2.2E-
04 -1.94 
3.3E-
06 -1.31 
3.0E-
04 -1.54 
1.3E-
04 -0.83 
4.0E-
05 -0.96 
2.2E-
04 
FLJ39963 zinc finger protein ZNF713 0.90 1.5E-03 1.01 
6.7E-
07 0.26 0.29 0.47 0.13 0.53 
1.7E-
03 0.73 
6.0E-
04 
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FLJ90396 zinc finger protein ZNF791 1.55 2.5E-04 1.83 
4.7E-
05 1.69 
3.5E-
03 2.19 
7.3E-
05 -0.32 0.15 -0.04 0.77 
FOXE3 forkhead box E3 -0.16 0.75 -0.26 0.52 0.59 0.025 1.02 7.0E-03 -0.94 
8.9E-
04 -0.35 0.094 
FOXF2 forkhead box F2 -1.27 0.013 -1.63 1.1E-05 -1.77 
2.9E-
04 -1.54 
4.4E-
04 0.33 0.68 0.15 0.57 
FOXQ1 forkhead box Q1 -1.70 5.1E-05 -1.52 
4.5E-
06 0.04 0.77 -0.21 0.044 -1.84 
3.5E-
05 -1.56 
5.1E-
04 
GSH1 genomic screened homeo box 1 (mouse) homolog 0.58 0.15 0.68 0.027 -0.36 0.27 -1.10 
1.8E-
03 1.54 
5.4E-
04 2.13 
4.1E-
05 
GTF2F1 general transcription factor IIF, polypeptide 1 (74kD subunit) 1.76 
4.4E-
03 0.92 0.016 -1.32 0.010 -2.06 
3.6E-
03 0.92 0.018 1.00 0.060 
GTF2I general transcription factor II, i 0.47 0.036 0.43 0.12 1.50 3.6E-03 1.65 
4.3E-
06 -1.40 
2.9E-
04 -1.14 
1.1E-
03 
HIF3A hypoxia inducible factor 3, alpha subunit -1.52 
1.1E-
04 -1.35 
8.6E-
05 -0.97 
2.0E-
03 -0.50 0.037 -0.77 
8.2E-
04 -0.94 
1.9E-
03 
HOXC9 homeobox C9 -0.74 0.085 -0.77 5.3E-04 -1.29 
3.9E-
04 -1.12 
1.3E-
03 1.15 0.014 0.31 0.39 
HOXD1 homeobox D1 -1.05 0.042 0.37 0.14 1.54 1.9E-03 1.65 
8.8E-
05 -1.37 0.051 -0.82 
9.4E-
03 
INSM1 insulinoma-associated 1 -0.51 0.046 -0.33 0.089 -0.59 2.6E-03 -1.12 
1.1E-
03 0.53 0.026 0.92 
2.8E-
04 
KBTBD7 kelch repeat and BTB (POZ) domain containing 7 2.79 
3.1E-
03 2.64 
3.0E-
05 1.76 0.014 3.08 
3.4E-
07 1.38 
1.3E-
03 1.21 
1.3E-
03 
KIAA0339 SET domain containing 1A (SETD1A) -0.54 0.012 -0.77 
9.4E-
06 -0.81 0.019 -1.09 
1.1E-
03 0.78 
5.2E-
04 0.55 
3.1E-
03 
KIAA0543 KIAA0543 gene product -0.88 0.20 -1.63 5.4E-05 -3.13 
1.4E-
05 -3.00 
3.7E-
05 1.07 
3.5E-
04 1.65 
2.2E-
05 
KIAA0798 zinc finger protein ZNF432 0.56 0.60 0.59 0.42 -0.99 0.10 -1.27 2.2E-03 0.94 0.21 0.86 0.063 
KIAA1441 zinc finger protein ZNF687 0.00 0.00 0.00 0.00 -2.16 1.6E-04 -2.32 
2.1E-
06 2.28 
7.7E-
05 3.27 
3.1E-
05 
KLF14 Kruppel-like factor 14 2.38 0.016 1.89 7.2E-04 -1.44 0.055 -0.93 0.18 3.07 
1.1E-
05 3.19 
1.0E-
06 
LISCH7 liver-specific bHLH-Zip transcription factor 0.55 0.021 0.43 
8.7E-
05 3.17 
1.9E-
06 3.46 
5.7E-
07 -2.95 
3.0E-
06 -3.10 
1.2E-
06 
LOC115468 zinc finger protein ZNF493 0.07 0.56 0.17 0.14 -1.36 1.2E-04 -1.58 
3.4E-
04 2.19 
1.9E-
03 1.70 
8.4E-
05 
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LOC51058 zinc finger protein ZNF691 -0.84 1.0E-03 -0.39 0.065 -1.13 0.021 -0.23 0.54 -0.52 0.35 -0.24 0.33 
LOC90589 zinc finger protein ZNF625 1.36 1.2E-03 1.12 
2.3E-
03 1.19 
1.5E-
05 1.50 
1.6E-
04 0.33 
2.2E-
04 0.47 
9.1E-
04 
MADH4 mothers against decapentaplegic homolog 4 (SMAD4) -2.80 
9.1E-
05 -2.47 
3.6E-
07 -2.84 
4.1E-
07 -3.35 
6.3E-
06 0.67 0.012 1.55 0.024 
MCM7 minichromosome maintenance deficient (S. cerevisiae) 7 -0.85 
6.3E-
03 -0.71 0.055 0.31 0.34 0.06 0.69 -0.55 0.26 -1.19 0.019 
MEF2B 
MADS box transcription enhancer 
factor 2, polypeptide B (myocyte 
enhancer factor 2B) 
1.15 4.8E-03 0.90 
6.2E-
04 0.61 0.062 1.03 
3.6E-
05 0.51 0.074 0.34 0.23 
MGC4400 zinc finger protein ZNF577 4.38 2.2E-04 4.33 
3.3E-
08 3.33 
3.9E-
05 4.47 
2.9E-
06 0.65 
4.5E-
03 0.42 0.10 
MGC45380 zinc finger protein ZNF545 -1.53 0.045 -2.66 2.7E-05 -1.09 0.018 -0.58 0.24 0.25 0.39 -1.95 
6.1E-
04 
MHC2TA MHC class II transactivator 0.62 0.016 0.92 4.7E-03 -0.76 0.064 -0.55 0.020 0.42 0.11 1.34 
1.1E-
04 
MTX1 metaxin 1 -0.72 0.018 -0.48 5.6E-04 -2.36 
4.9E-
05 -1.73 
4.3E-
04 1.31 
7.6E-
03 2.19 
1.9E-
03 
NFKBIL1 
nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
inhibitor-like 1 
-1.37 1.1E-03 -0.99 0.010 0.71 0.066 0.39 0.10 -1.32 0.017 -1.23 0.064 
Notch3 Notch gene homolog 3 0.27 0.11 0.36 0.026 -1.04 5.8E-04 -0.94 
1.6E-
04 1.09 
1.0E-
03 1.56 
5.3E-
05 
OG2x NOBOX oogenesis homeobox 3.14 1.5E-04 2.83 
2.0E-
05 2.77 
1.5E-
06 3.09 
1.4E-
05 0.00 0.00 0.00 0.00 
OLIG1 oligodendrocyte transcription factor 1 -1.19 0.030 -0.89 4.8E-04 -1.51 
9.5E-
04 -1.01 
2.6E-
04 0.58 0.10 0.10 0.69 
OLIG2 oligodendrocyte transcription factor 2 -1.65 2.0E-06 -1.23 
2.0E-
04 -0.43 
4.5E-
03 -0.57 
2.1E-
03 -1.23 
2.2E-
05 -0.45 
4.1E-
03 
PAX8 paired box gene 8 2.13 1.0E-04 2.39 
4.6E-
03 3.44 
4.9E-
04 3.99 0.031 -0.48 0.25 -0.89 0.29 
PRDM7 PR domain containing 7 0.57 0.019 0.87 1.6E-03 1.55 0.015 1.07 
4.2E-
03 -0.08 0.80 -0.87 
3.0E-
03 
RELA 
v-rel reticuloendotheliosis viral 
oncogene homolog A, nuclear factor 
of kappa light polypeptide gene 
enhancer in B-cells 3, p65 (avian) 
1.33 0.038 0.87 3.4E-03 1.50 0.010 1.57 
2.3E-
03 0.01 0.97 -0.28 0.25 
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RORC RAR-related orphan receptor C 0.25 0.57 -0.05 0.89 -1.97 1.5E-05 -2.66 
1.4E-
04 2.38 
2.6E-
03 2.25 
7.2E-
03 
Rxrb retinoid X receptor beta -0.11 0.28 0.51 8.8E-04 -1.51 
4.5E-
06 -1.62 
1.8E-
06 1.49 
5.2E-
06 0.54 0.030 
SALL3 sal-like 3 (Drosophila) 0.74 0.014 0.81 2.9E-03 0.67 0.014 1.17 0.014 -0.65 0.067 -0.75 0.031 
SBB103 ring finger protein RNF41 2.62 4.9E-04 2.11 
1.6E-
03 2.46 
3.4E-
06 2.94 
1.2E-
05 -1.38 0.041 -0.74 0.16 
SP100 nuclear antigen Sp100 0.89 0.035 1.13 1.3E-03 0.96 0.010 1.22 
6.5E-
04 -0.21 0.11 0.00 0.98 
SZF1 KRAB-zinc finger protein SZF1-1 0.64 4.1E-03 0.23 0.038 -0.74 0.028 -1.26 
4.7E-
04 1.26 
1.6E-
04 1.28 
6.3E-
03 
TAF2H 
TAF10 RNA polymerase II, TATA 
box binding protein (TBP)-associated 
factor, 30kDa 
0.04 0.94 -0.31 0.033 -0.54 0.019 -1.07 4.6E-06 0.59 0.080 0.55 
2.8E-
03 
TRIM T cell receptor associated transmembrane adaptor 1 -1.03 0.38 -1.33 0.068 -2.78 
6.4E-
04 -2.05 0.014 1.16 0.074 0.89 0.17 
TRIM4 tripartite motif-containing 4 -1.42 4.8E-03 -0.99 
3.5E-
03 -0.50 0.043 -0.61 0.010 -0.45 0.065 0.02 0.88 
VAV1 vav 1 oncogene 3.81 3.1E-04 3.90 
2.7E-
04 2.68 
8.5E-
03 3.59 
5.5E-
04 0.07 0.85 0.28 0.30 
Wnt10b wingless related MMTV integration site 10b 3.72 
3.0E-
03 3.75 
1.3E-
05 5.01 
1.7E-
03 4.98 
1.7E-
04 0.00 0.00 0.00 0.00 
ZBTB4 zinc finger and BTB domain containing 4 0.00 0.00 0.00 0.00 -2.63 
7.6E-
04 -2.33 
3.0E-
05 1.68 
1.4E-
03 2.36 
2.4E-
05 
ZFD25 zinc finger protein (ZFD25) -0.52 0.075 -1.00 1.4E-04 -1.11 
6.3E-
05 -0.81 
1.0E-
03 0.59 0.010 -0.29 
2.6E-
03 
ZFP1 zinc finger protein 1 homolog 1.33 0.016 2.15 1.4E-05 1.84 
8.5E-
03 1.92 
2.1E-
03 -0.33 0.037 0.67 0.032 
ZIC5 zinc finger protein of the cerebellum 5 -1.89 
8.9E-
05 -1.33 
2.5E-
05 0.34 0.19 0.49 
7.4E-
03 -2.45 
5.9E-
06 -2.05 
1.5E-
04 
ZNF12 zinc finger protein 12 (KOX 3) -0.49 0.30 -0.02 0.93 -1.01 3.0E-03 -1.19 
2.2E-
03 0.77 0.052 0.89 
4.9E-
03 
ZNF2 zinc finger protein 2 (A1-5) -3.69 6.3E-06 -4.05 
3.7E-
09 0.00 0.00 0.00 0.00 -3.36 
4.6E-
07 -4.21 
2.7E-
07 
ZNF21 zinc finger protein ZNF182 -1.12 0.040 -0.93 0.021 -1.46 1.8E-04 -1.71 
1.3E-
03 0.54 0.017 1.01 0.022 
ZNF211 zinc finger protein 211 0.88 5.5E-03 1.31 
2.1E-
05 1.37 
7.0E-
03 2.23 
1.7E-
04 -0.59 0.27 -0.83 0.023 
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ZNF223 zinc finger protein 223 -0.95 1.1E-03 -0.74 
3.0E-
05 -0.21 0.15 -0.10 0.55 -1.09 
1.2E-
04 -0.72 
2.5E-
03 
ZNF31 zinc finger protein 31 (KOX 29) 3.37 3.3E-03 2.80 
3.5E-
04 3.67 
6.4E-
05 4.27 
1.2E-
03 -0.83 0.049 -0.10 0.77 
ZNF323 zinc finger protein 323 -0.42 0.015 -0.19 0.10 -1.39 7.5E-06 -1.35 
5.6E-
05 0.88 
2.3E-
04 1.30 
1.4E-
04 
ZNF42 zinc finger protein 42 (myeloid-specific retinoic acid-responsive) -0.08 0.80 -0.53 
7.6E-
03 -1.16 
5.7E-
04 -1.72 
6.6E-
05 1.64 
5.2E-
04 1.39 
2.5E-
04 
ZNF426 zinc finger protein 426 -1.79 4.2E-04 -2.07 
1.2E-
06 -1.67 
1.8E-
04 -1.31 
1.6E-
04 -0.57 
6.2E-
03 -1.38 
1.0E-
04 
ZNF433 zinc finger protein 433 -0.75 4.5E-03 -1.40 
2.2E-
06 -1.07 
1.9E-
05 -1.16 0.010 -0.05 0.51 -0.47 0.012 
ZNF495 zinc finger protein 495 -0.41 4.9E-03 -0.12 0.59 -1.69 
2.9E-
05 -1.55 
2.5E-
05 1.22 
7.3E-
04 1.28 
3.1E-
04 
ZNF496 zinc finger protein 496 -0.39 0.041 -0.59 4.1E-03 -1.57 
3.8E-
05 -1.32 
8.9E-
03 0.55 
6.4E-
03 0.44 0.046 
ZNF514 zinc finger protein 514 0.77 3.8E-04 0.92 
2.7E-
04 -0.77 
3.1E-
04 -0.89 
3.9E-
03 1.64 
1.9E-
05 1.76 
2.0E-
05 
Table 2-2: Genes differentially expressed with unclear orthologs in the chicken genome.  Data are presented as in Table 2-1.
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Species-specific patterns can be defined for these differentially expressed 
genes (Table 2-3).  For instance, 65 of the 232 genes with known orthologs are 
expressed at higher levels in NC cells of the duck than in NC cells from either the 
chicken or the quail in at least one (though generally at both) of the 
developmental stages.  The largest group of genes, and those with the largest 
fold changes, are differentially expressed in the morphologically distinct duck 
compared to either the chicken or the quail.  One notable exception to this is the 
gene with the largest fold change.  The nucleoporin gene NUP153 encodes a 
nuclear pore complex subunit and is expressed 36-fold higher in chicken NC 
compared to quail NC.  This gene product is involved with mitosis and shuttles a 
transducer for TGFβ signaling (Mackay et al. 2009, Xu et al. 2002), which has a 
number of changes in expression in birds (Figure 2-2, Table 2-1 and Table 2-2, 
and see below).   
 
Overall trend 
Number of genes 
with known 
orthologs 
Number of genes 
with unknown 
orthologs 
Up-regulated Chicken 53 18 
Down-regulated Chicken 8 6 
Up-regulated Duck 65 25 
Down-regulated Duck 32 19 
Up-regulated Quail 55 30 
Down-regulated Quail 19 4 
Table 2-3: Trends of differentially expressed genes. 
 
The differentially expressed genes can also be classified into functional 
categories based on their described functions in NCBI (Table 2-4).  Of the 232 
genes with know orthologs, 37 genes (16%) are members of the Fgf, Notch, 
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Tgfβ, and Wnt signaling pathways and an additional 20 genes (9%) have been 
previously implicated in craniofacial development.  I also identified 140 genes 
that were not previously known to be expressed in the developing face; 115 of 
these have a described function in another developmental system, but 25 
transcription factors have, as yet, unknown functions (Table 2-4). 
 
Functional Group 
Number of genes 
with known 
orthologs 
Number of genes 
with unknown 
orthologs 
Cell cycle 15 3 
Chromatin modification or polycomb 9 2 
Craniofacial development 20 5 
Fgf signaling 8 4 
General transcription factor 11 4 
Notch signaling 7 1 
TGFβ/BMP signaling 9 1 
Wnt signaling 13 1 
Not previously implicated in 
craniofacial development 115 42 
Unknown function 25 39 
Table 2-4: Functional categories of differentially expressed genes.  
 
 
Assessing divergence as a source of false positives 
 In this study I used three species of birds that diverged approximately 90 
million years ago (MYA) (van Tuinen and Hedges 2001). While the 
oligonucleotides on the cross-species microarray have been shown to accurately 
report in the chicken (Hawkins et al. 2003, Hawkins et al. 2007), it is possible that 
evolutionary divergence between the chicken, quail, and duck could contribute to 
false positives in the data set due to varying degrees of sequence homology with 
the probes on the microarray.  This might be expected to manifest itself as higher 
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chicken signals relative to duck, due to more extensive base pairing. In other 
words, microarrays cannot distinguish between a transcript that is not expressed 
and one in which the sequence has diverged enough in duck or quail so it no 
longer hybridizes  to the microarray probe.  To address this issue, I first analyzed 
quail and duck sequences that have been deposited in the NCBI GenBank 
database (http://www.ncbi.nlm.nih.gov/genbank/) using BLAST.  I found that duck 
and quail sequences are well conserved to chicken transcripts--92.6% and 
95.8% average identity, respectively (Table 2-5).  It is not surprising that the quail 
has a slightly higher sequence conservation to chicken given that these two 
species diverged from each other 38.8 MYA, while both diverged from the duck 
89.8 MYA (van Tuinen and Hedges 2001).  Further, I found that the duck and 
chicken have an equal degree of sequence divergence from human--73.0% and 
72.7%, respectively (Table 2-5)—and these values agree with homology 
estimates across the entire chicken genome (70-75%) (International Chicken 
Genome Sequencing Consortium 2004). 
 
Species 
comparison 
Total 
sequence 
analyzed (kbp) 
Average 
sequence 
identity 
Range of 
sequence 
identity 
Duck vs Chicken 25.9 92.6% 82.2% to 100% 
Quail vs Chicken 37.4 95.8% 92.1% to 98.5% 
 
Duck vs Human 5.6 73.0% 67.8% to 89.3% 
Quail vs Human 12.0 72.7% 64.1% to 85.4% 
Table 2-5: Sequence identity of NCBI GenBank entries.  Summary of BLAST analysis of 
chicken, duck, quail, and human GenBank sequences. 
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 To directly address whether sequence identity between the species may 
be causing false positives in the microarray data set, I DNA sequenced selected 
cDNA segments from regions that include microarray probe targets for duck and 
quail.  These sequences were then aligned to the reference chicken genome 
using BLAST.  This analysis was conducted for five genes—CALM2 (quail only), 
OSR1, SATB2, TCEA2, and TGFB2—all of which showed higher gene 
expression in NC cells of the chicken than those of the duck by cross-species 
microarray analysis, and were thus potential false positives.  In total, 953bp of 
duck and 778bp of quail were sequenced and had overall sequence identity to 
the chicken genome of 96.7% and 98.7%, respectively.  In regions where the 50-
70mer microarray probes align, there were at most one or two base pair 
changes.  As this is not enough to appreciably affect target hybridization under 
the conditions I employed (see Materials and Methods), I conclude that 
sequence divergence is most probably not a major source of error in our 
microarray data. 
 
Minimal changes in gene expression between HH20 and HH25 
I first compared HH20 to HH25 neural crest samples within each species 
to measure temporal differences in TF expression between stages that exhibit 
substantial morphological changes (Figure 1-2). In general, I found only minimal 
changes in gene expression between HH20 and HH25 for all three species.  Ten 
genes were differentially expressed by >1.5-fold, but only one of these genes 
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(the transcriptional coactivator PSIP1) had more than a 1.7-fold change between 
the two developmental stages (Table 2-6).  These data indicate that, at least for 
the ~2,400 genes measured on our array, the species-specific genetic program 
for frontonasal mesenchyme was established by HH20, prior to visible 
morphological variations.  This genetic program is then largely maintained 
through HH25, when morphological variations are evident. Thus, frontonasal 
mesenchymal cells show dramatic, species-specific changes in gene expression 
and importantly, these changes predate any species-specific variation in facial 
morphology. 
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CDK5RAP1 CDK5 regulatory subunit associated protein 1 XM_417464 -0.61 
4.4E-
03 0.00 0.98 -0.21 0.29 
ETV4 
ets variant gene 4 (E1A 
enhancer-binding protein, 
E1AF) 
XM_418106 -0.88 0.023 0.00 0.99 0.62 0.048 
FMR2 fragile X mental retardation 2 XR_027199 -0.06 0.20 -0.18 0.23 0.73 
9.8E-
04 
HOXB6 homeobox B6 BX931212 -0.27 0.43 -0.66 7.1E-03 -0.17 0.34 
JUN v-jun avian sarcoma virus 17 oncogene homolog NM_001031289 0.41 0.065 0.66 0.048 -0.50 0.058 
LMO1 LIM domain only 1 (rhombotin 1) XM_420991 -0.68 0.024 -0.18 0.055 0.16 0.37 
MYNN myoneurin XM_001233289 0.69 8.2E-03 0.20 0.30 0.21 0.052 
PSIP1 PC4 and SFRS1 interacting protein 1 NM_001031610 1.98 
4.2E-
03 0.53 
5.3E-
03 -0.09 0.42 
RBBP5 retinoblastoma binding protein 5 NM_001030914 0.63 0.020 0.22 0.39 -0.50 0.35 
SMARCC1 
SWI/SNF related, matrix 
associated, actin 
dependent regulator of 
chromatin, subfamily c, 
member 1 
XR_026888 -0.05 0.75 0.06 0.52 0.71 3.8E-03 
Table 2-6: Genes differentially expressed between HH20 and HH25 in chick, quail, and 
duck embryos.  Average fold changes and p-values for comparisons between HH20 and HH25 
for chicken, duck and quail.  Fold changes are log2 scale, with HH25 relative to HH20. 
Highlighted comparisons pass >1.5-fold change and p-values<0.05 criteria.  Highlighted gene 
names are also differentially expressed between the three species (see Table 2-1). 
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Dramatic changes in Wnt signaling in duck neural crest 
Although there were only subtle changes between the developmental 
stages within each species, the interspecies comparisons at both HH20 and 
HH25 revealed numerous gene expression differences.  In particular, thirteen 
members of the canonical Wnt signaling included some dramatic variations 
between the three species.  For instance, DKK2, FZD1, and WNT1 were all 
expressed 20-fold higher in duck NCs compared to either chicken or quail, at 
either HH20 or HH25 (Figure 2-2, Table 2-1).  Additionally, the Wnt antagonist 
APC and receptor LRP5 were elevated 4- to 5-fold, and the expression levels of 
genes with known Wnt interactions including C3IP1 (Angers et al. 2006), PFDN5 
(Yoshida et al. 2008), and TBX20 (Buescher et al. 2004, Song et al. 2006)  were 
elevated by at least 9-fold in duck NCs compared to the other species.   
Although Wnt signaling has been extensively studies in other aspects of 
facial development—e.g. neural crest induction (Sauka-Spengler and Bronner-
Fraser 2008)—it is just beginning to be evaluated as controlling the facial 
development of different species.  Our collaborators found that the regions of 
Wnt responsiveness differ in mice and birds (Brugmann et al. 2007), as well as 
between different bird species (see Chapter 4).  However, my work was the first 
description of changes in specific Wnt signaling molecules in the species-specific 
facial morphologies.  After this study was published, it was demonstrated that the 
Wnt signaling components DKK3 and CTNNB1 are more highly expressed in 
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Darwin’s finches with a broader beak (Mallarino et al. 2011).  This finding agrees 
very well with my finding that Wnt signaling is differential in the broad-billed duck. 
 
Many additional gene expression changes are observed in the duck 
In contrast to changes in Wnt signaling, nine members of the TGFβ 
signaling pathway are differentially expressed between the species and many of 
these are up-regulated in chick and quail compared to duck.  For example, 
BMP10, TGFB2, and TGFB3 were up-regulated in both quail and chick by 2- to 
4-fold relative to the duck (Figure 2-2 and Table 2-1).  Furthermore, eight 
components of Fgf signaling and seven components of Notch signaling varied 
across the comparisons, including a 2- to 6-fold up-regulation of FGF10, FGF13, 
FGF16, HES1, and LFNG in duck.   
Finally, I observed remarkably large gene expression changes in specific 
transcription factor genes (TFs).  Given the fact that the microarray platform 
interrogates mostly transcription factor gene expression changes, it is not 
surprising that the majority of differences (180 out of 232 genes with known 
orthologs) are in this class of genes.  Many of the observed TF differences, 
however, were remarkably large, particularly between duck and the other two 
species.  For example, the homeobox gene IRX2 was up-regulated by ~8-fold in 
duck NC cells relative to the chicken or quail (Figure 2-2, Table 2-1).  Numerous 
studies have indicated that TF gene expression changes as low as 1.5-fold can 
have biological relevance, since small changes in these regulators can have 
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large effects on downstream targets (Hawkins et al. 2003, Hawkins et al. 2007, 
Wagner et al. 2005).  
 
Changes between morphologically similar chicken and quail 
Despite their similar beak morphologies, comparisons between chicken 
and quail embryo FNP NCs revealed a few large differences in gene expression. 
Among these were the Calmodulin pathway members CALM1 and CALM2 
genes, which were expressed 2-fold less in duck than in chicken (see also Figure 
2-3), and 2-fold less in chicken than in quail.   Comparisons between duck and 
quail showed similar results, with expression of CALM1 and CALM2 being 4-fold 
less in duck than in quail.  Up-regulation of calmodulin gene expression in quail 
was coupled with changes in the Bmp signaling network, in agreement with 
previous observations in the beaks of Darwin’s finches (Abzhanov et al. 2004, 
Abzhanov et al. 2006).  In quail NCs there is a 2- to 4-fold up-regulation of Bmp 
pathway members BMP2, BMP9, and the Bmp antagonist NOGGIN, along with a 
5-fold down-regulation of MADH1.  By contrast, chicken NCs exhibited up-
regulated BMPR1A, JAGGED2, MADH2, OSR2, PAX9, PITX2, and SATB2 
(Figure 2-2, Table 2-1).  It is interesting to note that knock-out of any of these 
genes in mice results in a variety of craniofacial defects (Stanier and Moore 
2004). 
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RNA in situ hybridization confirms the microarray data 
In order to qualitatively validate the microarray data, I conducted whole 
mount RNA in situ hybridizations on HH25 chicken and duck embryos (Figure 2-
3).  All in situs confirmed the trends observed in the microarray data and 
revealed spatial variations in gene expression. Sense strand controls for all 
probes showed no signal (data not shown). 
I started by confirming expression of three genes that have been 
previously implicated in facial development: CALM2, SATB2, and WNT1 (Figure 
2-3).  First, as previously mentioned, the Calmodulin pathway has been 
previously associated with species-specific beak morphology (Abzhanov et al. 
2006).  By in situ, CALM2 (and CALM1, see below) is expressed in higher levels 
and across the entire width of the frontonasal prominence (FNP) of the chicken, 
while its expression is absent from the midline in the duck (Figure 2-3B-C).  The 
probe used was designed to the coding region of CALM2, and could potentially 
cross-hybridize with CALM1.  Therefore, I also designed probes to CALM1 and 
CALM2 3’UTRs, which are conserved between species, but not between the 
genes within a species.  In situ hybridization using CALM1 UTR and CALM2 UTR 
probes demonstrated no appreciable differences in gene expression between the 
two genes, and showed similar expression patterns to the CALM2 coding probe 
(data not shown, Figure 2-3B-C).  Second, mutation of the transcription factor 
SATB2 in mice results in isolated cleft palate (FitzPatrick et al. 2003).  In situs 
show that this gene has a similar expression pattern in chicken and duck as it 
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does in mouse (FitzPatrick et al. 2003): it is expressed across the FNP, with the 
strongest expression in regions that will fuse with the maxillary prominence 
(Figure 2-3F-G). By both microarray and in situ, SATB2 is expressed at higher 
levels in the FNP of the chicken than the duck.  In contrast, this gene is 
expressed at higher levels in the mandibular prominences of the duck compared 
to the chicken (Figure 2-3F-G).   Finally, WNT1 is a marker of neural crest cells 
when they are migrating to the face (Echelard et al. 1994).  I found that this gene 
is extensively expressed throughout the facial prominences in both species 
(Figure 2-3J-K), but at higher levels in both the epithelia and mesenchyme of the 
duck FNP compared to the chicken (Figure 2-3L-M). 
Additionally, I confirmed differential expression patterns for two genes that 
were previously not known to be expressed in the developing face, PHF16 and 
TBX20 (Figure 2-3).  PHF16, a transcription factor of as yet unknown function, is 
expressed throughout the FNP, maxillary, and mandibular prominences.  It has 
higher transcript levels in chicken relative to duck, but a similar spatial distribution 
in both species (Figure 2-3D-E).  TBX20 is particularly interesting since it has 
been shown to negatively regulate the Wnt signaling pathway during Drosophila 
segmentation (Buescher et al. 2004) and positively regulate non-canonical Wnt 
signaling during facial neuron development (Song et al. 2006). It is strongly 
expressed in the developing heart of both species, as previously described 
(Figure 2-4 and data not shown) (Iio et al. 2001), but has never before been 
implicated in facial development. TBX20 is highly expressed in the FNP of the 
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duck, but it is only detectable after extensive RT-PCR in the developing face of 
the chicken (Figure 2-3H-I and Figure 2-4). 
 
Figure 2-3: RNA in situ hybridization confirmation on HH25 chickens and ducks. (A) 
Schematic of vertebrate embryonic facial structures.  (B,D,F,H,J,L) HH25 chicken embryos and 
(C,E,G,I,K,M) HH25 duck embryos probed for (B-C) CALM2, (D-E) PHF16, (F-G) SATB2, (H-I) 
TBX20, or (J-M) WNT1.  See text for description of expression patterns. mn, mandibular 
prominence; mx, maxillary prominence; np, nasal pits (indicated by dotted lines). 
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RT-PCR confirmation 
PCR-based approaches are not ideal for verification of cross-species 
comparisons. As discussed above, the chicken, quail, and duck diverged 
approximately 90 MYA (van Tuinen and Hedges 2001), and thus may have minor 
differences in DNA sequences.  While these sequence differences are not a 
large source of error in the microarray data, the duck and quail genomes are not 
sequenced, and primers designed against the chicken genome may or may not 
work as efficiently in other birds.  For example, if there is sequence divergence in 
the duck it would be predicted that primers designed to the chicken reference 
sequence would have less sequence matches, and thus may produce less or no 
PCR products.   
With these caveats in mind, I verified differential expression of two genes, 
FZD1 and TBX20, both of which are more highly expressed in the duck.  This 
RT-PCR analysis confirmed that FZD1 and TBX20 are more highly expressed in 
the FNP of the duck than in chicken FNP from HH17 to HH27 (Figure 2-4A).  In 
contrast to this differential FNP expression, TBX20 gene expression in the hearts 
of chicken and duck appeared quite uniform (Figure 2-4B).  It should be noted 
that of those genes verified by RT-PCR and in situ hybridization, none were 
found to be uniquely expressed in one species, but not in the others.  This is 
consistent with the idea that evolutionary pressures primarily result in 
modifications  to current genetic programs, rather than utilizing novel genes and 
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pathways, to develop species-specific expression (Carroll S.B. 2005, Carroll S. 
B. 2008, Jacob 1977). 
 
 
Figure 2-4: RT-PCR confirmation on HH17 to HH25 FNPs and hearts from the chicken and 
duck.  (A) FZD1 and TBX20 are expressed at higher levels in duck versus chicken FNPs. 
Amplicons for FZD1 in HH19 embryos were detected in replicate PCR reactions.  (B) In contrast 
the frontonasal prominence, the developing heart of chickens and ducks has similar TBX20 levels 
during the same developmental timecourse. 
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Gene expression changes in the FNP are largely specific to facial 
structures, rather than reflecting species-specific changes in all tissues 
RT-PCR results suggest that the up-regulation of TBX20 may be specific 
to the FNP, as these same changes are not seen in stage-matched hearts 
(Figure 2-4).  I wanted to further evaluate whether the genes changing in the 
FNP have a general upregulation in duck or chicken embryos, rather than 
differential expression specifically in the FNP.  Therefore, I used our cross-
species microarrays to compare gene expression in HH23 chickens and ducks 
for both the developing heart and limb bud.  At later stages the limb buds have 
species-specific morphologies between the speciess—i.e. webbed feet in the 
duck (Merino et al. 1999).  However, at HH23  the leg and wing buds are visually 
indistinguishable (data not shown).   
Though the hearts and wing buds of chickens and ducks have numerous 
changes in gene expression (79 and 155 genes, respectively, with >2-fold 
change and p-value<0.05), only 4 of these genes—the transcription factors FBI1, 
GPA33, IRX2, and JMJD1B--are also differentially expressed with the same 
trend in both these tissues  and the FNP (Table 2-7).    Importantly, neither wing 
buds nor hearts show most of the gene expression changes I identified in the 
FNP--for instance the dramatic differences in Wnt signaling.  This suggests that 
the genes listed in Tables 2-1 and 2-2 are likely contributors to differential beak 
morphology between the chicken, quail, and duck. 
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ProbeID Description 
NCBI 
Accession 
Chick 
Fold 
change 
FNP 
Fold 
change 
limb 
bud 
Fold 
change 
heart 
C5orf7 jumonji domain containing 1B (JMJD1B) Unclear -1.31 -2.93 -3.47 
FBI1 
HIV-1 inducer of short 
transcripts binding 
protein; lymphoma related 
factor 
NM_204680 2.19 1.50 1.71 
GPA33 glycoprotein A33 (transmembrane) 
XM_416656 
 -1.01 -2.45 -2.55 
IRX2 iroquois homeobox protein 2 
NM_001030
336 3.28 2.04 3.53 
Table 2-7: Genes differentially expressed in the same trends among FNP, heart, and limb 
of chicken and duck.  Average fold changes for genes differentially expressed (>2-fold, p-
value<0.05) between staged-matched chicken and duck, and common to the FNP, wing bud, and 
heart.  Fold changes are log2 scale, with expression in duck relative to chicken.  For example, a 
negative number is expressed at a lower level in the duck versus chicken.   
 
 
Conclusions 
In this study, I employed custom cross-species microarrays to describe 
the molecular genetic signatures, developmental signaling pathways, and the 
spectrum of transcription factor gene expression changes that differ between 
cranial neural crest cells in the developing beaks of ducks, quails and chickens. 
Surprisingly, I observed that the neural crest cells established a species-specific 
transcription factor gene expression profile that predates morphological 
differences between the species and this profile remains relatively constant even 
after morphological changes are visually evident. 
I identified 232 genes that were differentially expressed between the three 
species (>2-fold and p-value <0.05) and have identifiable chicken orthologs. 
Twenty-two of these genes, including FGFR2, JAGGED2, MSX2, SATB2, and 
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TGFB3, have already been implicated in a variety of mammalian craniofacial 
defects (Stanier and Moore 2004).  However, the vast majority of genes were not 
previously known to be expressed in the developing face (e.g. TBX20, Figure 2-3 
and Figure 2-4).  Furthermore, 25 of these genes have as yet unknown functions 
(e.g. PHF16, Figure 2-3).  Confirmatory whole-mount RNA in situ hybridizations 
revealed spatial differences in expression; for example, CALM1 and CALM2 are 
expressed across the width of the chicken FNP, but are not expressed at the 
midline of the duck.   
The most dramatic observed changes were in the Wnt signaling pathway.  
Duck neural crest cells show a 20-fold up-regulation of DKK2, FZD1, and WNT1, 
as well as a 10-fold elevation of transcripts for the Wnt interacting genes C3IP1 
(Angers et al. 2006), PFDN5 (Yoshida et al. 2008), and TBX20 (Buescher et al. 
2004, Song et al. 2006).  Additionally, I identified changes in both Bmp and 
Calmodulin signaling between the three bird species.  My work is thus, 
complimentary to, and extends upon previous studies of morphological variation 
in avian beaks (Abzhanov et al. 2004, Abzhanov et al. 2006, Merino et al. 1999, 
Wu et al. 2004, Wu et al. 2006). 
Previous studies (Abzhanov et al. 2004, Abzhanov et al. 2006, Wu et al. 
2004, Wu et al. 2006) that implicated modulations in BMP4 and CALM1 activity in 
altered beak morphology were conducted after morphological variation is evident.  
They did not clarify whether these genes are initiating morphological changes or 
whether their expression is simply changing in response to an upstream 
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mediator. Consistent with this latter role for Bmp activity in patterning the face, 
our microarray analyses did not detect significant variations in BMP4 expression 
levels between billed and beaked embryos, though they do demonstrate 
differences in gene expression as morphological variation arises (Brugmann et 
al. 2006). One explanation for this finding is that BMP4 expression begins to 
gradually switch to mesenchyme (which we analyzed in this study) from epithelia 
at HH24 (Francis-West et al. 1994) and it may be at this later stage of embryonic 
development when Bmp signaling becomes most critical for the growth of the 
facial prominences.   
In contrast to the previous studies, my study evaluated the developing 
beak of chickens, quails, and ducks prior to morphological variation and thus may 
identify the early modulators of differential form.  The >300 genes I identified 
using an unbiased microarray approach of transcription factors and members of 
developmental signaling pathways can therefore be used to further study 
evolution of the face.  This study is the first of its kind, extending on previous 
work in Darwin’s finches, and provides the first large-scale insights into cross-
species facial morphogenesis.   Additionally, given the conserved molecular 
“toolbox” of facial development  (Abzhanov et al. 2004, Albertson et al. 2005, Liu 
et al. 2005, Suzuki et al. 2009, Terai et al. 2002) exploiting natural variation in 
bird beak shapes may be a useful tool to discover new candidate genes that 
regulate mammalian craniofacial development.  I explore this concept further in 
Chapter 4. 
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CHAPTER 3 
Next-Generation Sequencing to Detect miRNAs in Frontonasal  
Neural Crest Cells of Chickens, Ducks, and Quails 
 80 
 Introduction 
 Through my studies in Chapter 2 and previous work (Abzhanov et al. 
2004, Abzhanov et al. 2006, Mallarino et al. 2011, Wu et al. 2004, Wu et al. 
2006), we are beginning to understand some of the changes in transcription 
factor and developmental signaling pathway gene expression that influence 
species-specific beak morphology.  However, the potential roles of microRNAs 
(miRNAs) in craniofacial development and species-specific facial form are largely 
unexplored.  It is clear that miRNAs play major roles in overall facial specification, 
since disruption of their processing pathway results in widespread failures in 
facial development (Huang T. et al. 2010, Zehir et al. 2010).  One previous study 
(Mukhopadhyay et al. 2010) described an analysis of some of the miRNAs 
expressed in one area of the developing vertebrate face.  Using microarrays, 70 
miRNAs were detected in the developing mouse palate from embryonic stages 
E12-E14.  Many of these miRNAs were developmentally regulated and 
potentially regulate mRNAs involved in cell proliferation, differentiation, 
apoptosis, and other processes necessary for normal facial development 
(Mukhopadhyay et al. 2010).   
 In this chapter, I used comprehensive deep miRNA sequencing to assess 
all the miRNAs that are expressed in frontonasal neural crest cells, which give 
rise to the bones and cartilage of the upper bill in birds (Kontges and Lumsden 
1996, Noden 1978, Schneider and Helms 2003, Tucker and Lumsden 2004). I 
employed genome-wide bioinformatic approaches to identify miRNAs expressed 
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in the developing beak of chickens, ducks, and quails both before (HH20) and 
after (HH25) morphological variations are evident (Figure 1-2).  I then examined 
patterns of differential miRNA expression between the developmental stages 
within the three bird species.  Finally, I verified a number of changes in miRNA 
gene expression using quantitative reverse transcription PCR (qRT-PCR) and 
RNA in situ hybridization.  My follow-up studies on potential mRNA targets of 
these various miRNAs are presented in Chapter 4. 
 
Results 
Identification of expressed microRNAs and novel avian microRNA 
orthologs 
 Short RNAs were purified from the upper beak primordia of the chicken, 
duck, and quail (see Materials and Methods) and were analyzed by Next- 
Generation miRNA sequencing (miRNA-seq) on the Illumina GAIIX platform.   
Figure 3-1 illustrates the analysis pathway used to annotate the resulting 
sequence reads and Figure 3-2 displays the classification of reads for each 
sample. 
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Figure 3-1: Schematic of analysis pipeline to annotate small RNA reads from frontonasal 
neural crest cells.  See text for further details.  Embryo images adapted from (Brugmann et al. 
2010).
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Figure 3-2: Classification of Next-Generation short RNA sequencing (miRNA-seq) reads.  Reads are annotated as “mapped” if they 
can be located within the current version of the chicken genome (Gallus gallus, gga3 genome build). 
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gga-let-7a UGAGGUAGUAGGUUGUAUAGUU 
chr12: 6302911-
6303000 (7a-1), 
chr24: 3380993-
3381064 (7a-2), 
chr1: 73421272-
73421347 (7a-3) 
9139.27 52203.34 
15524.
66 
30817.
19 
7790.4
9 19168.02 
3356.7
6 
22898.
99 
4151.6
4 
18529.
14 
gga-let-
7a_ukstar CUAUACAAUCUACUGUCUUUC 
chr12: 6302911-
6303000 (7a-1), 
chr24: 3380993-
3381064 (7a-2), 
chr1: 73421272-
73421347 (7a-3) 
3.88 107.97 1.48 8.81 4.10 5.81 56.33 28.78 7.99 11.66 
gga-let-7b UGAGGUAGUAGGUUGUGUGGUU chr1: 73422101-73422185 11.64 519.10 25.79 29.89 24.59 30.02 4.20 44.90 3.46 19.00 
gga-let-7c UGAGGUAGUAGGUUGUAUGGUU chr1: 102425086-102425169 12995.39 
36930.
00 
23616.
55 
25975.
08 
8306.8
4 18837.46 
3579.4
9 
30090.
55 
4702.1
1 
21031.
66 
gga-let-
7c_ukstar CUGUACAACCUUCUAGCUUUCC 
chr1: 102425086-
102425169 9.58 44.56 5.93 17.62 10.70 17.43 46.00 47.52 18.68 15.79 
gga-let-7d AGAGGUAGUGGGUUGCAUAGU chr12: 6301452-6301554 7.53 47.02 12.75 25.80 19.12 38.42 3.07 15.82 2.05 15.60 
gga-let-7f UGAGGUAGUAGAUUGUAUAGUU chr12: 6302497-6302583 4781.53 
20195.
87 
13096.
68 
45740.
92 
6532.6
4 13093.86 
3843.0
5 
11984.
18 
6518.3
0 
19168.
47 
gga-let-7g UGAGGUAGUAGUUUGUACAGU chr12: 2809078-2809160 478.11 
4179.3
0 930.10 
3278.6
3 670.02 1363.26 334.42 
1668.0
8 354.49 
1948.3
7 
gga-let-7i UGAGGUAGUAGUUUGUGCUGU chr1: 34895687-34895770 9.58 259.96 22.53 116.10 14.80 23.89 7.91 67.76 9.50 79.58 
gga-let-7k UGAGGUAGUAGAUUGAAUAGUU chr26: 1442897-1442979 192.16 839.47 460.75 801.41 133.64 192.40 211.43 662.57 712.76 713.59 
gga-miR-
100 AACCCGUAGAUCCGAACUUGUG 
chr24: 3372894-
3372973 4589.60 
18485.
50 
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9 
4243.0
1 5955.04 
3406.4
7 
7458.4
9 
2209.2
3 
5100.4
9 
gga-miR-
100_ukstar CAAGCUUGUAUCUAUAGGUAUG 
chr24: 3372894-
3372973 20.54 89.66 44.47 37.44 30.73 53.59 17.59 26.84 27.10 36.90 
gga-miR-
101 GUACAGUACUGUGAUAACUGAA 
chrZ: 28037874-
28037952 (101), 
chr8: 29051918-
29051993 (101-2) 
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gga-miR-
103 AGCAGCAUUGUACAGGGCUAUGA 
chr13: 4449242-
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chr4: 91906889-
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43640.
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23456.
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86 
gga-miR-
106 AAAAGUGCUUACAGUGCAGGUA 
chr4: 3970359-
3970439 14118.66 
14005.
25 
10901.
75 
13715.
48 
12962.
38 15972.76 
9061.3
8 
9670.4
8 
12530.
94 
11001.
87 
gga-mir-
106_ukstar CUGCAGUAUAAGCACUUCUGGC 
chr4: 3970359-
3970439 12.10 7.38 28.17 20.45 4.33 5.17 19.85 9.52 25.37 17.26 
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gga-miR-
107 AGCAGCAUUGUACAGGGCUAUCA 
chr6: 20487964-
20488044 135.33 303.15 94.58 205.15 90.16 132.03 152.20 131.85 87.79 96.56 
gga-miR-
10a UACCCUGUAGAUCCGAAUUUGU 
chrUn_random: 
379304-379377 18.03 3.28 22.83 7.55 22.54 24.86 11.94 72.49 29.37 41.12 
gga-miR-
10b UACCCUGUAGAACCGAAUUUGU 
chr7: 17389048-
17389157 2.51 0.82 3.85 13.22 19.81 15.50 4.03 26.16 2.48 16.06 
gga-miR-
122 UGGAGUGUGACAAUGGUGUUUGU 
chrZ: 649337-
649413 (122-1), 
chrUn_random: 
12066796-
12066872 (122-2) 
19.40 2.19 20.46 3.78 142.75 18.72 50.52 525.99 49.45 140.17 
gga-miR-
125b UCCCUGAGACCCUAACUUGUGA 
chr1: 102457647-
102457736 5816.25 
13707.
29 
3012.9
6 
2806.9
7 
3014.2
9 4129.18 
4673.7
7 
7733.2
9 
2382.6
4 
4737.1
8 
gga-miR-
125b_ukst
ar 
UCACAAGUCAGGCUCUUGGGAC chr1: 102457647-102457736 1056.86 
2341.2
7 
1062.9
3 909.33 782.49 1733.22 
1037.6
3 
1369.1
4 956.79 
1244.2
4 
gga-miR-
126 UCGUACCGUGAGUAAUAAUGCGC 
chr17: 8431742-
8431825 29194.22 
4782.0
4 
39285.
01 
23690.
12 
20419.
57 22925.64 
15666.
45 
16078.
93 
34285.
67 
36728.
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gga-miR-
126* CAUUAUUACUUUUGGUACGCG 
chr17: 8431742-
8431825 1080.59 209.94 
1393.2
2 
1090.5
7 
1354.6
1 1573.74 740.82 517.30 
1140.1
4 991.81 
gga-miR-
128 UCACAGUGAACCGGUCUCUUU 
chr7: 32228150-
32228231 (128-1), 
chr2: 45549176-
45549259 (128-2) 
420.37 638.01 489.21 665.48 737.64 499.40 866.06 390.61 1059.91 524.86 
gga-miR-
130a CAGUGCAAUAUUAAAAGGGCAU 
chr15: 408399-
408481 1352.62 
1307.7
2 
1376.0
2 
1868.0
6 
1252.8
4 1647.67 
1527.4
7 
1375.2
9 
1561.7
9 
2197.9
5 
gga-mir-
130a_ukst
ar 
GCCCUUUUUCUGUUGUACUAC chr15: 408399-408481 36.97 39.36 21.64 21.40 49.63 34.86 130.41 60.34 41.03 16.61 
gga-miR-
130b CAGUGCAAUAAUGAAAGGGCGU 
chr15: 398720-
398796 12435.58 
9991.3
3 
20911.
35 
36747.
67 
15780.
65 20471.89 
21554.
74 
12525.
17 
23722.
30 
23780.
17 
gga-miR-
130b_ukst
ar 
CCUCUUUCCCUGUUGCACUAC chr15: 398720-398796 326.80 227.43 578.75 384.18 605.59 425.48 688.36 391.29 597.87 461.90 
gga-miR-
130c CAGUGCAAUGUUAAAAGGGCAU 
chr19: 7145027-
7145120 242.36 361.37 206.06 430.44 254.76 333.15 206.43 198.57 304.07 360.10 
gga-miR-
1329 UACAGUGAUCACGUUACGAUGG 
chr3: 99798387-
99798481 243.73 194.08 104.66 131.84 12.29 15.50 122.18 340.99 63.06 192.67 
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gga-miR-
135a UAUGGCUUUUUAUUCCUAUGUGA 
chr12: 2830742-
2830829 (135a-1), 
chr1: 48192659-
48192758 (135a-
2), chr26: 1925942-
1926037 (135a-3) 
47.01 2706.74 110.59 186.59 222.88 215.00 223.86 121.06 167.15 216.90 
gga-mir-
135a-
3_ukstar 
AUGUAGGGCGAAAAGCCAUGG chr26: 1925942-1926037 32.18 907.26 61.67 75.20 111.56 129.45 35.83 55.32 38.44 87.39 
gga-miR-
135b_ukst
ar 
AUGUAGGGCUAAAAGCCAUGGG chr3: 38893084-38893150 10.73 160.73 13.94 15.10 20.03 11.94 5.33 15.97 12.20 25.61 
gga-miR-
137 UAUUGCUUAAGAAUACGCGUAG 
chr8: 13210193-
13210288 51.80 
1119.3
8 97.55 65.76 37.11 64.24 25.66 47.07 60.79 54.16 
gga-miR-
138 AGCUGGUGUUGUGAAUC 
chr2: 40745148-
40745243 (138-1), 
chr11: 2023954-
2024036 (138-2) 
382.03 707.71 295.60 364.68 454.19 385.45 239.03 170.08 298.02 264.73 
gga-miR-
140-3p CCACAGGGUAGAACCACGGAC 
chr11: 21030641-
21030735 12042.14 
10822.
60 
15195.
26 
24397.
44 
14850.
41 25781.62 
14906.
10 
33941.
15 
16723.
39 
39693.
35 
gga-miR-
140-5p AGUGGUUUUACCCUAUGGUAG 
chr11: 21030641-
21030735 923.81 697.87 
1256.8
3 
2036.0
8 
1361.6
7 1704.48 859.61 
2149.5
4 
1461.1
6 
3658.1
7 
gga-miR-
142-3p UGUAGUGUUUCCUACUUUAUGG 
chr19: 496983-
497070 201.06 54.40 386.63 127.12 259.31 160.12 132.19 109.14 501.88 312.92 
gga-miR-
142-5p CCCAUAAAGUAGAAAGCACUAC 
chr19: 496983-
497070 6.16 1.37 11.56 9.44 13.66 5.49 12.43 6.07 18.68 15.70 
gga-miR-
144 CUACAGUAUAGAUGAUGUACUC 
chr19: 5824123-
5824207 4.79 6.83 21.94 5.03 16.16 3.55 9.36 5.40 32.83 26.16 
gga-miR-
144_ukstar GGAUAUCAUCAUAUACUGUAAG 
chr19: 5824123-
5824207 786.88 269.80 
2274.1
0 
2272.3
8 
1305.4
4 1107.91 
1784.7
4 660.99 
1953.0
0 
1733.3
9 
gga-miR-
1451 UCGCACAGGAGCAAGUUACCGC 
chr3: 78710207-
78710316 121.64 188.89 104.96 158.27 116.79 118.47 165.27 81.41 92.54 85.46 
gga-miR-
146a UGAGAACUGAAUUCCAUGGGUU 
chr13: 7555593-
7555691 44126.00 
39674.
20 
57559.
65 
30769.
05 
49111.
38 48752.13 
45759.
32 
68575.
23 
60226.
16 
59003.
92 
gga-miR-
146b UGAGAACUGAAUUCCAUAGGCG 
chr6: 24570060-
24570164 262.90 43.46 
3041.4
2 
1394.2
0 235.63 254.38 145.74 275.40 
3533.7
9 
2752.1
9 
gga-miR-
146c UGAGAACUGAAUUCCAUGGACUG 
chr4: 92169271-
92169399 (146c-1), 
chrUn_random: 
14731534-
14731662 (146c-2) 
35344.57 33936.24 
45844.
03 
26167.
02 
39107.
06 39397.80 
40658.
01 
55716.
57 
51278.
36 
46702.
65 
gga-miR-
148a UCAGUGCACUACAGAACUUUGU 
chr2: 32053543-
32053610 20508.64 
14914.
42 
38440.
31 
28040.
43 
21598.
65 31209.50 
18211.
05 
14185.
15 
20588.
78 
21031.
66 
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gga-miR-
148a_ukst
ar 
AAAGUUCUGUGACACUCAGACU chr2: 32053543-32053610 104.07 147.88 165.74 64.19 131.59 190.79 147.03 168.81 180.00 149.62 
gga-miR-
1552-5p UUAGUGCGCGGUAAGCUAGGGUG 
chrUn_random: 
9521375-9521457 136.93 113.17 689.05 499.03 269.33 202.73 71.02 87.93 366.37 731.03 
gga-miR-
1552-5p UUAGUGCGCGGUAAGCUAGGGU 
chrUn_random: 
9521375-9521457 94.94 79.27 671.56 484.87 230.85 166.25 53.91 62.82 360.32 717.72 
gga-miR-
1559 UUCGAUGCUUGUAUGCUACUCC 
chr7: 1330064-
1330139 344.37 322.56 767.62 530.81 512.02 591.08 216.92 343.24 567.21 714.32 
gga-miR-
15a UAGCAGCACAUAAUGGUUUGU 
chr1: 173700493-
173700575 43.82 181.51 107.33 155.12 133.18 121.70 62.62 55.17 157.00 116.12 
gga-miR-
15b UAGCAGCACAUCAUGGUUUGCA 
chr9: 23742966-
23743056 263.13 844.93 476.76 
1023.2
3 369.73 484.23 256.14 292.64 431.16 561.76 
gga-miR-
15b_ukstar CGAAUCAUUAUUUGCUGCUUUA 
chr9: 23742966-
23743056 27.16 54.67 19.57 19.51 62.61 58.75 138.16 50.52 46.43 24.42 
gga-miR-
15c UAGCAGCACAUCAUGGUUUGUA 
chr4: 4049055-
4049130 178.23 576.23 366.47 686.88 169.16 292.15 148.81 233.42 292.51 455.47 
gga-miR-
16 UAGCAGCACGUAAAUAUUGGUG 
chr1: 173700351-
173700434 (16-1), 
chr9: 23742791-
23742884 (16-2) 
16928.20 29409.24 
31949.
48 
44855.
19 
11699.
74 20355.35 
8993.6
0 
15636.
74 
26935.
07 
30370.
26 
gga-miR-
1662 UUGACAUCAUCAUACUUGGGAU 
chr2: 1721334-
1721406 9.13 24.33 43.58 30.21 4.55 3.55 2.74 7.50 43.95 57.19 
gga-miR-
16c UAGCAGCACGUAAAUACUGGAG 
chr4: 4048689-
4048759 16410.15 
28254.
60 
30839.
12 
42737.
29 
10673.
65 19017.91 
8427.9
0 
15028.
30 
25473.
16 
29228.
28 
gga-miR-
17-3p ACUGCAGUGAAGGCACUUGU 
chr1: 152248781-
152248865 101.78 281.83 135.20 97.23 167.33 186.27 124.28 87.33 207.64 149.71 
gga-miR-
17-5p CAAAGUGCUUACAGUGCAGGUAGU 
chr1: 152248781-
152248865 11764.64 
12780.
08 
11717.
40 
10119.
37 
11092.
10 13575.83 
7089.4
2 
7634.8
0 
9103.8
3 
9958.5
6 
gga-miR-
181a AACAUUCAACGCUGUCGGUGAGU 
chr8: 2001561-
2001664 (181a-1), 
chr17: 10218497-
10218587 (181a-2) 
1451.67 4046.99 
1448.0
7 
1033.3
0 
1641.9
3 1353.26 
1231.3
1 
2299.6
1 
1524.6
5 
2821.4
0 
gga-miR-
181a* ACCAUCGACCGUUGAUUGUACC 
chr8: 2001561-
2001664 (181a-1), 
chr17: 10218497-
10218587 (181a-2) 
237.34 1162.30 565.71 580.52 479.24 614.32 276.96 615.27 309.90 600.41 
gga-miR-
181b AACAUUCAUUGCUGUCGGUGGG 
chr8: 2001750-
2001838 (181b-1), 
chr17: 10220137-
10220221 (181b-2) 
2704.10 2432.84 
3412.0
4 
1328.1
3 
2094.5
3 1443.65 
1972.9
3 
4275.7
0 
3248.1
9 
4556.3
5 
gga-miR-
183 UAUGGCACUGGUAGAAUUCACUG 
chrUn_random: 
22621072-
22621094 
1270.24 183.69 2622.78 
2653.7
4 712.82 1142.13 
1288.6
0 
2724.6
4 
2079.7
6 795.74 
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gga-miR-
184 UGGACGGAGAACUGAUAAGGGU 
chr10: 22146245-
22146318 1430.44 271.17 245.79 801.72 67.16 135.26 
1897.2
4 
1883.5
9 189.93 597.93 
gga-miR-
187 UCGUGUCUUGUGUUGCAGCC 
chr2: 85892470-
85892555 11.41 10.66 11.86 7.87 11.61 10.98 12.75 18.66 5.83 14.23 
gga-miR-
18a UAAGGUGCAUCUAGUGCAGAUA 
chr1: 152248626-
152248718 6312.39 
6845.8
6 
7633.8
0 
4018.6
8 
6270.6
0 6026.39 
2851.7
5 
3031.6
7 
6071.3
8 
4489.8
9 
gga-miR-
18a_ukstar ACUGCCCUAAAUGCUCCUUCUGG 
chr1: 152248626-
152248718 149.71 239.73 90.13 92.51 204.67 143.65 288.74 76.98 211.64 49.57 
gga-miR-
18b UAAGGUGCAUCUAGUGCAGUUA 
chr4: 3970228-
3970311 10043.22 
12087.
13 
12142.
87 
6179.9
9 
9121.8
8 9911.51 
5545.0
0 
5292.6
8 
10383.
47 
7043.3
5 
gga-mir-
18b_ukstar CUGCCCUAAAUGCUCCUUCU 
chr4: 3970228-
3970311 82.61 154.72 54.26 52.86 175.99 95.23 255.17 51.65 161.43 30.11 
gga-miR-
190 UGAUAUGUUUGAUAUAUUAGGU 
chr10: 5209724-
5209808 83.75 132.85 81.54 52.55 150.94 138.81 32.60 68.59 54.31 89.13 
gga-miR-
193a_ukst
ar 
UGGGUCUUUGCGGGCGAGAUGA chr18: 6423770-6423846 31.49 3.01 13.64 3.78 23.68 18.08 11.46 14.24 9.39 11.93 
gga-miR-
193b AACUGGCCCACAAAGUCCCGCUUU 
chr14: 759453-
759535 6.16 5.19 4.15 5.66 10.24 4.20 13.88 2.62 3.56 3.03 
gga-miR-
193b_ukst
ar 
UGGGUCUUUGCGGGCGAGAUGA chr14: 759453-759535 31.49 3.01 13.64 3.78 23.68 18.08 11.46 14.24 9.39 11.93 
gga-miR-
199 CCCAGUGUUCAGACUACCUGUUC 
chr17: 5667150-
5667243 (199-1), 
chr8: 4732773-
4732880 (199-2) 
1521.04 57.40 2897.92 
3282.0
9 
2252.7
5 2856.63 
2217.2
9 
3865.9
0 
2553.2
4 
5004.8
5 
gga-miR-
199* UACAGUAGUCUGCACAUUGG 
chr17: 5667150-
5667243 (199-1), 
chr8: 4732773-
4732880 (199-2) 
6804.19 258.05 5740.10 
9006.7
8 
21859.
10 18221.84 
6160.5
7 
12982.
12 
3724.0
5 
7882.7
0 
gga-miR-
19a UGUGCAAAUCUAUGCAAAACUGA 
chr1: 152248492-
152248572 301.93 955.64 511.15 429.18 653.40 385.77 244.52 247.44 748.83 825.57 
gga-mir-
19a_ukstar GUUAGUUUUGCAUAGUUGCAC 
chr1: 152248492-
152248572 119.36 307.52 354.90 516.65 295.97 316.04 134.77 71.66 577.68 337.61 
gga-miR-
19b UGUGCAAAUCCAUGCAAAACUGA 
chr1: 152248183-
152248269 1461.94 
2687.6
1 
1779.2
5 
2471.5
6 
3101.2
6 2085.41 
1594.1
3 826.51 
2965.5
0 
2288.7
3 
gga-miR-
19b_ukstar AGUUUUGCAGGUUUGCAUCCAGC 
chr1: 152248183-
152248269 33.32 64.24 45.07 60.10 120.66 78.12 65.53 17.47 67.27 24.60 
gga-miR-
1a UGGAAUGUAAAGAAGUAUGUA 
chr20: 8107831-
8107901 (1a-1), 
chr2: 105673483-
105673567 (1a-2) 
168.42 89.93 374.17 284.76 259.77 497.46 43.09 339.87 138.64 179.54 
gga-miR-
1b UGGAAUGUUAAGAAGUAUGUA 
chr23: 4663912-
4663975 3.88 3.28 18.68 11.96 5.69 13.24 0.48 3.90 8.64 21.11 
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gga-miR-
200a UAACACUGUCUGGUAACGAUGU 
chr21: 2583317-
2583403 193.75 11.75 869.02 642.51 473.54 308.94 75.21 201.27 284.31 127.59 
gga-miR-
200b UAAUACUGCCUGGUAAUGAUGAU 
chr21: 2585642-
258572 57.97 2.19 211.70 128.38 144.34 75.22 34.54 80.88 79.47 33.04 
gga-miR-
203 GUGAAAUGUUUAGGACCACUUG 
chr5: 53206814-
53206911 28.98 11.75 88.06 143.48 42.12 33.90 12.91 23.16 22.68 91.24 
gga-miR-
204 UUCCCUUUGUCAUCCUAUGCCU 
chr28: 1784403-
1784424 (204-1), 
chr10: 6651274-
6651374 (204-2) 
26.47 79.55 18.68 23.60 38.70 20.01 52.29 67.91 53.34 68.84 
gga-miR-
205a UCCUUCAUUCCACCGGAGUCUG 
chr26: 2896047-
2896142 35.60 14.49 95.17 138.76 287.77 81.03 47.45 18.14 23.00 67.01 
gga-miR-
20a UAAAGUGCUUAUAGUGCAGGUAG 
chr1: 152248306-
152248403 15628.98 
18886.
79 
16715.
38 
19226.
21 
16075.
25 19027.92 
8407.7
2 
10160.
94 
17014.
29 
16477.
33 
gga-miR-
20b CAAAGUGCUCAUAGUGCAGGUAG 
chr4: 3970047-
3970131 51596.57 
36893.
10 
43401.
82 
21338.
44 
30810.
92 36328.44 
25007.
21 
29799.
48 
30020.
22 
29747.
73 
gga-mir-
20b_ukstar ACUGUAAUGUGGGCACUUACAGU 
chr4: 3970047-
3970131 19.40 15.85 24.91 7.87 18.90 12.59 15.82 8.02 8.42 7.80 
gga-miR-
21 UAGCUUAUCAGACUGAUGUUGA 
chr19: 7322072-
7322168 62784.97 
18764.
32 
38879.
41 
31810.
22 
29582.
43 32997.91 
37014.
76 
43764.
32 
33669.
00 
29563.
14 
gga-miR-
211 UUCCCUUUGUCAUCCUAUGCCU 
chr28: 1784394-
1784467 26.02 75.99 18.09 22.34 37.11 19.37 51.49 66.41 51.83 64.80 
gga-miR-
2131 AUGCAGAAGUGCACGGAAACAGC 
chrZ: 68816728-
68816816 13.92 29.80 16.60 33.35 23.68 29.70 46.32 14.62 18.03 17.35 
gga-mir-
2131_ukst
ar 
CUGUUACUGUUCUUCUGAUG chrZ: 68816728-68816816 115.93 213.49 67.90 122.40 42.57 45.52 182.38 153.29 99.56 84.17 
gga-miR-
215 AUGACCUAUGAAUUGACAGAC 
chr3: 19924793-
19924897 249.44 889.49 26.09 47.51 275.70 524.58 168.82 289.42 31.42 61.50 
gga-miR-
218 UUGUGCUUGAUCUAACCAUGU 
chr4: 77774698-
77774806 (218-1), 
chr13: 4322860-
4322954 (218-2) 
377.47 1379.89 428.43 850.18 480.83 737.96 214.50 429.59 298.34 651.81 
gga-miR-
2188 AAGGUCCAACCUCACAUGUCCU 
chr22: 2684926-
2685094 19.40 8.75 23.72 21.71 41.66 33.25 70.05 23.16 41.14 14.50 
gga-miR-
22 AAGCUGCCAGUUGAAGAACUGU 
chr19: 5352096-
5352195 65.50 53.85 172.56 113.59 104.50 204.67 40.51 53.45 163.59 145.40 
gga-miR-
22* AGUUCUUCAGUGGCAAGCUUUA 
chr19: 5352096-
5352195 3.88 2.73 8.60 18.88 15.94 7.75 6.62 3.97 28.72 15.60 
gga-miR-
221 AGCUACAUUGUCUGCUGGGUUUC 
chr1: 114218926-
114219024 433.83 384.06 588.54 616.39 
1302.7
0 613.03 646.40 368.65 619.25 360.10 
gga-miR-
221_ukstar ACCUGGCAUACAAUGUAGAUUU 
chr1: 114218926-
114219024 852.15 533.04 
1514.1
9 
1046.2
0 
1154.4
9 1087.90 
1436.9
3 449.38 660.39 427.66 
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gga-miR-
222 AGCUACAUCUGGCUACUGGGUCUC 
chr1: 114216027-
114216124 (222-
1), chr1: 
114218422-
114218519 (222-2) 
849.41 470.17 1321.77 
1586.1
4 988.75 555.57 952.25 437.69 
1204.2
8 630.24 
gga-miR-
223 UGUCAGUUUGUCAAAUACCCC 
chr4: 232949-
233048 65.50 16.67 58.11 70.80 70.35 66.50 171.73 57.49 154.52 51.04 
gga-miR-
23b AUCACAUUGCCAGGGAUUACC 
chrZ: 41157406-
41157491 160.66 202.01 347.49 533.01 272.97 286.66 268.08 243.24 483.63 705.33 
gga-miR-
24 UGGCUCAGUUCAGCAGGAACAG 
chrZ: 41158175-
41158242 2993.71 
2171.5
2 
5471.1
8 
5497.5
2 
1837.7
2 3069.36 
1993.2
7 
2060.7
2 
3837.7
5 
5740.8
3 
gga-miR-
26a UUCAAGUAAUCCAGGAUAGGC 
chr2: 4467516-
4467592 1662.31 
2299.7
2 
3483.7
9 
5407.8
4 
2847.4
2 2994.79 
1984.2
3 
2207.4
1 
4573.0
8 
4836.9
6 
gga-miR-
27b UUCACAGUGGCUAAGUUCUGC 
chrZ: 41157642-
41157738 1497.77 
1554.5
6 
2873.3
1 
3137.9
8 
1166.7
9 1735.48 
1083.4
7 
1219.9
7 
2422.0
5 
3828.3
5 
gga-miR-
27b_ukstar AGAGCUUAGCUGAUUGGUGAAC 
chrZ: 41157642-
41157738 54.77 30.89 91.32 39.96 33.24 36.80 19.69 46.03 40.17 98.31 
gga-miR-
2954 CAUCCCCAUUCCACUCCUAGCA chrZ 7016.43 
11991.
73 
4868.7
1 
2553.9
9 
12564.
87 6274.96 
11848.
73 
1668.3
8 
4839.5
7 
2301.4
9 
gga-miR-
2954_ukst
ar 
GCUGAGAGGGCUUGGGGAGAGGA chrZ 674.60 367.93 1362.09 174.94 909.52 588.50 
2070.5
8 76.76 522.72 72.88 
gga-miR-
2964 CACAAGAAUUGCGUUUGGACAA 
chr17: 5577814-
5577902 372.44 532.49 99.33 188.79 407.29 635.63 252.27 333.50 148.15 182.39 
gga-miR-
301 CAGUGCAAUAAUAUUGUCAAAGCAU 
chr15: 406313-
406405 257.20 636.09 528.94 557.24 403.65 197.24 390.26 277.65 564.62 833.74 
gga-mir-
301_ukstar UCUGACAAUGUUGCACUAC 
chr15: 406313-
406405 109.09 110.71 108.52 78.66 351.29 181.42 151.88 84.25 107.65 81.05 
gga-miR-
301b-3p CAGUGCAAUAGUAUUGUCAAAGCAU 
chr19: 7144739-
7144828 214.52 516.36 447.70 453.09 319.42 161.41 316.82 231.85 451.89 686.97 
gga-miR-
302b UAAGUGCUUCCAUGUUUUAGUAG 
chr4: 58651314-
58651385 444.79 84.74 271.88 66.39 613.33 197.57 306.33 58.02 585.89 68.29 
gga-miR-
302b* ACUUUAACAUGGAGGUGCUUUCU 
chr4: 58651314-
58651385 130.99 16.67 85.69 16.68 89.47 22.27 121.69 17.62 245.65 18.17 
gga-miR-
302c UAAGUGCUUCCAUGUUUCAGUGG 
chr4: 58651576-
58651640 170.25 73.81 177.30 59.47 476.28 171.09 238.06 28.78 447.46 47.00 
gga-miR-
30a-3p CUUUCAGUCGGAUGUUUGCAGC 
chr3: 85102239-
85102310 2230.79 
6708.6
3 
4468.7
4 
9692.7
1 
3766.7
3 5483.08 
7062.7
9 
3622.3
5 
8660.2
6 
7415.1
1 
gga-miR-
30a-5p UGUAAACAUCCUCGACUGGAAG 
chr3: 85102239-
85102310 3014.70 
23342.
44 
11160.
29 
22406.
35 
7587.6
4 13890.26 
3701.3
5 
5572.9
5 
12593.
78 
20119.
25 
gga-miR-
30b UGUAAACAUCCUACACUCAGCU 
chr2: 148331598-
148331684 69.83 238.64 42.99 87.47 295.74 190.79 239.19 97.60 90.59 55.72 
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gga-miR-
30c UGUAAACAUCCUACACUCUCAGCU 
chr23: 5249637-
5249725 (30c-1), 
chr3: 85126853-
85126924 (30c-2) 
1217.29 3467.21 
2112.5
1 
3377.1
1 
3642.6
5 2435.99 
3511.0
6 
2046.8
5 
4232.1
9 
2262.3
9 
gga-miR-
30c-
1_ukstar 
CUGGGAGAGGAUUGUUUACGCC chr23: 5249637-5249725 80.10 91.85 109.70 167.71 94.03 96.52 143.00 91.23 121.15 93.72 
gga-miR-
30c-
2_ukstar 
CUGGGAGAAGGCUGUUUACUCU chr3: 85126853-85126924 71.89 290.57 194.50 238.50 125.67 219.19 149.62 119.04 233.88 203.13 
gga-miR-
30d UGUAAACAUCCCCGACUGGAAG 
chr2: 148337263-
148337326 7494.76 
15599.
44 
7904.2
0 
12015.
75 
5863.5
3 8637.67 
9888.8
7 
10383.
79 
10866.
78 
13060.
02 
gga-miR-
30d_ukstar CUUUCAGUCAGAUGUUUGCUGC 
chr2: 148337263-
148337326 15.29 50.57 14.23 24.86 19.12 31.96 23.89 12.74 52.80 22.31 
gga-miR-
30e UGUAAACAUCCUUGACUGG 
chr23: 5248414-
5248509 6082.12 
17439.
11 
8356.9
5 
11012.
66 
9500.2
6 11260.57 
4613.5
7 
7937.0
3 
10644.
56 
16134.
12 
gga-miR-
30e_ukstar CUUUCAGUCGGAUGUUUACAGC 
chr23: 5248414-
5248509 1881.85 
4385.4
0 
2803.6
4 
6567.3
2 
2771.6
0 3937.75 
6007.2
4 
2835.5
0 
5456.6
6 
4424.3
6 
gga-miR-
31 AGGCAAGAUGUUGGCAUAGCUG 
chrZ: 71882171-
71882264 130.31 24.60 378.32 93.76 8.42 13.88 155.59 161.01 74.50 48.47 
gga-miR-
32 UAUUGCACAUUACUAAGUUGC 
chr2: 86506451-
86506520 5.48 154.99 19.87 19.19 17.76 8.39 6.94 7.20 47.51 41.58 
gga-miR-
33 GUGCAUUGUAGUUGCAUUGC 
chr1: 51372282-
51372350 37.66 334.31 192.72 92.19 128.40 51.97 8.55 35.98 139.51 227.00 
gga-miR-
34a UGGCAGUGUCUUAGCUGGUUGUU 
chr21: 3251514-
3251622 11.41 10.93 9.49 1.89 18.44 11.94 4.20 4.95 4.00 2.48 
gga-miR-
34c AGGCAGUGUAGUUAGCUGAUUGC 
chr24: 5685637-
5685710 13.24 466.61 529.54 771.52 135.69 54.23 6.46 4.12 166.61 422.06 
gga-miR-
3529 AGGCAGACUGUGACUUGUUGU 
chr10: 14823529-
14823619 120.27 90.21 13.64 8.50 489.25 622.72 105.07 75.93 9.83 9.73 
gga-miR-
3535 GGAUAUGAUGACUGAUUAUCUGAAA 
chr9: 16372628-
16372709 523.98 900.15 198.35 482.98 252.48 465.51 636.23 
1175.2
2 241.11 376.90 
gga-miR-
365 UAAUGCCCCUAAAAAUCCUUAU 
chr14: 764271-
764355 (365-1), 
chr18: 6437296-
6437391 (365-2) 
6.39 1.91 7.12 17.31 11.38 21.63 28.73 16.49 36.71 19.74 
gga-miR-
367 AAUUGCACUUUAGCAAUGGUG 
chr4: 58652350-
58652422 2.28 3.01 4.45 0.63 15.25 3.87 1.78 0.75 6.48 1.19 
gga-miR-
429 UAAUACUGUCUGGUAAUGCCGU 
chr21: 2580812-
2580895 217.94 22.41 651.10 408.10 339.22 254.06 81.83 235.15 233.66 98.58 
gga-miR-
451 AAACCGUUACCAUUACUGAGUUU 
chr19: 5823968-
5824036 184.85 92.67 163.96 250.77 310.99 509.73 455.30 259.06 206.02 182.67 
gga-miR-
454 UAGUGCAAUAUUGCUUAUAGGGU 
chr15: 399833-
399953 1841.46 
2298.6
3 
3462.4
4 
5903.7
3 
3428.8
7 3652.70 
2834.1
5 
3052.8
1 
6890.8
2 
4315.5
8 
 92 
microRNA Sequence Chicken genomic location C
hi
ck
 
H
H
20
 B
S1
 
(P
M
M
R
) 
C
hi
ck
 
H
H
25
 B
S1
 
(P
M
M
R
) 
D
uc
k 
H
H
20
 B
S1
 
(P
M
M
R
) 
D
uc
k 
H
H
25
 B
S1
 
(P
M
M
R
) 
Q
ua
il 
H
H
20
 B
S1
 
(P
M
M
R
) 
Q
ua
il 
H
H
25
 B
S1
 
(P
M
M
R
) 
C
hi
ck
 
H
H
20
 B
S2
 
(P
M
M
R
) 
C
hi
ck
 
H
H
25
 B
S2
 
(P
M
M
R
) 
D
uc
k 
H
H
20
 B
S2
 
(P
M
M
R
) 
D
uc
k 
H
H
25
 B
S2
 
(P
M
M
R
) 
gga-miR-
455-3p UGCAGUCCAUGGGCAUAUACAC 
chr17: 5339701-
5339786 58.65 27.06 55.15 92.51 125.44 88.13 51.16 69.41 47.08 68.29 
gga-miR-
455-5p UAUGUGCCCUUGGACUACAUCG 
chr17: 5339701-
5339786 126.43 53.30 83.31 117.68 183.27 132.36 167.53 106.59 71.48 109.60 
gga-miR-
456 CAGGCUGGUUAGAUGGUUGUCA 
chr3: 32679710-
32679821 1983.18 
1114.7
3 
1750.4
9 775.29 
1599.1
2 1196.37 
1184.1
8 640.31 600.90 454.83 
gga-miR-
460 CCUGCAUUGUACACACUGUGUG 
chr2: 3583690-
3583779 252.63 9.57 118.60 47.51 311.45 267.94 75.21 178.55 66.84 49.57 
gga-mir-
460a_ukst
ar 
CACAGCGCAUACAAUGUGGAUU chr2: 3583690-3583779 227.76 9.02 357.57 52.23 277.07 327.02 111.53 44.23 135.51 39.56 
gga-miR-
460b-5p UCCUCAUUGUACAUGCUGUGUG 
chr4: 2687396-
2687485 12.10 98.95 7.71 6.92 5.69 2.26 11.78 24.74 2.81 18.73 
gga-miR-
489 AGUGACAUCAUAUGUACGGCUGC 
chr2: 23068877-
23068960 5.71 21.32 16.60 5.03 16.85 16.46 10.17 8.02 7.34 5.32 
gga-miR-
551 GCGACCCAUACUUGGUUUCAG 
chr9: 21966405-
21966517 22.59 25.15 44.18 76.77 62.84 66.82 27.44 22.19 56.26 51.31 
gga-miR-7 UGGAAGACUAGUGAUUUUGUUG 
chrZ: 39554766-
39554874 (7-1), 
chr10: 14823525-
14823623 (7-2), 
chr28: 4436025-
4436119 (7-3) 
349.85 1164.76 781.26 259.27 476.05 386.41 459.34 80.28 375.87 134.29 
gga-miR-7-
1_ukstar CAACAAAUCACAGUCUGCCAUA 
chrZ: 39554766-
39554874 12.78 34.99 12.16 18.25 44.62 37.45 37.12 20.16 29.80 18.27 
gga-miR-
92 UAUUGCACUUGUCCCGGCCUG 
chr1: 152248070-
152248147 9590.45 
14333.
82 
11031.
31 
8608.4
4 
20642.
00 11947.85 
17238.
47 
5177.9
9 
15575.
26 
6672.6
1 
gga-miR-
99a AACCCGUAGAUCCGAUCUUGUG 
chr1: 102424333-
102424413 1351.02 
2452.5
2 
1427.3
2 
1179.3
0 
1200.4
8 1316.46 
1044.0
9 
1566.3
6 
1049.3
3 
1484.5
5 
gga-miR-
99a* CAAGCUCGCUUCUAUGGGUCUG 
chr1: 102424333-
102424413 82.39 133.94 88.35 64.19 39.16 85.55 53.58 77.06 71.37 100.51 
hsa-miR-
1246 AAUGGAUUUUUGGAGCAGG unclear 4.34 1.64 2.96 1.26 38.25 10.65 3.71 24.89 3.24 12.67 
hsa-miR-
125b-1* ACGGGUUAGGCUCUUGGGAGCU unclear 88.78 226.06 91.91 185.96 93.57 120.41 126.05 115.36 77.10 110.24 
hsa-miR-
1261 AUGGAUAAGGCUUUGGCUU unclear 52.26 118.36 90.73 126.80 7.74 22.60 19.53 158.69 89.08 251.23 
hsa-miR-
129-3p AAGCCCUUACCCCAAAAAGCAU unclear 10.50 33.08 9.49 13.53 22.54 15.17 24.53 7.87 29.26 9.36 
hsa-miR-
129-5p CUUUUUGCGGUCUGGGCUUGC unclear 189.42 469.89 328.81 269.97 109.51 202.73 138.80 104.57 294.56 229.94 
hsa-miR-
132 UAACAGUCUACAGCCAUGGUCG unclear 19.17 8.75 35.88 21.08 38.93 44.87 13.40 27.81 14.47 14.59 
hsa-miR-
132* ACCGUGGCUUUCGAUUGUUACU unclear 5.71 6.29 12.45 11.64 16.16 13.56 8.72 12.97 6.91 8.63 
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hsa-miR-
139-5p UCUACAGUGCACGUGUCUCCAG unclear 23.05 30.62 30.24 25.49 78.54 55.20 51.81 45.35 37.90 20.93 
hsa-miR-
143 UGAGAUGAAGCACUGUAGCUC unclear 37422.46 
5166.9
2 
40077.
54 
112893
.90 
45352.
39 80640.83 
54488.
39 
39637.
86 
45335.
04 
53520.
65 
hsa-miR-
143* GGUGCAGUGCUGCAUCUCUGGU unclear 76.68 11.21 71.75 63.24 98.58 91.68 37.44 43.25 46.86 70.77 
hsa-miR-
145 GUCCAGUUUUCCCAGGAAUCCCU unclear 173.67 15.85 107.92 246.05 474.91 521.03 546.82 314.46 379.54 197.08 
hsa-miR-
145* GGAUUCCUGGAAAUACUGUUCU unclear 269.29 14.21 158.62 46.57 114.29 147.85 135.57 296.99 88.00 182.76 
hsa-miR-
148b UCAGUGCAUCACAGAACUUUGU unclear 2239.23 
1254.6
9 
3283.6
6 918.77 
2930.7
4 1863.96 943.05 946.59 
1160.1
1 985.02 
hsa-miR-
150 UCUCCCAACCCUUGUACCAGUG unclear 4.79 3.83 21.05 9.44 15.48 4.52 16.95 5.55 15.87 9.18 
hsa-miR-
181c* AACCAUCGACCGUUGAGUGGAC unclear 9.81 25.70 12.45 6.61 16.62 16.14 13.72 18.29 8.75 11.57 
hsa-miR-
182 UUUGGCAAUGGUAGAACUCACACU unclear 2683.79 322.01 
4595.0
5 
4681.3
2 
1623.7
1 1997.28 
4023.6
6 
6222.4
8 
5335.7
3 
1946.9
9 
hsa-miR-
190b UGAUAUGUUUGAUAUUGGGUU unclear 7.99 27.34 4.74 4.72 17.53 15.17 1.78 4.72 3.13 5.69 
hsa-miR-
191 CAACGGAAUCCCAAAAGCAGCUG unclear 181.66 168.11 189.16 131.52 122.48 122.67 181.25 140.62 205.91 169.81 
hsa-miR-
192 CUGACCUAUGAAUUGACAGCC unclear 6.62 8.75 11.56 14.79 55.10 24.21 68.43 223.75 47.08 107.58 
hsa-miR-
210 CUGUGCGUGUGACAGCGGCUGA unclear 72.80 364.65 123.93 240.71 187.82 187.88 65.20 74.58 184.97 161.74 
hsa-miR-
23a AUCACAUUGCCAGGGAUUUCC unclear 71.43 49.48 237.49 397.71 172.57 191.43 148.49 142.80 370.04 488.42 
hsa-miR-
27a UUCACAGUGGCUAAGUUCCGC unclear 473.31 252.03 
1529.9
0 
1694.0
6 433.93 521.35 375.74 469.02 
1416.6
7 
1915.4
2 
hsa-miR-
338-3p UCCAGCAUCAGUGAUUUUGUUG unclear 37.66 128.20 35.28 40.59 32.56 45.52 42.45 39.65 66.62 62.51 
hsa-miR-
338-5p AACAAUAUCCUGGUGCUGAGUG unclear 28.07 54.94 24.31 16.36 21.63 29.05 17.92 22.49 17.06 17.26 
hsa-miR-
363 AAUUGCACGGUAUCCAUCUGUA 
chr4: 3968811-
3968832 53650.26 
53033.
51 
53740.
52 
26901.
72 
43613.
93 47618.06 
24529.
15 
32400.
95 
38399.
19 
34717.
05 
hsa-miR-
363* CGGGUGGAUCACGAUGCAAUUU 
chr4: 3968811-
3968832 8822.74 
8746.7
5 
14453.
73 
22670.
03 
8254.4
8 10740.19 
10767.
85 
8414.3
8 
22453.
24 
19997.
26 
hsa-miR-
369-3p AAUAAUACAUGGUUGAUCUUU unclear 5.02 0.82 3.26 0.63 16.85 4.52 4.03 48.50 5.72 20.29 
hsa-miR-
378 ACUGGACUUGGAGUCAGAAGG unclear 18.71 16.95 22.83 49.40 143.66 77.48 14.04 57.64 4.64 18.27 
hsa-miR-
423-5p UGAGGGGCAGAGAGCGAGACUUU unclear 5.48 1.37 9.19 1.57 28.46 9.36 9.68 13.34 1.51 1.74 
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hsa-miR-
425 AAUGACACGAUCACUCCCGUUGA unclear 141.26 161.28 207.25 102.89 139.79 68.11 122.18 118.14 225.89 141.73 
hsa-miR-
92a-2* GGGUGGGGAUUUGUUGCAUUAC unclear 461.22 217.32 
1160.4
7 636.22 512.93 382.54 342.81 295.72 954.31 558.00 
hsa-miR-
92b UAUUGCACUCGUCCCGGCCUCC unclear 107.26 
3359.5
1 256.47 187.22 256.81 106.85 288.10 104.79 250.72 166.51 
hsa-miR-
96 UUUGGCACUAGCACAUUUUUGCU unclear 40.17 5.47 113.26 62.61 45.76 24.86 21.63 41.68 83.90 30.38 
tgu-miR-
1388 AUCUCAGGUUCGUCAGCCCAUG unclear 64.81 56.31 12.16 4.09 33.01 43.58 31.31 59.67 17.71 10.01 
tgu-miR-
2970 GACAGUCAGCAGUUGGUCUG unclear 372.90 745.71 63.15 50.34 400.69 522.32 258.56 298.41 45.03 57.83 
Table 3-1: microRNAs detectably expressed in frontonasal neural crest of chicken, quail, and duck at HH20 and HH25.  186 
mature miRNAs that are expressed at a normalized read count of >15 sequences per million mapped reads (PMMR) in at least one 
sample. Genomic locations are mapped to the gga3 build of the Gallus gallus genome.   
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Sequencing yielded between 3.10 and 10.89 million reads per sample 
(after removing adapter reads) with 98.45% of reads mapping to either the 
chicken genome or to known microRNA orthologs (see below, Figure 3-1 and 
Figure 3-2). Technical replicate sequence runs had correlation coefficients of 
>95% (data not shown).   Sequence runs on second biological samples had 
correlation coefficients of >80%.   Much of the variation in the latter comparison 
consisted of changes in very high abundance (>10,000 sequences per million 
mapped reads [PMMR]) miRNAs, whereas the more moderately-expressed 
miRNAs remained comparable between biological replicates (data not shown).    
While the majority of reads (56.36%) can be clearly identified as 122 
previously annotated chicken miRNAs (Table 3-1; www.mirbase.org, version 16) 
(Griffiths-Jones et al. 2008), the computational annotation of chicken miRNAs is 
clearly incomplete.   An additional 1.02% of reads map to 31 star (*) strands of 
known chicken microRNAs for which there is no annotated star activity in current 
databases (Figure 3-1 and Table 3-1).  Star strands are usually found at lower 
steady state levels than their partner strands, but many have been shown to be 
biologically active and relevant (Okamura et al. 2008, Yang et al. 2010).  These 
miRNAs are listed with the suffix “ukstar” in Table 3-1 and Table 3-2 to indicate 
that the star strand was previously not annotated in the chicken, although in all 
31 cases star activity is annotated in other vertebrates.  For simplicity, in the text 
below I refer to all star strands with an asterisk (*) irrespective of whether they 
are newly or previously described.    
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The Gallus gallus genomic sequence (gga3 genome build) is not yet gap-
free and may be missing as much as 10% in gapped areas (Brugmann et al. 
2010, Hawkins et al. 2006, International Chicken Genome Sequencing 
Consortium 2004).  This raises the possibility that additional miRNAs may not be 
annotated in microRNA databases (Griffiths-Jones et al. 2008) or are contained 
within the sequences that do not map back to the currently available chicken 
genome. Therefore, I analyzed reads that did not map to known chicken miRNAs 
to assess whether additional orthologs to known human or zebrafinch miRNAs 
are present within this set.   Another 11.07% of the total reads had 100% 
sequence identity to 29 human mature miRNAs and 2 zebrafinch miRNAs 
(Figure 3-1 and Table 3-1).  While 4 of these map to the chicken genome and are 
likely missing due to poor annotation, the other 27 miRNAs did not map to the 
current chicken genome assembly and likely fall into gapped regions of the 
genome.  For example, miR-143 and miR-143* have not previously been 
annotated in the chicken, but we identified multiple reads that matched the 
human versions of these miRNAs and confirmed expression of miR-143 in avians 
using qRT-PCR (see below).  These miRNAs are listed in Table 3-1 and Table 3-
2 with the prefix “hsa” or “tgu” to indicate they are newly described avian 
orthologs of known human or zebrafinch miRNAs, respectively.  I also searched 
the miRNA sequences for candidate miRNAs that had slight sequence 
divergence from the known human miRNAs by setting our search algorithms to 
allow one or two base mismatches outside of the miRNA seed sequence.  This 
 97 
identified 4 additional miRNAs that are novel orthologs of human miRNAs (Figure 
3-1).  Together these only account for 0.09% of total reads.  Of the 35 total 
predicted novel orthologs, only 4 clearly align to the available chicken genomic 
DNA sequence, suggesting that the majority of these miRNAs are not annotated 
because they fall into gaps in the current chicken genomic assembly.     
After these various computational steps, 68.54% of total sequence reads 
mapped to chicken, human, or zebrafinch miRNAs (Figure 3-1 and Figure 3-2).   
Within the remaining reads, 1.03% derive from degraded mRNA transcript, 
6.71% map to repetitive sequence families, and 18.57% are tRNA, rRNA, or 
snRNA sequences (Figure 3-1 and Figure 3-2).  The possibility cannot be 
discounted that additional data mining of the remaining reads (5.16% of total 
reads, Figure 3-1 and Figure 3-2) may yield novel miRNA families (Li T. et al. 
2011). 
 Overall, by the various analysis and filtering steps described above, I 
identified 186 mature miRNAs that are detectably expressed in the frontonasal 
NC cells of the chicken, duck, and quail at a normalized read count of  >15 
sequences per million mapped reads (PMMR) in at least one sample (Table 3-1).  
The 15 PMMR threshold of detection was selected based on the lowest read 
counts of miRNAs for which I could reproducibly verify trends by qRT-PCR (see 
below).  
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Dramatic changes in miRNAs occur between developmental stages 
As detailed in Chapter 2, I previously measured changes in steady state 
mRNA levels in these same neural crest samples for ~2,400 genes involved in 
developmental signaling pathways and nearly all known and predicted 
transcription factor.  Although I found many interesting gene expression 
differences between species, gene expression was essentially unchanged 
between HH20 and HH25 within species, suggesting that the gene expression 
profile is established prior to morphological variation.  In remarkable contrast to 
the relatively unchanged pattern of mRNA expression, in the current study I 
found that miRNA expression is dramatically different between the two 
developmental stages.  Of the 186 miRNAs that were detectably expressed, 170 
(91%) were differentially expressed by at least 2-fold either between the three 
species or between the two developmental stages, with fold changes as large as 
74-fold (Figure 3-2).   Of the 170 miRNAs that were differentially expressed, the 
vast majority (132 or 78%) showed at least 2-fold changes between the 
developmental stages in one or more of the species.  The specific miRNAs, 
patterns and trends of miRNA expression are shown in detail in Table 3-2.   
Table 3-3 and the sections below summarize these trends and relate specific 
miRNAs to their potential cellular functions.  
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HH25/HH20 
Fold 
gga-let-7a 0.76 -0.76 0.99 0.69 -0.23 -1.45 2.51 0.99 1.30 
gga-let-7a_ukstar -1.39 -3.62 -1.47 0.60 0.08 -4.22 4.80 2.57 0.50 
gga-let-7b 1.15 -4.12 0.07 -0.01 1.08 -4.11 5.48 0.21 0.29 
gga-let-7c 0.86 -0.51 1.51 0.46 -0.65 -0.97 1.51 0.14 1.18 
gga-let-7c_ukstar -0.69 -1.34 -0.85 0.02 0.16 -1.35 2.22 1.57 0.70 
gga-let-7d 0.76 -0.87 -0.58 -0.57 1.34 -0.29 2.64 1.02 1.01 
gga-let-7f 1.45 1.18 1.00 1.80 0.45 -0.63 2.08 1.80 1.00 
gga-let-7g 0.96 -0.35 0.47 1.27 0.49 -1.62 3.13 1.82 1.02 
gga-let-7i 1.23 -1.16 0.61 2.28 0.63 -3.44 4.76 2.37 0.69 
gga-let-7k 1.26 -0.07 1.79 2.06 -0.52 -2.13 2.13 0.80 0.53 
gga-miR-100 -0.13 -2.70 -0.02 -1.06 -0.11 -1.63 2.01 -0.55 0.49 
gga-miR-
100_ukstar 1.11 -1.26 0.53 -0.52 0.58 -0.74 2.13 -0.25 0.80 
gga-miR-101 1.04 -0.29 0.22 0.73 0.82 -1.02 1.83 0.50 -0.01 
gga-mir-
106_ukstar 1.22 1.47 2.70 1.99 -1.48 -0.51 -0.71 -0.46 0.26 
gga-miR-107 -0.52 -0.56 0.07 0.64 -0.59 -1.20 1.16 1.12 0.55 
gga-miR-10a 0.34 1.20 0.02 -1.72 0.32 2.92 -2.46 -1.60 0.14 
gga-miR-10b 0.62 4.01 -2.36 -0.23 2.98 4.24 -1.61 1.78 -0.35 
gga-miR-122 0.08 0.79 -2.80 -2.31 2.88 3.10 -3.15 -2.44 -2.93 
gga-miR-125b -0.95 -2.29 0.00 -0.56 -0.95 -1.73 1.24 -0.10 0.45 
gga-miR-
125b_ukstar 0.01 -1.36 0.44 -0.93 -0.43 -0.43 1.15 -0.23 1.15 
gga-miR-126 0.43 2.31 0.94 0.05 -0.52 2.26 -2.61 -0.73 0.17 
gga-miR-126* 0.37 2.38 0.04 -0.53 0.33 2.91 -2.36 -0.35 0.22 
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gga-mir-
130a_ukstar -0.77 -0.88 -1.20 -0.70 0.42 -0.18 0.09 -0.02 -0.51 
gga-miR-130b 0.75 1.88 0.41 0.84 0.34 1.03 -0.32 0.81 0.38 
gga-miR-130c -0.23 0.25 -0.31 0.37 0.07 -0.12 0.58 1.06 0.39 
gga-miR-1329 -1.22 -0.56 3.09 3.09 -4.31 -3.65 -0.33 0.33 0.33 
gga-miR-135a 1.23 -3.86 -1.01 -0.20 2.25 -3.65 5.85 0.75 -0.05 
gga-mir-135a-
3_ukstar 0.94 -3.59 -0.86 -0.78 1.79 -2.81 4.82 0.29 0.21 
gga-miR-
135b_ukstar 0.38 -3.41 -0.52 0.34 0.90 -3.75 3.91 0.12 -0.75 
gga-miR-137 0.91 -4.09 1.39 0.03 -0.48 -4.12 4.43 -0.57 0.79 
gga-miR-140-3p 0.34 1.17 0.03 -0.08 0.30 1.25 -0.15 0.68 0.80 
gga-miR-140-5p 0.44 1.54 -0.12 0.26 0.56 1.29 -0.40 0.70 0.32 
gga-miR-142-3p 0.94 1.22 0.58 -0.33 0.37 1.56 -1.89 -1.60 -0.70 
gga-miR-142-5p 0.91 2.79 -0.24 0.78 1.15 2.01 -2.17 -0.29 -1.32 
gga-miR-144 2.19 -0.44 0.44 0.50 1.75 -0.94 0.51 -2.12 -2.19 
gga-miR-
144_ukstar 1.53 3.07 0.80 1.04 0.73 2.04 -1.54 0.00 -0.24 
gga-miR-146b 3.53 5.00 3.69 2.45 -0.16 2.55 -2.60 -1.13 0.11 
gga-miR-148a 0.91 0.91 0.83 -0.15 0.07 1.07 -0.46 -0.46 0.53 
gga-miR-
148a_ukstar 0.67 -1.20 0.33 -1.57 0.34 0.37 0.51 -1.37 0.54 
gga-miR-1552-5p 2.33 2.14 1.36 1.30 0.98 0.84 -0.27 -0.47 -0.41 
gga-miR-1559 1.16 0.72 0.58 -0.16 0.57 0.87 -0.09 -0.53 0.21 
gga-miR-15a 1.29 -0.23 -0.31 0.35 1.60 -0.58 2.05 0.53 -0.13 
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gga-miR-15b 0.86 0.28 0.37 1.08 0.49 -0.80 1.68 1.10 0.39 
gga-miR-
15b_ukstar -0.47 -1.49 -1.68 -1.59 1.21 0.10 1.01 0.00 -0.09 
gga-miR-15c 1.04 0.25 1.12 1.23 -0.08 -0.98 1.69 0.91 0.79 
gga-miR-16 0.92 0.61 1.45 1.14 -0.53 -0.53 0.80 0.49 0.80 
gga-miR-1662 2.26 0.31 3.26 3.09 -1.00 -2.78 1.41 -0.53 -0.36 
gga-miR-16c 0.91 0.60 1.53 1.17 -0.62 -0.57 0.78 0.47 0.83 
gga-miR-17-3p 0.41 -1.54 -0.31 -0.94 0.72 -0.60 1.47 -0.48 0.15 
gga-miR-181a 0.00 -1.97 -0.18 -0.39 0.18 -1.58 1.48 -0.49 -0.28 
gga-miR-181a* 1.25 -1.00 0.24 -0.08 1.01 -0.92 2.29 0.04 0.36 
gga-miR-181b 0.34 -0.87 0.70 -0.12 -0.37 -0.75 -0.15 -1.36 -0.54 
gga-miR-183 1.05 3.85 1.88 1.22 -0.83 2.64 -2.79 0.02 0.68 
gga-miR-184 -2.54 1.56 1.87 2.57 -4.41 -1.00 -2.40 1.71 1.01 
gga-miR-
18a_ukstar -0.73 -1.37 -1.18 -0.63 0.45 -0.74 0.68 0.04 -0.51 
gga-mir-
18b_ukstar -0.61 -1.55 -1.70 -0.85 1.09 -0.70 0.91 -0.04 -0.89 
gga-miR-190 -0.04 -1.34 -0.89 -1.40 0.85 0.06 0.67 -0.63 -0.12 
gga-miR-
193a_ukstar -1.21 0.33 -0.80 -2.26 -0.41 2.59 -3.39 -1.85 -0.39 
gga-miR-193b -0.57 0.12 -1.30 0.43 0.73 -0.31 -0.25 0.45 -1.29 
gga-miR-
193b_ukstar -1.21 0.33 -0.80 -2.26 -0.41 2.59 -3.39 -1.85 -0.39 
gga-miR-199 0.93 5.84 0.36 0.20 0.57 5.64 -4.73 0.18 0.34 
gga-miR-199* -0.25 5.13 -1.93 -1.02 1.68 6.14 -4.72 0.65 -0.26 
gga-miR-19a 0.76 -1.15 -0.35 0.15 1.11 -1.31 1.66 -0.25 -0.76 
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gga-mir-
19a_ukstar 1.57 0.75 0.26 0.71 1.31 0.04 1.37 0.54 0.09 
gga-miR-19b 0.28 -0.12 -0.80 0.25 1.08 -0.37 0.88 0.47 -0.57 
gga-miR-
19b_ukstar 0.44 -0.10 -1.42 -0.38 1.86 0.28 0.95 0.42 -0.63 
gga-miR-1a 1.15 1.66 0.53 -0.80 0.63 2.47 -0.91 -0.39 0.94 
gga-miR-1b 2.27 1.87 1.71 -0.15 0.55 2.01 -0.24 -0.64 1.22 
gga-miR-200a 2.17 5.77 0.88 1.06 1.29 4.72 -4.04 -0.44 -0.62 
gga-miR-200b 1.87 5.88 0.55 0.77 1.32 5.10 -4.73 -0.72 -0.94 
gga-miR-203 1.60 3.61 1.06 2.08 0.54 1.53 -1.30 0.70 -0.31 
gga-miR-204 -0.50 -1.75 -1.05 0.24 0.55 -1.99 1.59 0.34 -0.95 
gga-miR-205a 1.42 3.26 -1.60 0.78 3.01 2.48 -1.30 0.54 -1.83 
gga-miR-20b -0.25 -0.79 0.49 -0.77 -0.74 -0.02 -0.48 -1.02 0.24 
gga-mir-
20b_ukstar 0.36 -1.01 0.40 -0.68 -0.04 -0.33 -0.29 -1.66 -0.59 
gga-miR-21 -0.69 0.76 0.39 -0.05 -1.09 0.81 -1.74 -0.29 0.16 
gga-miR-211 -0.52 -1.77 -1.04 0.21 0.51 -1.97 1.55 0.30 -0.94 
gga-miR-2131 0.25 0.16 -0.51 0.17 0.77 0.00 1.10 1.01 0.33 
gga-mir-
2131_ukstar -0.77 -0.80 0.67 1.43 -1.45 -2.23 0.88 0.85 0.10 
gga-miR-215 -3.26 -4.23 -3.40 -3.46 0.14 -0.76 1.83 0.86 0.93 
gga-miR-218 0.18 -0.70 -0.17 0.20 0.35 -0.90 1.87 0.99 0.62 
gga-miR-2188 0.29 1.31 -0.81 -0.61 1.10 1.93 -1.15 -0.13 -0.33 
gga-miR-22 1.40 1.08 0.72 -0.85 0.67 1.93 -0.28 -0.60 0.97 
gga-miR-22* 1.15 2.79 -0.89 1.28 2.04 1.50 -0.51 1.13 -1.04 
gga-miR-221 0.44 0.68 -1.15 0.01 1.59 0.67 -0.18 0.07 -1.09 
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gga-miR-
221_ukstar 0.83 0.97 0.39 -0.06 0.44 1.03 -0.68 -0.53 -0.09 
gga-miR-222 0.64 1.75 0.42 1.51 0.22 0.24 -0.85 0.26 -0.83 
gga-miR-223 -0.17 2.09 -0.28 0.09 0.10 2.00 -1.97 0.28 -0.08 
gga-miR-23b 1.11 1.40 0.35 0.89 0.76 0.50 0.33 0.62 0.07 
gga-miR-24 0.87 1.34 1.57 0.84 -0.70 0.50 -0.46 0.01 0.74 
gga-miR-26a 1.07 1.23 0.29 0.85 0.78 0.38 0.47 0.63 0.07 
gga-miR-27b 0.94 1.01 1.30 0.85 -0.36 0.16 0.05 0.13 0.57 
gga-miR-
27b_ukstar 0.74 0.37 1.46 0.12 -0.72 0.25 -0.83 -1.19 0.15 
gga-miR-2954 -0.53 -2.23 -1.37 -1.30 0.84 -0.93 0.77 -0.93 -1.00 
gga-miR-
2954_ukstar 1.01 -1.07 0.58 -1.75 0.43 0.68 -0.87 -2.96 -0.63 
gga-miR-2964 -1.91 -1.50 -2.04 -1.75 0.13 0.26 0.52 0.93 0.64 
gga-miR-301 1.04 -0.19 0.39 1.50 0.65 -1.69 1.31 0.08 -1.03 
gga-mir-
301_ukstar -0.01 -0.49 -1.69 -1.21 1.69 0.71 0.02 -0.46 -0.95 
gga-miR-301b-3p 1.06 -0.19 0.49 1.49 0.57 -1.68 1.27 0.02 -0.98 
gga-miR-302b -0.71 -0.35 -1.17 -1.57 0.46 1.22 -2.39 -2.03 -1.63 
gga-miR-302b* -0.61 0.00 -0.06 -0.42 -0.55 0.42 -2.97 -2.36 -2.01 
gga-miR-302c 0.06 -0.31 -1.43 -1.52 1.48 1.21 -1.21 -1.58 -1.48 
gga-miR-30a-3p 1.00 0.53 0.25 0.82 0.76 -0.29 1.59 1.12 0.54 
gga-miR-30a-5p 1.89 -0.06 0.56 0.69 1.33 -0.75 2.95 1.01 0.87 
gga-miR-30b -0.70 -1.45 -2.78 -1.13 2.08 -0.32 1.77 1.02 -0.63 
gga-miR-30c 0.80 -0.04 -0.79 0.47 1.58 -0.51 1.51 0.68 -0.58 
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gga-miR-30c-
2_ukstar 1.44 -0.28 0.63 0.12 0.81 -0.41 2.02 0.29 0.80 
gga-miR-30d 0.08 -0.38 0.43 0.48 -0.35 -0.85 1.06 0.60 0.56 
gga-miR-
30d_ukstar -0.10 -1.02 -0.43 -0.36 0.32 -0.66 1.73 0.80 0.74 
gga-miR-30e 0.46 -0.66 -0.18 -0.03 0.64 -0.63 1.52 0.40 0.25 
gga-miR-
30e_ukstar 0.58 0.58 0.02 0.74 0.56 -0.16 1.22 1.23 0.51 
gga-miR-31 1.54 1.93 5.49 2.76 -3.95 -0.83 -2.41 -2.01 0.72 
gga-miR-32 1.86 -3.01 0.16 1.19 1.70 -4.21 4.82 -0.05 -1.08 
gga-miR-33 2.36 -1.86 0.59 0.83 1.77 -2.69 3.15 -1.06 -1.30 
gga-miR-34a -0.27 -2.53 -0.96 -2.66 0.69 0.13 -0.06 -2.33 -0.63 
gga-miR-34c 5.32 0.73 1.96 3.83 3.36 -3.10 5.14 0.54 -1.32 
gga-miR-3529 -3.14 -3.41 -5.16 -6.20 2.02 2.79 -0.41 -0.68 0.35 
gga-miR-3535 -1.40 -0.90 -0.35 0.05 -1.05 -0.95 0.78 1.28 0.88 
gga-miR-365 0.16 3.18 -0.68 -0.32 0.83 3.50 -1.74 1.28 0.93 
gga-miR-367 0.96 -2.26 -1.78 -2.62 2.74 0.37 0.40 -2.82 -1.98 
gga-miR-429 1.58 4.19 0.94 0.68 0.64 3.50 -3.28 -0.67 -0.42 
gga-miR-451 -0.17 1.44 -0.92 -1.02 0.75 2.46 -1.00 0.61 0.71 
gga-miR-454 0.91 1.36 0.01 0.69 0.90 0.67 0.32 0.77 0.09 
gga-miR-455-3p -0.09 1.77 -1.19 0.07 1.10 1.70 -1.12 0.75 -0.51 
gga-miR-455-5p -0.60 1.14 -1.14 -0.17 0.54 1.31 -1.25 0.50 -0.47 
gga-miR-456 -0.18 -0.52 0.13 -0.63 -0.31 0.10 -0.83 -1.17 -0.42 
gga-miR-460 -1.09 2.31 -1.39 -2.50 0.30 4.81 -4.72 -1.32 -0.22 
gga-mir-
460a_ukstar 0.65 2.53 0.37 -2.65 0.28 5.18 -4.66 -2.78 0.24 
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gga-miR-460b-5p -0.65 -3.84 0.44 1.62 -1.09 -5.45 3.03 -0.16 -1.33 
gga-miR-489 1.54 -2.08 -0.02 -1.71 1.56 -0.37 1.90 -1.72 -0.03 
gga-miR-551 0.97 1.61 -0.51 0.20 1.48 1.41 0.15 0.80 0.09 
gga-miR-7 1.16 -2.17 0.71 -0.58 0.44 -1.59 1.74 -1.59 -0.30 
gga-miR-7-
1_ukstar -0.07 -0.94 -1.88 -1.04 1.80 0.10 1.45 0.59 -0.25 
gga-miR-92 0.20 -0.74 -0.90 -0.47 1.11 -0.26 0.58 -0.36 -0.79 
gga-miR-99a 0.08 -1.06 0.25 -0.16 -0.17 -0.90 0.86 -0.28 0.13 
gga-miR-99a* 0.10 -1.06 1.17 -0.41 -1.07 -0.65 0.70 -0.46 1.13 
hsa-miR-1246 -0.55 -0.38 -3.69 -3.08 3.14 2.70 -1.40 -1.24 -1.84 
hsa-miR-125b-1* 0.05 -0.28 -0.03 0.63 0.08 -0.91 1.35 1.02 0.36 
hsa-miR-1261 0.80 0.10 3.55 2.49 -2.76 -2.39 1.18 0.48 1.55 
hsa-miR-129-3p -0.15 -1.29 -1.25 -0.17 1.10 -1.12 1.66 0.51 -0.57 
hsa-miR-129-5p 0.80 -0.80 1.59 0.41 -0.79 -1.21 1.31 -0.28 0.89 
hsa-miR-132 0.90 1.27 -0.12 -1.09 1.02 2.36 -1.13 -0.77 0.20 
hsa-miR-132* 1.13 0.89 -0.38 -0.22 1.50 1.11 0.14 -0.10 -0.25 
hsa-miR-139-5p 0.39 -0.26 -1.38 -1.11 1.77 0.85 0.41 -0.25 -0.51 
hsa-miR-143 0.10 4.45 -0.18 0.49 0.28 3.96 -2.86 1.49 0.83 
hsa-miR-143* -0.10 2.50 -0.46 -0.54 0.36 3.03 -2.77 -0.18 -0.10 
hsa-miR-145 -0.69 3.96 -2.14 -1.08 1.45 5.04 -3.45 1.19 0.13 
hsa-miR-145* -0.76 1.71 0.47 -1.67 -1.24 3.38 -4.24 -1.77 0.37 
hsa-miR-148b 0.55 -0.45 0.16 -1.02 0.39 0.57 -0.84 -1.84 -0.65 
hsa-miR-150 2.14 1.30 0.44 1.06 1.69 0.24 -0.32 -1.16 -1.78 
hsa-miR-181c* 0.34 -1.96 -0.42 -1.29 0.76 -0.67 1.39 -0.91 -0.04 
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hsa-miR-182 0.78 3.86 1.50 1.23 -0.72 2.63 -3.06 0.03 0.30 
hsa-miR-190b -0.75 -2.53 -1.89 -1.68 1.13 -0.85 1.77 -0.01 -0.21 
hsa-miR-192 0.81 0.76 -2.25 -0.71 3.06 1.47 0.40 0.35 -1.19 
hsa-miR-210 0.77 -0.60 -0.60 0.36 1.37 -0.96 2.32 0.96 0.00 
hsa-miR-23a 1.73 3.01 0.46 1.05 1.27 1.95 -0.53 0.74 0.15 
hsa-miR-27a 1.69 2.75 1.82 1.70 -0.13 1.05 -0.91 0.15 0.26 
hsa-miR-338-3p -0.09 -1.66 0.12 -0.17 -0.21 -1.49 1.77 0.20 0.48 
hsa-miR-338-5p -0.21 -1.75 0.17 -0.83 -0.38 -0.92 0.97 -0.57 0.43 
hsa-miR-363 0.00 -0.98 0.30 -0.82 -0.30 -0.16 -0.02 -1.00 0.13 
hsa-miR-363* 0.71 1.37 0.81 1.08 -0.10 0.30 -0.01 0.65 0.38 
hsa-miR-369-3p -0.62 -0.38 -2.37 -2.84 1.75 2.46 -2.61 -2.37 -1.90 
hsa-miR-378 0.29 1.54 -2.65 -0.65 2.94 2.19 -0.14 1.11 -0.89 
hsa-miR-423-5p 0.75 0.20 -1.63 -2.57 2.38 2.78 -2.00 -2.55 -1.60 
hsa-miR-425 0.55 -0.65 0.57 0.60 -0.02 -1.24 0.19 -1.01 -1.04 
hsa-miR-92a-2* 1.33 1.55 1.18 0.73 0.15 0.82 -1.09 -0.87 -0.42 
hsa-miR-92b 1.26 -4.17 0.00 0.81 1.26 -4.97 4.97 -0.45 -1.27 
hsa-miR-96 1.50 3.52 1.31 1.33 0.19 2.18 -2.88 -0.86 -0.88 
tgu-miR-1388 -2.41 -3.78 -1.44 -3.41 -0.97 -0.37 -0.20 -1.57 0.40 
tgu-miR-2970 -2.56 -3.89 -2.67 -3.38 0.10 -0.51 1.00 -0.33 0.38 
 Table 3-2: microRNAs differentially expressed among chicken, quail, and duck frontonasal neural crest cells. Fold changes for 
the first biological sample only (BS1 in Table 3-1) are log2 scale, with expression in duck relative to chicken or quail, in quail relative to 
chicken, or HH25 relative to HH20.  For example, a negative number is expressed at a lower level in the duck versus chicken.  Highlighted 
comparisons pass >2-fold change and normalized read count of >15 sequences per million mapped reads (PMMR) criteria. DC, 
duck/chicken comparison; DQ, duck/quail comparison; QC, quail/chicken comparison. 
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Expressed at higher levels at HH20 than HH25 in all three species 
microRNA 
Average 
Fold 
Change 
Known Functions and/or Targets Reference 
gga-miR-122 7.30 Targets CyclinG1 to induce p53 and inhibit cell cycle progression at G1 
(Fornari et al. 
2009) 
gga-miR-142-3p 2.79 Down-regulates cAMP production (Huang B. et al. 2009a) 
gga-miR-
2954_ukstar 3.72 Unknown  
gga-miR-302b 4.15 
gga-miR-302b* 5.67 
gga-miR-302c 2.69 
Expression of miRNA cluster 
promotes somatic cell 
reprogramming 
(Lin et al. 
2010, Lin et al. 
2008) 
hsa-miR-1246 2.86 Unknown  
hsa-miR-148b 2.31 Targets DNA methyltransferase DNMT3B 
(Duursma et 
al. 2008) 
hsa-miR-369-3p 5.01 Unknown  
hsa-miR-423-5p 4.30 Unknown  
hsa-miR-92a-2* 1.76 Unknown  
hsa-miR-96 3.67 
Morpholino results in abnormal 
cranial cartilage; overexpression 
leads to cell cycle arrest in G1 
(Gessert et al. 
2010, Yu S. et 
al. 2010) 
Expressed at higher levels at HH25 than HH20 in all three species 
microRNA 
Average 
Fold 
Change 
Known Functions and/or Targets Reference 
gga-let-7a 3.39 
gga-let-7a_ukstar 11.73 
gga-let-7c_ukstar 3.08 
gga-let-7d 3.43 
gga-let-7f 3.24 
gga-let-7g 4.77 
gga-let-7i 11.30 
gga-let-7k 2.52 
miRNA family associated with 
cellular differentiation 
(Roush and 
Slack 2008) 
gga-miR-107 1.96 Induced by p53 to inhibit cell cycle progression at G1 
(Takahashi et 
al. 2009, 
Yamakuchi et 
al. 2010) 
gga-miR-15b 2.22 
Targets BCL2 to induce apoptosis; 
Targets CCNE1 to inhibit cell cycle 
progression at G1 
(Xia H. et al. 
2009b, Xia L. 
et al. 2008) 
gga-miR-15c 2.28 Unknown  
gga-miR-218 2.39 Targets ROBO1 and IKK-beta to (Song et al. 
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inhibit cell migration and invasion 2010, Tie et al. 
2010) 
gga-miR-30a-3p 2.21 
gga-miR-30a-5p 3.86 
gga-miR-
30d_ukstar 2.24 
gga-miR-
30e_ukstar 2.03 
 
miRNA family targets EMT regulators 
SNAIL1 and VIMENTIN 
(Braun J. et al. 
2010, Joglekar 
et al. 2009) 
hsa-miR-1261 2.19 Unknown  
Expressed at higher levels in duck versus quail and chick at both HH20 and 
HH25 
microRNA 
Average 
Fold 
Change 
Known Functions and/or Targets Reference 
gga-miR-
106_ukstar 3.89 Unknown  
gga-miR-
144_ukstar 3.78 Unknown  
gga-miR-146b 15.51 Targets metalloprotease MMP16 to inhibit cell migration 
(Xia H. et al. 
2009a) 
gga-miR-1552-5p 3.62 Unknown  
gga-miR-16c 2.13 Unknown  
gga-miR-183 5.63 
Targets stemness regulator BMI1 
and pro-apoptotic PDCD4; 
Repressed by EMT regulator ZEB1 
(Li J. et al. 
2010, Wellner 
et al. 2009) 
gga-miR-200a 2.10 
miRNA family targets positive Wnt 
signaling regulators; Negative 
feedback loop with  EMT regulators 
ZEB1 and ZEB2 
(Bracken et al. 
2008, Gregory 
et al. 2008, 
Kennell et al. 
2008) 
gga-miR-200b 1.71 
Morpholino results in abnormal 
cranial cartilage; miRNA family 
targets positive Wnt signaling 
regulators; Negative feedback loop 
with  EMT regulators ZEB1 and 
ZEB2 
(Bracken et al. 
2008, Gessert 
et al. 2010, 
Gregory et al. 
2008, Kennell 
et al. 2008) 
gga-miR-203 5.39 
Targets Wnt signaling activator 
LEF1/TCF1; Repressed by EMT 
regulator ZEB1; Targets BMI1 and 
p63 to inhibit stemness 
(Thatcher et al. 
2008, Wellner 
et al. 2009, Yi 
et al. 2008) 
gga-miR-24 2.28 Inhibited by RUNX2; Targets SATB2 (Hassan et al. 2010) 
gga-miR-27b 2.05 Activates Wnt signaling; Targets RUNX1 
(Feng et al. 
2009, Wang 
and Xu 2010) 
hsa-miR-182 5.36 Targets FOXO1 transcription factor (Guttilla and 
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White 2009) 
hsa-miR-23a 3.70 Inhibited by RUNX2; Targets SATB2 (Hassan et al. 2010) 
hsa-miR-27a 4.18 
Activates Wnt signaling; Targets 
RUNX1 and SATB2; Inhibited by 
RUNX2 
(Feng et al. 
2009, Hassan 
et al. 2010, 
Wang and Xu 
2010) 
hsa-miR-363* 2.02 Unknown  
Expressed at higher levels quail and chick versus duck at both HH20 and HH25 
microRNA 
Average 
Fold 
Change 
Known Functions and/or Targets Reference 
gga-miR-
18a_ukstar 2.02 Targets K-RAS oncogene 
(Tsang and 
Kwok 2009) 
gga-miR-215 12.47 Induced by p53 to inhibit cell cycle progression at G2 
(Braun C. J. et 
al. 2008) 
gga-miR-2964 3.51 Unknown  
gga-miR-3529 32.15 Unknown  
tgu-miR-1388 8.12 Unknown  
tgu-miR-2970 9.36 Unknown  
Expressed at higher levels in quail and chick versus duck only at HH25 
microRNA 
Average 
Fold 
Change 
Known Functions and/or Targets Reference 
gga-let-7c 2.55 miRNA family associated with cellular differentiation 
(Roush and 
Slack 2008) 
gga-miR-
100_ukstar 3.05 related to let-7 family 
(Christodoulou 
et al. 2010) 
gga-miR-
125b_ukstar 2.22 related to let-7 family 
(Christodoulou 
et al. 2010) 
gga-miR-137 11.67 
Targets CDK6 and CDC42 to inhibit 
cell cycle progression at G1 and 
promote differentiation 
(Liu M. et al. 
2010b, Silber 
et al. 2008) 
gga-miR-
148a_ukstar 2.58 Unknown  
gga-miR-30c-
2_ukstar 2.89 
miRNA family targets EMT regulators 
SNAIL1 and VIMENTIN 
(Braun J. et al. 
2010, Joglekar 
et al. 2009) 
hsa-miR-129-5p 2.17 Target stem cell regulator SOX4 
(Huang Y. W. 
et al. 2009b, 
Shen et al. 
2010) 
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Expressed at higher levels in duck versus quail and chicken only at HH25 
microRNA 
Average 
Fold 
Change 
Known Functions and/or Targets Reference 
gga-miR-10b 3.43 Induced by EMT regulator TWIST1 (Ma et al. 2007) 
gga-miR-142-5p 3.40 Induced by miR-223 via CEBPB and LMO2 
(Sun W. et al. 
2010) 
gga-miR-205a 3.00 
Coordinately expressed with miR-
200 family; Targets SHIP2 to induce 
the AKT pathway 
(Gregory et al. 
2008, Yu J. et 
al. 2008) 
gga-miR-22* 2.20 Unknown  
gga-miR-222 1.79 Targets p27(KIP1) to induce cell cycle progression 
(Galardi et al. 
2007, Lambeth 
et al. 2009) 
gga-miR-454 1.71 Unknown  
gga-miR-551 1.74 Unknown  
Table 3-3: Differentially expressed microRNAs with discernable trends among chicken, 
duck, and quail. For a complete list of differentially expressed microRNAs, see Table 3-2. 
 
 
MiRNAs that regulate stemness, cellular differentiation and epithelia-
mesenchyme transitions are differentially regulated between the two 
developmental stages in all three species 
Twelve miRNAs are down-regulated and seventeen are up-regulated from 
HH20 to HH25 in all three bird species (Table 3-3).  The extent of these changes 
varies depending upon the particular species.   For example, miR-96 is down-
regulated at HH25 by 1.81-fold in duck, by 1.84-fold in quail and by 7.35-fold in 
chicken NC cells.  Knockdown of this particular microRNA in zebrafish has 
previously been shown to result in abnormal cranial cartilage (Gessert et al. 
2010).  MiR-302b, miR-302b*, and miR-302c, which are the only members of the 
9-member miR-302 family that are detectable at either stage, are down-regulated 
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between 2.3- and 7.8-fold at HH25 in all three species (Table 3-2).  This miRNA 
family has been previously associated with “stemness.”  They are highly 
expressed in embryonic stem cells and when induced can reprogram somatic 
cells into a pleuripotent state (Lin et al. 2010, Lin et al. 2008).  
Of the seventeen miRNAs that are expressed at higher levels at the later 
stage of development (HH25) in the chicken, duck, and quail (Table 3-3) four 
belong to the miR-30 family (miR-30a-3p, miR-30a-5p, miR-30d*, and miR-30e*).  
These are up-regulated by between 1.4- to 7.7-fold (Table 3-2). This family of 
miRNAs has been previously implicated in regulating mesenchymal-to-epithelial 
transitions (MET) (Braun J. et al. 2010, Joglekar et al. 2009).  While epithelial-to-
mesenchymal transitions (EMT) are crucial for neural crest migration (Sauka-
Spengler and Bronner-Fraser 2008) and later events of facial development such 
as lip fusion (Sun D. et al. 2000), it is unclear if MET or EMT is occurring in the 
HH20-HH25 developmental window.  Interestingly, EMT has also been 
associated with stemness, while MET is associated with cellular differentiation 
(Brabletz and Brabletz 2010, Mani et al. 2008, Wellner et al. 2009).  Thus, up-
regulation of the miR-30 family might reflect an increase in cellular differentiation 
at HH25.  In agreement with this, let-7a, let-7a*, let-7c*, let-7d, let-7f, let-7g, let-
7i, and let-7k are all up-regulated by 1.4- to 27.9-fold at HH25 in all three species 
(Table 3-2).  These 8 miRNAs belong to the 19 member let-7 family of miRNAs, 
the expression of which has been associated with cellular differentiation (Roush 
and Slack 2008).   An additional seven miRNAs are up-regulated at HH25 only in 
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chicken and quail, but not in duck neural crest (Table 3-3).  These include miR-
30c-2*, miR-129-5p which targets the stem cell regulator SOX4 (Huang Y. W. et 
al. 2009b, Shen et al. 2010), let-7c, the differentiation-promoting miR-137 (Silber 
et al. 2008), and the let-7-related miR-100* and miR-125b-2* (Christodoulou et 
al. 2010) (Table 3-2).  In all, 9 of 10 detectable members of the let-7 family are 
up-regulated in chicken and quail NC by HH25 (Table 3-2).  
A final set of seven miRNAs are only up-regulated in the duck NC 
compared to chicken and quail after morphological variations are evident at 
HH25 (Table 3-3).  For example, miR-222 is expressed at similar levels in the 
duck, chicken, and quail at HH20.  However, by HH25, it is down-regulated 1.8-
fold in the beaked birds, but remains more highly expressed in duck (Table 3-2).  
This miRNA has been shown to down-regulate the cell cycle regulator p27(KIP1) 
in a number of systems, including chicken cell lines (Galardi et al. 2007, Lambeth 
et al. 2009) (see Chapter 4 for more on this). 
 
MiRNAs that regulate bone formation and Wnt signaling are differentially 
regulated in the duck compared to the chicken and quail  
Twenty-one miRNAs are differentially regulated in the duck compared to 
chicken and quail (which are, at least superficially, quite similar in bill 
morphology) at both developmental stages.  Six miRNAs with unrelated or 
unknown functions are expressed at lower levels in the flat-billed duck compared 
to the conical-billed chicken and quail (Table 3-3).  Fifteen miRNAs are more 
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highly expressed in duck NC cells at both stages (Table 3-3), including the miR-
23a-27a-24-2 cluster, which is negatively regulated by the osteoblast 
transcription factor RUNX2 (Hassan et al. 2010).  Expression of each of these 
miRNAs suppresses bone formation and directly down-regulates SATB2 (Hassan 
et al. 2010), which has been previously implicated in facial development and 
associated with morphological variation in the avian beak (Brugmann et al. 2010, 
FitzPatrick et al. 2003).  
Additionally, miR-200a, miR-200b, miR-203, miR-27a, and miR-27b, all of 
which interact with Wnt signaling (Kennell et al. 2008, Thatcher et al. 2008, Wang 
and Xu 2010), are all expressed at 1.5- to 58.9-fold higher levels in duck neural 
crest cells versus the other species (Table 3-2).  As shown in Chapter 4, the Wnt 
pathway regulates regional growth in facial structures and its activation correlates 
with differences in beak morphology. MiR-200a and 200b have also been shown 
to regulate mesenchymal-to-epithelia transitions (MET) via direct repression of 
ZEB1 and ZEB2 (Bracken et al. 2008, Gregory et al. 2008), though, as stated 
above, it is unclear if MET is occurring in the HH20 to HH25 developmental 
window. 
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qRT-PCR and in situ hybridization validate the sequencing data 
I confirmed miRNA trends from the sequencing data both in vitro and in 
vivo.  First, I conducted quantitative real-time polymerase chain reaction (qRT-
PCR) on mature miRNAs using a second biological sample of NC cells from 
HH20 and HH25 ducks and chickens.  For nine of ten miRNAs examined, qRT-
PCR confirmed expression trends identified by Next-Generation sequencing 
(Table 3-2 and Table 3-4).  One miRNA, gga-miR-215, showed a slight 
discrepancy between qRT-PCR and miRNA-seq data.  By sequencing, this 
microRNA is expressed at higher levels in chicken than duck neural crest at both 
developmental stages.  However, by qRT-PCR I only confirmed differential 
expression at HH20.  This microRNA has lower read numbers (approximately 50 
PMMR, rather than hundreds or thousands of reads) than most of the other 
miRNAs confirmed by qRT-PCR, which may account for this discrepancy.  
Further, absolute changes in miRNA expression did not always agree between 
sequence data and qRT-PCR as the only commercially available primers for 
miRNA qRT-PCR are designed from human, not chicken, orthologs.  Some 
sequence differences exist between the miRNAs across that evolutionary period 
--approximately 310 million years (Kumar and Hedges 1998)-- and this may 
account for the differences observed between the sequencing and RT-PCR data. 
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 Chick HH20 
Chick 
HH25 
Duck 
HH20 
Duck 
HH25 
Overall trend 
from 
qRT-PCR 
Overall trend 
from 
sequencing 
gga-let-
7a 2.13 3.90 3.54 6.05 
Higher at 
HH25 than 
HH20 in both 
species 
Higher at 
HH25 than 
HH20 in both 
species 
gga-miR-
146b 1.00 0.50 3.29 3.84 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
gga-miR-
16 4.00 3.79 5.15 5.84 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
gga-miR-
183 -2.65 -2.29 -0.68 -0.96 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
gga-miR-
200a -0.29 -0.44 1.74 1.14 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
gga-miR-
200b -1.20 -1.16 0.98 0.11 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
gga-miR-
203 -4.52 -4.58 -2.50 -0.04 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
gga-miR-
215 -6.67 -6.30 -8.02 -6.35 
Higher in 
chicken than 
duck only at 
HH20 
Higher in 
chicken than 
duck at both 
stages 
gga-miR-
222 5.23 4.19 6.61 7.01 
Higher in duck 
than chick only 
at HH25 
Higher in duck 
than chick only 
at HH25 
hsa-miR-
143 3.16 3.06 4.05 5.66 
Higher in duck 
than chick at 
both stages 
Higher in duck 
than chick at 
both stages 
Table 3-4: qRT-PCR validation of miRNA sequencing data. Delta Ct (cycle threshold) values 
for all microRNAs relative to RNU6B input control.  Note that values are in log2 scale, with more 
positive values being more highly expressed. 
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 For one of the differentially expressed miRNAs, miR-222, I performed 
RNA in situ to assess the relative levels and pattern of the mature miRNA in 
FNPs from duck and chicken (Figure 3-3).  In both duck and chicken, this miRNA 
is expressed throughout the facial prominences, and at higher levels in the 
maxillary prominences and around the nasal pits.  Though they have similar 
spatial patterns, miR-222 is expressed at higher levels in the duck, in agreement 
with my sequencing data (Figure 3-3). 
 
Figure 3-3: in situ validation of expression changes for gga-miR-222 in HH25 chickens and 
ducks.  
 
 
Conclusions 
The unbiased genomic approaches presented in this chapter are the first 
large-scale investigations of the roles of microRNAs in species-specific facial 
development and the first comprehensive analysis of miRNAs in the developing 
facial primordial.  Using Next-Generation miRNA sequencing and various 
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bioinformatic approaches, I identified 186 microRNAs that are expressed in the 
frontonasal neural crest cells of the chicken, duck, and quail.  The vast majority 
of these are differentially expressed. In remarkable contrast to the relatively 
unchanged pattern of mRNA expression presented in Chapter 2, I found that 
miRNA expression is dramatically different between developmental stages before  
(HH20) and after (HH25) morphological variation in the beak is evident. 
The patterns of differentially expressed microRNAs (Table 3-3) are 
consistent with the following model (summarized in Figure 3-4).  At HH20, both 
the chicken and the duck have a multipotent, proliferative neural crest population 
that expresses high levels of the miR-302 family as well as high levels of miR-
222 (Table 3-3), which promote an undifferentiated fate (Lin et al. 2010, Lin et al. 
2008) and proliferation via repression of p27(KIP1) (Galardi et al. 2007, Lambeth 
et al. 2009), respectively.  By HH25, chicken NC cells have adopted molecular 
signatures of differentiation. At the same time as the miR-302 family and miR-
222 have been down-regulated, eleven miRNAs related to the let-7 family are up-
regulated, as well as 2 additional miRNAs associated with cellular differentiation 
(Table 3-3) (Roush and Slack 2008).  By HH26, chicken facial primordia express 
molecular markers of the bones and skeleton that will eventually form the adult 
face (Eames and Helms 2004). 
Duck NC cells at HH25 have down-regulated the miR-302 family and up-
regulated some of the miRNAs associated with cellular differentiation (i.e. the let-
7 family), though not as many as chicken NC (Table 3-3).  However, in contrast 
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to the chicken, duck NC still express high levels of miR-222, and this may act to 
maintain a higher proliferation rate via continued repression of p27(KIP1) 
(Galardi et al. 2007, Lambeth et al. 2009).  The duck also has higher levels of the 
miR-23a-27a-24-2 cluster (Table 3-3).  Each of these miRNAs can independently 
repress the bone-promoting transcription factor SATB2 (Dobreva et al. 2006, 
Hassan et al. 2010), and thus the duck may also have a delay in bone formation, 
as NC cells continue to proliferate.   
 
 
Figure 3-4: Model of differences in timing of neural crest differentiation and bone 
formation in duck and chicken based on miRNA expression changes.  HH20 to HH25 may 
be the developmental window when multipotent, proliferative neural crest cells (yellow) gain the 
molecular signatures of differentiation (green) before becoming the cartilage and bones of the 
face.  See text for further descriptions.  Adult skeletal pictures adapted from (Liu B. et al. 2010a) 
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Taken together, these miRNA changes (Table 3-3 and Figure 3-4), 
including differential expression of let-7, miR-302, and miR-30 families (Table 3-
3), indicate that the HH20-HH25 developmental window may be a critical 
transition phase in which multipotent NC cells begin to differentiate to form the 
various tissues of the face.  In addition, given that a number of miRNAs related to 
let-7 and cellular differentiation are only up-regulated in the chicken and quail at 
HH25 (Table 3-3), the timing of this transition may be slightly delayed in the 
morphologically different duck, perhaps allowing a more prolonged period of 
proliferation.  This fits well with current theories that differential regions and levels 
of proliferation can influence the depth, width, and curvature of the beak (Wu et 
al. 2004, Wu et al. 2006) and that microRNAs function during the transitions 
between different cellular states (Giraldez et al. 2006). 
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CHAPTER 4 
Follow-up Studies 
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Introduction 
My studies detailed in Chapter 2 and Chapter 3 describe new 
approaches and new candidate pathways in craniofacial morphogenesis.  In this 
chapter I illustrate specific examples of how these genomic approaches can 
initiate new avenues of investigation and testable hypotheses.  The experiments 
described below have either already been incorporated into my published work or 
are parts of my miRNA studies.   I have  grouped them together here as they all 
stem from the genomic data sets presented in the previous two chapters. 
First, I present follow-up studies of the differences in Wnt signaling that I 
observed in my cross-species analysis.  Viral mis-expression of the Wnt signaling 
pathway completed by our collaborators functionally validates some of the gene 
expression changes identified in Chapter 2.  Next, I show how differentially 
expressed miRNAs described in Chapter 3 can be correlated with the protein 
levels of specific mRNA targets in frontonasal neural crest cells.  I then present 
an assessment of the application of my work to human health by evaluating 
whether the differentially expressed genes I identified in Chapter 3 may serve as  
candidates for genes involved in human craniofacial disorders.  Finally, I use 
DNA sequence analysis and PCR to show that my approaches in Chapter 3 can 
identify and validate interesting species-specific miRNAs. 
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Results 
Changes in Wnt activity promote proliferation, regional growth, and Bmp 
expression in the frontonasal prominence 
Following upon my gene expression studies our collaborators evaluated 
one of our microarray observations, the dramatic up-regulation of multiple 
components of Wnt signaling in the duck neural crest relative to chicken and 
quail, by examining the functional consequences of Wnt mis-expression in the 
developing face.   First, they found that an ectopic Wnt signal is sufficient to 
increase cell proliferation in frontonasal neural crest cells.  Using a retrovirus 
expressing a Wnt ligand, they found that injection of RCAS-WNT2B into an HH20 
chicken face (Figure 4-1A) resulted in wide-spread infection of frontonasal 
mesenchyme after 24hrs, as measured by in situ hybridization using probes 
against the virus and WNT2B (Figure 4-1D-G).  Additionally, this increased 
activation of the Wnt pathway was sufficient to increase the size of the facial 
prominences after 24 hrs (Figure 4-1, B-C).  On the control (uninjected) side, the 
FNP is close to the lateral nasal and maxillary prominences but has yet to fuse 
with them to create the nasal pit (Figure 4-1B-C).  In contrast, the Wnt infected 
side demonstrated dramatic enlargement of the FNP (Figure 4-1B-C).  Further, 
FNPs infected with RCAS-WNT2B showed increased expression of BMP4 by in 
situ (Figure 4-1H-I) and quantitative real-time PCR (qRT-PCR, data not shown), 
placing these findings in context with previously published reports regarding 
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molecular mechanisms involved in beak morphology (Abzhanov et al. 2004, 
Abzhanov et al. 2006, Wu et al. 2004, Wu et al. 2006).  
 
Figure 4-1. Over-expression of Wnt induces outgrowth of the facial prominences and 
expression of BMP4.  (A) Schematic diagram of unilateral injection of RCAS-WNT2B in HH20 
chicks. (B-C) Transverse sections of uninjected side shows normal facial morphology, with the 
frontonasal prominence (f) not fused to the lateral nasal (ln) prominence. On the RCAS-Wnt 
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injected side, the frontonasal prominence has fused to the lateral nasal and maxillary 
prominences (mx) and the nasal pit has been drastically reduced in size. White arrows indicate 
continuous mass of tissue spanning from the frontonasal to lateral nasal prominence. (D-I) 
Section RNA in situ hybridizations of injected and uninjected embryos.  (D-E) Viral probe (RSCH, 
yellow) is not detected in uninjected embryos, but is expressed throughout FNP (f) neural crest 
cells of RCAS-Wnt injected embryos. (F-G) Injected embryos have robust up-regulation of 
WNT2B (yellow) in FNP neural crest relative to uninjected embryos.  (H-I) BMP4 expression (red) 
is expanded throughout the FNP neural crest in RCAS-Wnt injected embryos, relative to 
uninjected controls. Black scale bar denotes 200 µm, white scale bar denotes 250 µm. f, 
frontonasal prominence; fe, facial ectoderm; ln, lateral nasal promienence; mn, mandibular 
prominence; mx, maxillary prominence; te, telencephalon. 
 
Localization of Wnt activity in the face varies among avian species 
 Since our collaborators observed dramatic outgrowth of a chick FNP with 
excessive Wnt signaling, we hypothesized that different spatial patterning of Wnt 
signaling could account for shape differences in the chicken beak and duck bill.  
To test regions of Wnt responsiveness in the developing beak, we developed a 
Wnt reporter construct (Brugmann et al. 2007) in which enhanced green 
fluorescent protein (eGFP) is under the control of seven TCF binding sites 
(7xTCF-eGFP).  We examined Wnt responsiveness in both chick and duck in ovo 
by infecting embryos at HH13 with the GFP reporter, and examining them after 
48 hrs and 96hs, at HH25 and HH28, respectively (Figure 4-2). HH13 was 
chosen for injections because the neural crest cells that contribute to the upper 
beak have populated the FNP by that stage, but growth has yet to ensue; 
consequently, injections at this stage produce widespread infection by HH20 
(Brugmann et al. 2007).  HH25 and HH28 chicks displayed a robust region of 
reporter activity in a midline stripe down the frontonasal prominence, in keeping 
with the dramatically elongated V-shaped frontonasal prominence in chicks 
(Figure 4-2A,C).  In contrast, duck embryos showed prominent GFP expression 
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in two lateral domains of the FNP (Figure 4-2B,D); this expression corresponds 
to outgrowth of the U-shaped bill of ducks.  These experiments suggest that 
differential regulation and location of Wnt signaling may contribute to species-
specific beak morphology through alteration of the growth trajectories of the FNP 
and regulation of Bmp signaling, and functionally validate the dramatic changes 
in Wnt signaling identified by the microarray analysis presented in Chapter 2. 
 
 
Figure 4-2. Regions of Wnt responsiveness spatially differ in chick and duck.  Chicken and 
duck frontonasal prominences were injected with 7xTCF-eGFP at HH13 and examined after 
48hrs (A-B) and 96hrs (C-D), at HH St.25 and HH St.28, respectively.  (A,C) Wnt responsiveness 
(visualized by GFP expression) is present at the midline (white arrow) in the chicken frontonasal 
prominence (f).  (B,D) In the duck frontonasal prominence, Wnt responsiveness is absent at 
midline, but present in lateral domains (white arrows). f, frontonasal prominence; mx, maxillary 
prominence. 
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Correlation of miR-27a and miR-302b with protein levels of putative targets 
While it is possible to over-express microRNAs using viral vectors similar 
to those used to examine the Wnt pathway described above (Hornstein et al. 
2005), this approach is both labor and time-intensive.  As an alternative strategy 
to correlate specific microRNAs with their in vivo mRNA targets, I measured 
protein levels of known or predicted targets for two differentially expressed 
microRNAs, miR-27a and miR-302b (Table 3-2). 
MiR-27a has been demonstrated to directly target the fibroblast growth 
factor (Fgf) antagonist SPRY2 and promote proliferation in human pancreatic cell 
lines (Ma et al. 2010).  As described in Chapter 3, miR-27a is expressed at 
higher levels in the duck than the chicken at both HH20 and HH25 (Table 3-2 
and Table 3-3).  Consistent with this, I determined by western blotting that 
SPRY2 protein is at lower levels in duck FNPs compared to chicken at both 
stages (Figure 4-3) indicating that SPRY2 is also a plausible target of miR27a in 
the FNP. 
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Figure 4-3: Western blot analysis of putative targets of miR-302b and miR-27a.  Tubulin is 
used as control for variation in total protein loaded. 
 
The miR-302 family is associated with an undifferentiated cell fate (Lin et 
al. 2010, Lin et al. 2008), but direct targets of miR-302b have yet to be identified.  
In order to identify putative targets for this miRNA, I used two online target 
prediction tools, Microcosm  (http://www.ebi.ac.uk/enright-
srv/microcosm/htdocs/targets/v5/, version 5) and TargetScan 
(http://www.targetscan.org/, version 5.1), both of which require perfect alignment 
between a microRNA seed (nt 2-8) and the target 3’ UTR and imperfect 
alignment within the 3’ region of the miRNA.  While both algorithms predict a 
large number of potential targets (687 and 292 targets in Microcosm and 
TargetScan, respectively), only 32 targets were predicted by both programs 
(Table 4-1). 
BAMBI HIF1AN PRSS23 TRIM36 
C11orf30 HLF RAPGEF2 TRIP11 
CUL3 INOC1 RORA TRPS1 
EFEMP1 LATS2 RPS6KA3 TSHZ3 
EIF2C1 MAP3K2 RRAGD UBE2B 
FGD4 MLL3 RSBN1L UHRF1 
FOXK2 NTN4 SNRK UPF3A 
GUCY1A3 PAK7 TOR1B ZC3H6 
Table 4-1: Putative targets of miR-302b predicted by both Microcosm and TargetScan 
algorithms. 
 
I chose to further analyze CULLIN3 (CUL3) as a potential target of miR-
302b (see Discussion for the rationale behind this choice).  In both chicken and 
duck, miR-302b is more highly expressed at HH20 (Table 3-2 and Table 3-3).  
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CUL3 protein is at lower levels in chicken and duck FNPs at HH20 relative to 
HH25, consistent with CUL3 being a target of miR-302b (Figure 4-3).  However, 
steady-state mRNA levels have not been analyzed for either SPRY2 or CUL3 
and it is yet to be determined if their differential expression is indeed due to 
microRNA regulation or other mechanisms. 
 
Expression of miR-222 correlates with changes in the cell cycle regulator 
p27 protein but not with its steady state mRNA levels  
Previous studies have identified the mRNA encoding the cell cycle 
regulator p27(KIP1) as one target of miR-222 (Galardi et al. 2007, Lambeth et al. 
2009).  This miRNA is expressed at similar levels in the chicken, duck, and quail 
at HH20 (Chapter 3).  However, by HH25, miR-222 has been down-regulated 
1.8-fold in both chicken and quail, though it remains at higher levels in HH25 
duck neural crest cells (Table 3-2 and Table 3-3).  I sought to determine whether 
this miRNA may be altering p27 levels in the developing face by measuring 
levels of p27 protein by western blotting in chicken and duck FNPs from HH17, 
when neural crest cell have completed migration into the facial prominences, to 
HH31, when the adult bill is taking shape (Hamburger and Hamilton 1951, 
Lumsden et al. 1991).  
From HH17 to HH23, when the duck and chicken embryos are still 
morphologically similar (Brugmann et al. 2010b), p27 protein is present at similar 
levels in the FNP by western blotting (Figure 4-4A).   However, once the chicken 
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and duck diverge morphologically at HH25, I observed changes in the levels of 
p27 protein.  At HH25, the levels of p27 increase in the chicken but remain 
relatively constant in duck FNP (Figure 4-4A), correlating with the observed 
decrease in miR-222 in the chick (Table 3-2).   The levels of p27 protein remain 
at higher levels in chicken FNP through to the end of the time course at HH31.   
These observations were substantiated by a less quantitative measure, whole-
mount immunohistochemistry.  Consistent with the above western blotting results 
(Figure 4-4A), immunohistochemistry showed that p27 protein levels are at 
similar levels in the chicken and the duck from HH17 to HH23 (Figure 4-5).  At 
HH25 and HH26, p27 has been up-regulated in the FNP of the chicken 
compared to the duck (Figure 4-5).  However, for these immunohistochemistry 
experiments, I could not use the verified monoclonal anti-p27 antibody I 
employed for western blotting.  Instead, I used a polyclonal anti-p27 antibody that 
was not of the same quality as the monoclonal antibody and detected several 
bands by western blotting (data not shown). 
These increased levels of p27 protein are not accounted for by a 
corresponding increase in p27(KIP1) mRNA levels.  By RT-PCR, steady state 
levels of p27(KIP1) transcripts remain relatively constant from HH17 to HH27 in 
both chicken and duck FNPs (Figure 4-4B), indicating that post-transcriptional 
regulation most likely accounts for the observed decrease in p27 protein (Figure 
4-4A) and adding another piece of correlative evidence that changes in miR-222 
may account for changes in p27 protein.    
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Figure 4-4: p27(Kip1) protein, but not mRNA, is differential between chicken and duck at 
the onset of morphological divergence.  (A) Western blot analysis of p27 protein (lower 
doublet) relative to alpha-tubulin loading control (upper band) in HH17-HH31 chicken and duck 
frontonasal prominences.  (B)  Levels of p27(KIP1) mRNA transcripts relative to GAPDH control 
in chicken and duck frontonasal prominences, as measured by RT-PCR. 
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Figure 4-5: Whole-mount immunohistochemistry for p27(Kip1) in HH17 to HH31 chicken 
and duck heads.   
 
 
miR-222 may be expressed in different tissue layers in chicken and duck 
 As mentioned above, my sequencing data shows that miR-222 is 
expressed at higher levels in duck neural crest at HH25 compared to HH20 
(Table 3-2).   I confirmed these higher levels of miR-222 in isolated frontonasal 
neural crest of duck versus chicken by qRT-PCR (7.06-fold higher levels in 
duck).  However, comparisons of whole frontonasal prominences, including both 
epithelia and neural crest cells, showed roughly equal levels of miR-222 in duck 
and chicken FNPs at each stage from HH23 to HH27 (Table 4-2).  This is 
consistent with miR-222 being expressed in different tissue layers in the chicken 
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and the duck. That is, miR-222 is expressed at higher levels in duck neural crest 
(Table 3-2 and qRT-PCR results above), but this miRNA is expressed at higher 
levels in chicken surface epithelia and/or neuroectoderm.  Thus, measures of 
miR-222 levels in whole FNP samples show equivalent expression (Table 4-2) 
but the underlying tissues show differential expression.  
Comparison miR-222 fold change 
Duck HH23/ Chicken HH23 1.32 
Duck HH24/ Chicken HH24 1.42 
Duck HH25/ Chicken HH25 -1.01 
Duck HH26/ Chicken HH26 1.04 
Duck HH27/ Chicken HH27 -1.50 
Table 4-2: qRT-PCR results for miR-222 levels in stage-matched chicken and duck whole 
frontonasal prominences.  Level of miR-222 is relative to RNU6B in all samples.  Fold changes 
are expressed as duck relative to chicken, where a negative fold change is expressed at lower 
levels in the duck versus chicken.  
 
Assessing whether measuring species-specific variations in gene 
expression is a useful source of candidate genes for human craniofacial 
disorders 
Given the conservation of the molecular “toolkit” used to build the face 
across vertebrates (Abzhanov et al. 2004, Albertson et al. 2005, Liu et al. 2005, 
Suzuki et al. 2009), insights gained from work in evolutionary models may benefit 
human health. In Chapter 2, I employed a novel comparative genomic approach 
exploiting natural variation in bird beak shape as a potential tool to discover new 
candidate genes that regulate mammalian craniofacial development.   
In order to assess whether this approach enriches for genes implicated in 
human facial disorders, I first compiled a list of genes and genomic intervals 
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previously correlated with a variety of mammalian craniofacial defects, as listed 
in the Online Mendelian Inheritance in Man database (OMIM, 
http://www.ncbi.nlm.nih.gov/omim/ and included in a recent review (Dixon et al. 
2011) (see also Materials and Methods).  Of the 334 genes differentially 
expressed among NC cells from the three bird species (Table 2-1 and Table 2-2), 
17 genes (e.g. FGFR2, JAGGED2, OSR2, SATB2, and TGFB3) have previously 
been implicated in human facial defects.  Remarkably, an additional 104 genes 
(nearly 1/3 of the data set) reside in genomic intervals associated with various 
human craniofacial abnormalities (Table 4-3), and may serve as a new source of 
candidate genes for these disorders (see discussion below).  
 
 
Locus OMIM# 
Region 
size 
(Mb) 
Title Differentially expressed genes 
1p34 %606713 12.2 Van Der Woude Syndrome 2 GJB5, LOC51058, MYCBP, PTCH2 
1p36 #607872 28 Chromosome 1p36 Deletion Syndrome HES5, ID3 
1p36.3 %119530 7.2 Orofacial cleft 1 HES5 
1p36.32 #202370 3.1 Adrenoleukodystrophy, Autosomal Neonatal Form HES5 
1p36.32 #214100 3.1 Zellweger Syndrome HES5 
1q22 #214100 1.5 Zellweger Syndrome MTX1, THBS3 
1q4 %119530 34.8 Orofacial cleft 1 FLJ12517, FLJ22301, TGFB2, ZNF496 
1q42-
q44 #612337 25.2 
Chromosome 1q43-q44 Deletion 
Syndrome 
FLJ12517, FLJ22301, 
ZNF496 
2p13 %602966 6.4 Orofacial cleft 2 BMP10, RAI15 
2q31 %183600 13.3 Split-Hand/Foot Malformation 1 EVX2, HOXD1, NFE2L2 
2q31 %606708 13.3 Split-Hand/Foot Malformation 5 EVX2, HOXD1, NFE2L2 
2q32-
q33 #612313 26 
Chromosome 2q32-q33 Deletion 
Syndrome 
FZD5, FZD7, NAB1, 
SATB2 
2q34-
q36 %185900 22 Syndactyly, Type I WNT6 
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2q37.1-
q37.3 %236100 12.2 Holoprosencephaly 1 SP100, TNRC15 
2q37.1-
q37.3 %605934 12.2 Holoprosencephaly 6 SP100, TNRC15 
3q29 %609425 5.7 Chromosome 3q29 Microdeletion Syndrome HES1 
4p16 %600593 11.3 Craniosynostosis, Adelaide Type WHSC1 
4p16.3 #194190 4.5 Wolf-Hirschhorn Syndrome WHSC1 
4q33-
qter %607258 21.1 Hypercalciuria, Absorptive, 1 DUX4, MORF4 
6p24.3 %119530 3.5 Orofacial cleft 1 RREB1 
6p25 %608545 7.1 Larsen-Like Syndrome FOXF2, FOXQ1 
6q21-
q22 %218400 24.8 
Craniometaphyseal Dysplasia, 
Autosomal Recessive FOXO3A, SCML4 
7p11.2 #180860 4 Silver-Russell Syndrome FLJ39963 
7q11 #214100 17.6 Zellweger Syndrome GTF2I 
7q11.23 #194050 5.3 Williams-Beuren Syndrome GTF2I 
7q11.2-
q21.3 %129900 36.3 
Ectrodactyly, Ectodermal 
Dysplasia, and Cleft Lip/Palate 
Syndrome 1; EEC1 
FZD1, GTF2I 
7q11-
q21 %608027 38.1 Pontocerebellar Hypoplasia Type 3 FZD1, GTF2I 
7q36 #120200 11.2 Coloboma, Ocular BC052625, CDK5, PAXIP1 
8q24.3 %612858 6.5 Orofacial cleft 12 ARC 
10p14-
p13 %601362 10.7 
DiGeorge 
Syndrome/Velocardiofacial 
Syndrome Complex 2 
TAF3 
10q24 %600095 8.8 Split-Hand/Foot Malformation 3 CNNM1, FLJ10895, HOX11 
11p11.2 #601224 5.3 Potocki-Shaffer Syndrome ZFPM1 
11q23-
q24 %225000 20.4 Rosselli-Gulienetti Syndrome 
HSPC063, LZTS1, 
OCT11 
12p13.3 #214100 10.1 Zellweger Syndrome CCND2, WNT5B, ZNF384 
13q12.2
-q13 %157900 12.3 Moebius Syndrome HMG1 
13q14 %601499 15.2 Axenfeld-Rieger Syndrome, Type 2 KBTBD7, RGC32 
13q31.1
-q34 %610361 36.2 Orofacial cleft 9 ZIC5 
14q13 %609408 4.5 Holoprosencephaly 8 PAX9 
14q21-
q22 %608664 20.3 Seckel Syndrome CDKN3, TRIM9 
14q32 %164210 17.5 Hemifacial Microsomia CRIP1, JAG2, TRIP11 
17p11.2 #610883 6.2 Potocki-Lupski Syndrome ALDH3A2, SREBF1 
17p11.2 %604547 6.2 Van Der Woude Syndrome Modifier ALDH3A2, SREBF1 
17p12-
p11.1 #119540 13.3 Cleft Palate, isolated ALDH3A2, SREBF1 
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17p13.3 #247200 3.3 Miller-Dieker Lissencephaly Syndrome HIC1 
17q24.3
-q25.1 %261800 7.7 Pierre Robin Syndrome FLJ14297, GPRC5C 
18p11.3
1-q11.2 %606744 22.1 Seckel Syndrome 2 GATA6, TAF2C2 
19q13 %600757 26.7 Orofacial cleft 3 
AB075831, AK128361, 
ATF5, 
DKFZp686B0797, 
FLJ12586, FLJ13265, 
FLJ14779, FLJ22059, 
FLJ23233, FLJ32191, 
HIF3A, KIAA0798, 
LISCH7, MGC4400, 
RELB, ZNF211, 
ZNF223, ZNF42 
21q22.3 %236100 5.5 Holoprosencephaly 1 PFKL, PTTG1IP 
22q11 #115470 11.2 Cat Eye Syndrome LZTR1, PCQAP 
22q11.2 #145410 8 Opitz GBBB Syndrome, Autosomal Dominant LZTR1, PCQAP 
22q11.2 #608363 8 Chromosome 22q11.2 Microduplication Syndrome LZTR1, PCQAP 
22q11.2 #611867 8 Chromosome 22q11.2 Deletion Syndrome, Distal LZTR1, PCQAP 
22q11.2 #192430 8 Velocardiofacial Syndrome LZTR1, PCQAP 
22q12-
q13 %603116 25.4 CDAGS Syndrome 
HRIHFB2122, 
LOC90322, MFNG, 
PPARA, SOX10, 
TCF20 
Xp11.23
-q13.3 %311900 29.6 Tarp Syndrome 
CITED1, MLLT7, 
PHF16, ZNF21 
Xp22 #300209 24.9 Simpson-Golabi-Behmel Syndrome, Type 2 MID2 
Xq24-
q27.3 #300243 30.6 
Mental Retardation, X-Linked, 
Syndromic, Christianson Type FGF13 
Xq26-
q27 %300238 18.4 
Mental Retardation, X-Linked, 
Syndromic 11 FGF13 
Xq26-
q27 %300712 18.4 Craniofacioskeletal Syndrome FGF13 
Xq28 %300261 8.2 Armfield X-Linked Mental Retardation Syndrome FMR2 
Table 4-3: Genes differentially expressed in chicken, duck, and quail that reside within 
genomic intervals associated with human craniofacial disorders.  See Tables 2-1 and 2-2 for 
additional gene annotation. 
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Identification of putative avian specific miRNAs 
The miRNA arsenal is relatively dynamic across the metazoan lineage 
(Grimson et al. 2008, Heimberg et al. 2008, Hertel et al. 2006, Prochnik et al. 
2007, Sempere et al. 2006, Wheeler et al. 2009) compared to transcription 
factors and signaling pathways, which are largely conserved from sponges to 
humans (Larroux et al. 2008, Nichols et al. 2006).  The initiation rate for new 
microRNAs is estimated to be from 1-12 new miRNAs per million years 
(Berezikov et al. 2010, Lu et al. 2008), and there are numerous examples of 
microRNAs that appear to be restricted to specific vertebrate lineages, from 
primates to insects (Bentwich et al. 2005, Berezikov et al. 2006, Brameier 2010, 
Li et al. 2010, Yuan et al. 2010).  In all of these cases, miRNA evolution is 
determined by sequence homology, and it is still to be determined if these 
microRNAs are an evolutionary dead-end or have functional roles in 
development or species divergences. 
The studies in Chapter 3 represent the first large-scale evaluation of 
miRNAs in multiple avian species.  Therefore, I was interested in assessing 
whether any of the miRNAs that are detectably expressed in the frontonasal 
neural crest of chickens, ducks, and quails might be specific to the avian lineage.  
Birds and mammals shared a last common ancestor ~310 million years ago 
(Kumar and Hedges 1998), and the earliest divergences within birds occurred 
nearly 120 million years ago (Figure 4-6) (van Tuinen and Hedges 2001).   
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Figure 4-6: Phylogeny of avian species, adapted from (van Tuinen and Hedges 2001).  
Classification of birds used for miRNA sequencing and PCR of miR-2954 and miR-2954* are as 
indicated, excepting Gray-chested Dove (Neoave).  See also Table 6-5. 
 
As described in Materials and Methods, I compiled a list of seven mature 
miRNAs that are only annotated in chicken and zebrafinch in miRBase 
(http://mirbase.org/, release version 16) (Griffiths-Jones et al. 2008), as identified 
in other miRNA deep sequencing projects (Burnside et al. 2008, Glazov et al. 
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2008).  These sequences are also detectable by sequence alignment searches 
only in chicken and/or zebrafinch and (as determined by my studies) are 
expressed in the frontonasal neural crest of the chicken, duck, and quail (Table 
4-4).  
mature miRNA miRBase Accession miRNA sequence 
gga-miR-1451 MIMAT0007324 UCGCACAGGAGCAAGUUACCGC 
gga-miR-1559 MIMAT0007416 UUCGAUGCUUGUAUGCUACUCC 
gga-miR-2131 MIMAT0011207 AUGCAGAAGUGCACGGAAACAGC 
gga-miR-2131* N/A CUGUUACUGUUCUUCUGAUG 
gga-miR-2954 MIMAT0014448 CAUCCCCAUUCCACUCCUAGCA 
gga-miR-2954* MIMAT0014623 GCUGAGAGGGCUUGGGGAGAGGA 
tgu-miR-2970 MIMAT0014479 GACAGUCAGCAGUUGGUCUGG 
Table 4-4: Mature miRNAs that are putatively specific to the avian lineage.  
 
I chose to further analyze two of these mature miRNAs, gga-miR-2954 
and gga-miR-2954*.  These miRNAs are also detectable (and differentially 
expressed) at a substantial level in a second miRNA sequencing dataset we 
have recently derived from the chicken inner ear (Ku, personal communication).  
PCR and subsequent sequence analysis using the zebrafinch locus as a 
reference (data not shown) indicates that the hairpin precursor of these miRNAs 
is indeed conserved across the entire avian lineage (~118.6 million years since 
last common ancestor) (van Tuinen and Hedges 2001), from tinamous and 
ratites to songbirds (Figure 4-6 and see Materials and Methods for listing of 
species analyzed).   
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As yet, there are no known functions for the seven microRNAs that may 
be restricted to the avian lineage.  These microRNAs may just be an evolutionary 
novelty, but they may also influence species-specific differences.  To evaluate 
potential functionality of these seven putative avian-specific microRNAs, I 
identified potential targets using TargetScan (http://www.targetscan.org/, version 
5.1; note that the Microcosm prediction software does not include nor allow 
prediction of targets for any of these miRNAs) (Table 4-5). Many of these 
predicted targets are members of developmental pathways (e.g. Fgf, Tgfb, and 
Wnt signaling), regulate body patterning (e.g. HOX genes), or influence 
chromatin modifications (e.g. HDAC4) (Table 4-6).   These possible 
miRNA:mRNA target relationships are attractive follow-up candidates for 
species-specific regulation of these important developmental regulators. 
 
 
 
miRNA 
total 
targets 
predicted 
Predicted 
target Gene description 
HOXA10 homeobox A10 gga-miR-1451 8 ONECUT2 one cut homeobox 2 
gga-miR-1559 2 HDAC4 histone deacetylase 4 
ACVR2A activin A receptor, type IIA 
ACVR2B activin A receptor, type IIB 
CALM2 calmodulin 2 
EN2 engrailed homeobox 2 
FGF9 fibroblast growth factor 9 
FZD10 frizzled homolog 10 
HMGA2 high mobility group AT-hook 2 
ONECUT2 one cut homeobox 2 
SMAD2 SMAD family member 2 
TWIST1 twist homolog 1 
ZEB1 zinc finger E-box binding homeobox 2 
gga-miR-2131 142 
ZEB2 zinc finger E-box binding homeobox 2 
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CALM2 calmodulin 2 gga-miR-
2131* 44 LRP6 low density lipoprotein receptor-related protein 6 
gga-miR-2954 20 HMGB1 high-mobility group box 1 
CTNNB1 beta-catenin 
LRP6 low density lipoprotein receptor-related protein 6 
NUP153 nucleoporin 153kDa 
gga-miR-
2954* 54 
ONECUT2 one cut homeobox 2 
ACVR1B activin A receptor, type IB 
CUL3 cullin 3 
EYA4 eyes absent homolog 4 tgu-miR-2970 132 
HOXA9 homeobox A9 
Table 4-5: Selected predicted targets of miRNAs that are potentially limited to the avian 
lineage. 
 
 
Conclusions   
 Our collaborators demonstrated that a Wnt signal is capable of inducing 
BMP4 expression in the FNP cranial neural crest (Figure 4-1). Given that my 
studies were completed at stages prior to identifiable species-specific facial 
morphologies (Figure 2-1), this suggests that the transcription factors and 
signaling pathways identified in Chapter 2 may function upstream of, and likely in 
conjunction with, the Bmp and Calmodulin pathways to influence species-specific 
facial morphology.   Additionally, activation of the Wnt signaling pathway 
promoted regional growth fields that collectively influence the growth trajectory of 
the facial prominences.  Further, our collaborators showed that discrete domains 
of Wnt activity differ in birds with distinct beak shapes, and these domains 
correlate with morphological differences (Figure 4-2). Taken together, these 
experiments integrate my results from Chapter 2 into the existing framework of 
craniofacial morphogenesis (Abzhanov et al. 2004, Abzhanov et al. 2006, Wu et 
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al. 2004, Wu et al. 2006) by showing that Wnt signals regulate Bmp pathway 
activity and regional growth in the embryonic face, and in doing so, control 
morphological variation within and among vertebrate species. 
I then correlated expression levels of specific miRNAs and their known or 
computationally predicted targets.  For instance, levels of miR-27a inversely 
correlate with protein levels of the Fgf signaling antagonist SPRY2 (Figure 4-3), 
which has been shown to be a direct target of this miRNA in other cell types (Ma 
et al. 2010).  Fgfs are critical for a number of processes in facial development 
(Nie et al. 2006).  Additionally, proper levels of SPRY2 appear to be critical for 
normal facial morphogenesis (Goodnough et al. 2007, Welsh et al. 2007), 
indicating the importance of transcriptional and translational control of this gene 
by mechanisms such as miRNA regulation. 
I also demonstrated that levels of miR-302b inversely correlated with 
protein levels of a computationally predicted target, CUL3 (Figure 4-3).  CUL3 is 
an E3 ubiquitin ligase, which specifically identifies targets to be marked for 
degradation by the proteasome. Thus, modulations in protein level may affect a 
wide range of genes and pathways.  CUL3 has also been shown in other 
systems to target CyclinE to regulate mitosis (Sumara et al. 2008), and thus 
proliferation, as well GLI3 (Jiang 2006), an effector molecule of Hedgehog 
signaling, a pathway critical in facial development (Brugmann et al. 2006, 
Brugmann et al. 2010a). 
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However, much of the follow-up presented in this chapter relates to miR-
222.  I speculated that differences in miR-222 levels in the duck versus chicken 
at HH25 could regulate morphological differences in the beak via its target, the 
cell cycle regulator p27(Kip1) (Galardi et al. 2007, Lambeth et al. 2009).  My 
hypothesis is that higher levels of miR-222 in HH25 duck, and the commensurate 
decrease of p27 protein, could result in an increased proliferation level.  On the 
other hand, lower miR-222 levels in the beaked chicken and quail could lead to a 
release of p27 repression and a consequent decrease in proliferation.  This 
model agrees with previous analysis that identified higher proliferation levels in 
HH26-HH31 duck bills compared to chicken beaks (Wu et al. 2004, Wu et al. 
2006).   
 I first demonstrated p27 protein is expressed at similar levels in the FNP of 
the chicken and duck while they are morphologically similar (Figure 4-4).  
However, at HH25, when species-specific morphologies are evident, p27 levels 
are dramatically different in the chicken and duck, in patterns consistent with 
alterations in miR-222 expression levels (Figure 4-4).  Further, these changes in 
p27 protein are not associated with changes in mRNA level, indicating that post-
transcriptional mechanisms (such as miRNA inhibition) are important for proper 
regulation of this cell cycle regulator.  Additionally, preliminary qRT-PCR data 
suggests that miR-222 may be expressed in different tissues (neural crest versus 
epithelia) in the chicken and the duck, though this observation needs further 
analysis. 
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In order to assess the application of my analysis in Chapter 2 to human 
health, I evaluated the overlap of candidates from a number of genomic studies 
with genes and genomic loci implicated in a variety of human craniofacial 
disorders.  First, many genes in my data set have been previously implicated in 
mammalian craniofacial disorders.  Second, 1/3 of the genes I identified lie within 
genomic loci linked to facial disorders for which causative genes have not been 
unequivocally identified (Table 4-3).  For example, deletions and duplications of a 
3Mb region at 22q11.2 have been associated with DiGeorge, Opitz GBBB, and 
velocardiofacial syndromes, and result in craniofacial dysmorphisms such as 
broad nasal root, midface hypoplasia, and cleft palate (Lindsay 2001).  While 
TBX1 has been proposed as a candidate gene for these disorders, mutations in 
this gene do not explain all cases (Lindsay 2001), suggesting additional genes 
may have roles in disease pathogenesis.  Within the 3Mb region, I observe 
differential expression of the transcription factors LZTR1 and PCQAP, suggesting 
they may also serve as candidate genes for these disorders. 
 Finally, I assessed potential avian-specific miRNAs.  I identified seven 
mature miRNAs that appear to be specific to the avian lineage by sequence 
alignments (Table 4-4) and further evaluate two of these using PCR.  The hairpin 
precursor for miR-2954 and miR-2954* was detected across the entire avian 
lineage, which has been evolving for nearly 120 million years (van Tuinen and 
Hedges 2001).  This is the first described example of a validated avian-specific 
miRNA and joins several other examples of miRNAs that have independently 
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evolved within defined vertebrate lineages (Bentwich et al. 2005, Berezikov et al. 
2006, Brameier 2010, Li et al. 2010, Yuan et al. 2010). My computational 
analysis of the putative targets of these avian-specific miRNAs (Table 4-5) 
suggests that they may indeed regulate important developmental regulators of 
morphogenesis. 
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CHAPTER 5 
General Conclusions 
  
 156 
 The face is our external identity to the world.  There are over six billion 
human faces, and each is unique.  Moreover, other vertebrates, and particularly 
birds, have extraordinary variation in their facial structures.  Avian beaks have 
evolved to scoop, tear, crush, pry, sip, and pluck, as suits their ecological niche 
best.  Yet despite these drastic differences in adult structures, embryonic facial 
primordial are remarkably similar at stages when neural crest cells have 
populated the face and are beginning to grow to form the beak.  These neural 
crest cells form all the bones and cartilage of the face and contain species-
specific patterning information.   
 In the previous chapters, I described the use of cross-species microarrays 
and Next-Generation sequencing to identify the transcription factor genes, 
developmental signaling pathways, and microRNAs that encode species-specific 
patterning information in the neural crest cells of chickens, ducks, and quails.  
Changes in gene expression for the neural crest of the presumptive upper beak 
were analyzed in the three species prior to (HH20) and after (HH25) 
morphological variation was evident.  Using custom microarrays I identified 334 
transcription factors and members of developmental signaling pathways that are 
expressed in a species-specific pattern that predates morphological variation.  
Duck neural crest had particularly dramatic changes in Wnt signaling 
components compared to either the chicken or the quail.  Further experiments 
demonstrated that regions of Wnt activation correlate with differing beak 
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morphology, and this pathway may contribute to species-specific facial structures 
by promoting growth in particular facial regions.  
  I also observed differential expression of the Calmodulin and Bmp/TGFβ 
signaling pathways among the developing beak primordial of chickens, ducks, 
and quails.  These pathways were previously shown to influence the formation of 
narrower and broader beaks in Darwin’s finches.  While the beak of the chicken 
and quail are more conical in shape, roughly similar to the finches, the bill of the 
duck is broad and flat—a very different sort of facial adaptation.  Despite this 
morphological distinction, it appears that similar genes and pathways may 
regulate the development of very different facial shapes within birds.  It will be 
interesting to see whether cases of morphological convergence in the face (e.g. 
broad versus narrow jaws in both birds and fishes) are also influenced by the 
same molecular genetic regulators.  
Previous QTL analyses of morphological variation in the faces of mice, 
baboons, and fish estimated that one to forty genes account for variability in 
various features of the face.  This raises the question, why did I detect changes 
in so many genes?  While the genes I identified as being differentially expressed 
in the developing beaks of chickens, ducks, and quails predate morphological 
variation, many (if not most) are likely to be downstream effectors.  That is, a set 
of “master regulator” genes begins a cascade that ultimately results in differential 
expression of hundreds of genes to control species-specific facial morphologies. 
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 BMP4 appears to be one such downstream gene.  It is only differentially 
expressed in the mesenchyme of the developing upper beak after morphological 
variation is evident, and we show that its expression can be induced by Wnt 
signaling.  Whether there is a linear relationship between Wnt signaling and 
BMP4, or whether multiple signals converge on BMP4 to influence facial shape is 
yet to be determined.  But it is clear that these downstream effectors can have a 
major influence on species-specific facial form; ectopic expression of BMP4 
alone is sufficient to alter beak shape.   
In addition to the microarray analysis, I also comprehensively identified 
changes in microRNAs between chicken, duck, and quail neural crest samples 
using high-throughput Next-Generation sequencing.  In contrast to the subtle 
changes in mRNA expression observed in my mRNA analysis, many microRNAs 
dramatically change in expression between the two developmental stages that I 
examined.  Interestingly, the changes in microRNA expression revealed potential 
new insights into neural crest biology.  Prior to my study, little was known about 
neural crest cells from the time they finish migrating to the facial prominences 
(HH14-HH15) to when they begin bone pre-condensation (HH25-HH26).  
MicroRNA profiling indicates that the HH20 to HH25 developmental window may 
be a transition state from a population of multipotent, proliferative neural crest 
cells, and those that have the molecular signatures of differentiation.  Further, 
differences in microRNA expression between the species are consistent with this 
transition being delayed in the duck.  This delay would allow a prolonged period 
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of neural crest proliferation in duck, which may ultimately influence differential 
facial form. 
 The genomic studies described here represent a number of “firsts:” the 
first large-scale insights into cross-species facial morphology, the first 
comprehensive analysis of microRNAs in the developing face, and the first 
evaluation of miRNAs in multiple avian species.  Numerous studies can be 
initiated from this work, from hypothesis-driven testing of specific genes and 
pathways in facial development (e.g. the Wnt pathway) to evaluations of 
microRNA evolution within the avian lineage.  I hope that, by revealing for the 
first time the broader spectrum of mRNA and miRNA expression differences in 
this important developmental process, my studies will provide a new set of 
candidate genes and pathways for studying the evolution of species-specific 
facial structures and overall facial development in both avians and mammals. 
 
 160 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
Materials and Methods 
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Frontonasal mesenchyme tissue isolation 
Chick, quail, and duck embryos were obtained through AA Farms 
(Westminster, CA). Eggs were set in a rocking incubator at 37°C and windowed 
at 48hrs to determine developmental stage.  Staging was done according to 
Hamburger-Hamilton criteria (Hamburger and Hamilton 1951).  Frontonasal 
prominences (FNPs) were isolated in cold PBS from Hamburger-Hamilton stage 
20 (HH20) and HH25 embryos, by cutting off the head between pharyngeal 
arches 1 and 2, and collecting the tissue rostral to the eyes.  To isolate 
frontonasal mesenchyme, FNPs were placed in 1.26U dispase in 1x PBS at room 
temperature for 15mins, then into Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS).  Surface ectoderm and 
forebrain neuroectoderm were removed using sharpened tungsten needles.  
Unlike the other facial prominences, FNP mesenchyme consists of a pure 
population of neural crest cells, rather than a combination of neural crest and 
mesoderm (Tapadia et al. 2005).    
 
Total RNA isolation  
Isolated samples of frontonasal mesenchyme (neural crest) from 40 
embryos were pooled and homogenized in 500µl of TRIZOL (Invitrogen), and 
total RNA extracted per manufacturer’s instructions.  After adding 120µl of 
chloroform to the TRIZOL, the tube was inverted 4-6 times to mix.  Samples were 
incubated at room temperature for 2-3 mins, and then centrifuged at 13000 x g 
 162 
for 3 mins in a bench-top centrifuge.  The upper, aqueous layer was removed 
and placed in a new tube. To precipitate the total RNA, a volume of cold 
isopropanol equal to that of the aqueous layer is added (generally 300µl) with 1µl 
of 20mg/ml glycogen as a carrier to aid in precipitation.  The tube was inverted 4-
6 times to mix, and incubated at room temperature for 30 mins. Samples were 
spun at 13000 x g at 4°C for 20 mins, inverted 4-6 times, and spun at the same 
conditions for an additional 20 mins.  Supernatant was removed, and the pellet 
was washed with 500µl 80% cold ethanol.  Samples were inverted to mix and 
spun at 13000 x g at 4°C for 5 mins.  After removing the supernatant, the pellet 
was air dried and resuspended in 5-20µl of RNase-free water. 
 
cDNA amplification 
Due to limited cell numbers, cDNA was linearly amplified as previously 
described (Hawkins et al. 2003, Hawkins et al. 2007).  Briefly, polyadenylated 
RNA was isolated using 10µl paramagnetic oligo-dT25 beads (Dynal), then 
subjected to cDNA synthesis and PCR amplification.  In all steps, supernatant 
can be removed from beads by placing the tube next to a magnet, keeping the 
beads in place as liquid is aspirated by pipette.  Beads were washed twice with 
binding buffer (20mM Tris-HCl pH 7.5, 1M LiCl, 2mM EDTA).  Total RNA was 
denatured at 65°C for 5 mins, combined with an equal volume of binding buffer, 
and allowed to cool in the presence of the washed oligo-dT beads at room 
temperature for 20 mins with periodic mixing.  Beads (and bound polyadenylated 
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mRNAs) were washed twice in 50µl wash buffer (10mM Tris-HCl pH 7.5, 0.15M 
LiCl, 1mM EDTA), then once in 50µl 1x reverse transcriptase (International 
Chicken Genome Sequencing Consortium) buffer (50mM Tris-HCl pH 8.3, 75mM 
KCl, 3mM MgCl2).  A 10µl cDNA synthesis reaction was conducted on the beads 
using 200U Superscript II reverse transcriptase enzyme (Invitrogen) at 42°C for 1 
hr in 1X RT buffer supplemented with 0.5mM each dNTP, 10mM dithiothreitol 
(DTT), and 1uM 3G-SP6-NotI primer (5’- 
GCGGCCGCTATTTAGGTGACACTATAGAAGAGGG-3’). During this RT 
reaction, the RT enzyme adds three cytosines (Burnside et al.) to the 3’ end of 
the first-strand cDNA (which corresponds to the 5’ end of the mRNA transcript).  
The 3G-SP6-NotI primer anneals to these 3 Cs, providing a template to extend 
the first-strand cDNA and adding an SP6 promoter sequence upstream of the 
mRNA coding region.  Because the RT enzyme is likely to add another set of Cs 
at the end of the primer sequence, the 3G-SP6-NotI primer also contains a NotI 
restriction enzyme site to remove concatenated primers.  The beads with 
attached cDNA were washed twice with 50µl sterile water and once with 50µl 1X 
digestion buffer (50mM Tris-HCl pH 7.5, 10mM MgCl2, 100mM NaCl, 1mM DTT) 
prior to a 10µl digestion with 5U NotI enzyme (Invitrogen) at 37°C for 20 mins in 
1X digestion buffer.  Beads were washed three times with 50µl sterile water. 
 The resultant cDNA was linearly amplified with 16 total cycles of PCR.  An 
initial 6 rounds of PCR were conducted on the beads in a 50µl reaction with 
0.5mM each dNTP, 0.2uM CDSII primer (5’-
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AAGCAGTGGTAACAACGCAGAGTACTTTTTTTTTTTTTTTVN-3’), 0.2uM SP6-
5’ primer (5’-ATTTAGGTGACACTATAGAA-3’), and 1x Advantage 2 Taq 
polymerase mix (Clontech) in 1x Advantage 2 PCR buffer (40mM tricine-KOH pH 
8.7, 15mM potassium acetate, 3.5mM magnesium acetate, 3.75ug/ml bovine 
serum albumin [BSA], 0.005% Tween-20, 0.005% nonidet-P40).  Cycle settings 
included an initial denaturation at 95°C for 2 mins, followed by 6 cycles of 95°C 
for 10 secs, 34°C for 10 secs, and 68°C for 6 mins, and finally a 4 min elongation 
at 68°C.  During this reaction, the SP6 5’ primer binds to the SP6 promoter 
sequence added to the 5’ end of the mRNA transcript, while the CDSII primer 
binds to the polyadenine (polyA) tract of the mRNA and adds a known nucleotide 
sequence on the 3’ end of the transcript (after the polyA) to use in the second set 
of PCR reactions detailed below.  After these 6 cycles of PCR, the supernatant 
was transferred to a new PCR tube for an additional 10 PCR cycles and the 
beads were washed three times with 50µl sterile water prior to storage at 4°C.  
The supernatant from first set of PCRs serves as template for the second set of 
PCRs and was supplemented with a 50µl reaction with 0.5mM each dNTP, 
0.5uM PCR3’ primer (5’ - AAGCAGTGGTAACAACGCAG - 3’), 0.5uM 3G-SP6-
NotI primer used in the RT reaction, and 1x Advantage 2 Taq polymerase mix 
(Clontech) in 1x Advantage 2 PCR buffer.  Cycle settings included an initial 
denaturation at 95°C for 2 mins, followed by 10 cycles of 95°C for 10 secs, 60°C 
for 10 secs, and 68°C for 6 mins, and finally a 4 min elongation at 68°C.  During 
this reaction, the 3G-SP6-NotI primer binds to the SP6 promoter sequence 
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added to the 5’ end of the mRNA transcript, while the PCR3’ primer aligns to the 
sequence added 3’ of the polyA sequence.  Amplified cDNA was desalted on a 
Sephadex G50 minicolumn and concentrated in a vacuum centrifuge. 
 
In vitro transcription (RNA run-offs) 
The purified cDNA was used as template for an in vitro transcription using 
the SP6 promoter (Ambion Megascript kit) per manufacturers protocols.  
Approximately 300ng-1.0µg of cDNA was incubated at 37° overnight 
(approximately 12-16hr) in a 20µl reaction with 5mM each nucleotide (ATP, CTP, 
GTP, and UTP) and 2µl SP6 enzyme mix in 1x reaction buffer (Ambion). 
Following this, the reaction was supplemented with 2U TURBO DNase (Ambion) 
and incubated at 37°C for 15 minutes to degrade the cDNA template. Run-off 
RNAs were LiCl precipitated by adding 30 µl lithium chloride (LiCl) solution (7.5M 
LiCl, 50mM EDTA) and 30 µl nuclease-free water to the reaction, mixing, and 
incubating at -20°C for at least 1hr. RNA was pelleted by spinning samples at 
13000 x g at 4°C for 15 mins.  Supernatant was removed, and the pellet was 
washed with 500µl 80% cold ethanol.  Samples were inverted to mix and spun at 
13000 x g at 4°C for 5 mins.  After removing the supernatant, the pellet was air 
dried and resuspended in 30-50µl of RNAse-free water at a concentration of 0.5-
1.0 µg/µl. The quality of cDNA and run-off products was assessed by gel 
electrophoresis.  This protocol generally produced over 25µg of purified, sense 
strand polyadenylated RNA for use in microarray hybridizations. 
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Microarray target labeling  
Sense strand RNAs from each sample were used as templates in cDNA 
synthesis reaction using an oligo dT17-primer tagged with either Cy3- or Cy5-
specific oligonucleotide sequence (3DNA Array 50 kit, Genisphere) per 
manufacturers instructions. 1 µg of run-off RNAs was incubated in a total volume 
of 24µl with 5pmole of either Cy3-RT primer (5’-
TTCTCGTCTTCCGTTTGTACTCTAAGGTGGA-T17-3’) or Cy-5 RT primer (5’-
ATTGCCTTGTAAGCGATGTGATTCTATTGGA-T17-3’) at 80°C for 10 mins, then 
snap-cooled on ice for 3 mins.  The oligo dT tract of these primers bind to the 
polyA tail of the sense mRNAs, while the remaining sequence provide a specific 
“capture sequence” to which the Cy3 and Cy5 dye molecules hybridize in later 
steps. The RNA/primer sample was supplemented to a total reaction volume of 
40µl with 200U Superscript II reverse transcriptase enzyme (Invitrogen), 0.5mM 
each dNTP, 10mM dithiothreitol (DTT), and 1µl Superase-In RNase inhibitor 
(Genisphere) in 1x RT buffer (50mM Tris-HCl pH 8.3, 75mM KCl, 3mM MgCl2) 
and incubated at 42°C for 2 hrs.  The RNA was degraded by adding 7µl of 0.5M 
NaOH/50mM EDTA and incubating at 65°C for 10 mins.  After neutralizing the 
hydrolysis with 10µl of 1M Tris-HCl ph 7.5, Cy3- and Cy5-labeled RT reactions 
were pooled, then cleaned and concentrated using a Microcon YM-30 centrifugal 
filter (Millipore) to a final volume of 20µl. 
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Transcription factor microarray design 
Oligonucleotide probes on the array are 50-70mers designed to coding 
regions of genes, thus allowing cross-species comparisons. The probes on the 
array interrogate ~2,000 known transcription factors genes, as well as many 
genes and ESTs predicted to contain transcription factor motifs (Messina et al.).  
An additional ~400 morphogens implicated in craniofacial development and 
growth factors, including nearly all components of the fibroblast growth factor 
(Fgf), Wnt, transforming growth factor beta/bone morphogenetic protein 
(TGFbeta/ BMP), Pax-Eya-Six-Dach, Notch, and Hedgehog signaling networks.  
As necessary, new 50-70mer Tm-matched probes were designed using OligoWiz 
2.0 design software (Nielsen et al. 2003, Wernersson and Nielsen 2005) to 
conserved 3’ coding regions of genes. When suitable probes could not be 
designed to conserved regions, species-specific probes were designed.  
Sequence comparisons between our human and mouse probes and their chicken 
orthologs indicate that ~98% of our probes have >70% sequence identity with the 
correct chicken orthologs (data not shown).  We have previously shown that 
these probes accurately report in the chicken when used under appropriate 
hybridization conditions (Hawkins et al. 2003, Hawkins et al. 2007). 
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Microarray slide processing and production 
Glass slides for printing were pre-treated by washing at room temperature 
for 2 hrs in a 10% (w/v) NaOH, 57% (v/v) ethanol solution. Slides were then 
rinsed four times in water. They were coated in a solution of 10% poly-L-lysine 
(v/v), 10% 1xPBS (v/v) at room temperature for 1 hr, rinsed in water, dried by 
spinning in floor centrifuge at 1000 rpm for 5 minutes, and baked at 45°C for 10 
minutes.  Oligonucleotides were resuspended at a concentration of 60µM in 
printing buffer (6% dimethyl sulfoxide [DMSO], 1.5M betaine for oligonucleotides) 
and spotted in duplicate on prepared glass slides using a Genetic Microsystems 
GMS 417 arrayer. After printing, slides were baked at 80°C for 2 hrs, then cross-
linked at 65 milliJoules (mJ) before use.  
 
Microarray hybridizations 
Labeled cDNA was supplemented to a final volume of 40µl in 1x 
hybridization buffer (0.5M NaPO4, 0.5% SDS, 1mM EDTA, 1x saline sodium 
citrate (SSC) buffer [0.3M NaCl, 30mM trisodium citrate, pH 7.4], 2x Denharts 
solution [0.04% w/v Ficoll 400, 0.04% w/v polyvinylpyrrolidone, 0.04% w/v BSA]).  
Samples were denatured at 80°C for 5 mins and hybridized at 42°C overnight 
(12-16 hrs) in humidified chambers.  This temperature was calculated assuming 
approximately 70-75% sequence identity between chicken (target) and human or 
mouse (probe) sequences (International Chicken Genome Sequencing 
Consortium).  Slides were washed in 2x SSC plus 0.2% SDS and 10mM DTT at 
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60°C for 15 mins, then 2x SSC at room temperature for 10 mins, and finally 0.2x 
SSC at room temperature for 10 mins, before being dried by spinning in a floor 
centrifuge at 1000 rpm for 5 minutes. Cy3 and Cy5 capture reagents 
(Genisphere) contain approximately 50 fluorescent dyes per molecule, connected 
to an oligonucleotide that binds to the “capture sequence” added to cDNAs in the 
labeling RT reaction.  2µl of capture reagent for each dye was combined with 1µl 
of Anti-Fade reagent (Genisphere) in 1x hybridization buffer with a final volume of 
34µl.  Dyes were denatured at 80°C for 5 minutes and hybridized at 42°C for 3 
hrs in the dark in humidified chambers.  Slides were washed and dried as above 
and scanned using a GMS 418 scanner at gains ranging from 18-40 scanner 
units. 
 
Microarray comparisons 
For each species, the early (HH20) was compared to the later (HH25) 
developmental stage. Stage-matched comparisons were also performed for each 
pair of bird species at both HH20 and HH25.  A minimum of four separate 
microarray hybridizations (two replicates and two dye switches) was carried out 
for each comparison. Given that the neural crest samples were a mixed pool 
containing at least 40 embryos from various hatchings, replicate biological 
samples were not necessary.  A total of 55 array comparisons were conducted 
for this study.  All data, array designs, and analysis parameters are available 
through http://www.ncbi.nlm.nih.gov/geo/ under accession number GSE11099 
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and comply with the “minimum information about a microarray experiment” 
(MIAME) requirements. 
 
Microarray data analysis 
Microarray image intensity levels were quantitatively measured using 
confocal laser scanning (GMS 418 Scanner, Affymetrix) and the resulting data 
was analyzed with the BioDiscovery Imagene 6.0.  Data from raw intensity values 
was normalized by locally weighted linear regression (LOWESS), which 
compensates for non-linear intensity variations (Quackenbush 2001). After 
normalization, fold changes from replicate oligonucleotide probes were averaged. 
Unsupervised hierarchical clustering was then performed using the dChip 
software package (http://biosun1.harvard.edu/complab/dchip/) to determine the 
quality of replicate microarray experiments. I implemented an arbitrary cut-off for 
background intensity values for each microarray chip based on the intensity of 
control oligonucleotides that are designed against C. elegans and moss 
transcripts.  Low intensity filtering was performed to exclude genes with 
intensities lower than this specified threshold. I next selected genes that followed 
the same trend in at least 80% of the replicated hybridizations; genes that did not 
follow the same trend over replicate hybridizations were excluded from further 
analysis. P-values were calculated using a one-sample t-test on fold change data 
from replicate hybridizations.   
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The genes identified by the above methods did not necessarily meet all 
criteria for all comparisons. For instance, a gene may be significant in duck 
relative to the other species, but not between chicken and quail comparisons. 
Therefore, I manually extracted the data for “missing” comparisons, allowing an 
analysis of the patterns of expression across all comparisons. 
 
Sequence homology analysis 
 For all genes with nucleotide sequences for chicken, duck, and quail in the 
NCBI GenBank database (http://www.ncbi.nlm.nih.gov/genbank/), nucleotide 
sequences were compiled and aligned using BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  Regions of cDNA to which microarray 
probes align were amplified by PCR for OSR1, SATB2, TCEA2, and TGFB2 in 
quail and duck and for CALM2 in quail only using the primers listed in Table 6-1.  
Fragments were gel purified and 350ng were used as template for a 12µl 
sequencing reaction with 2.5µl BigDye Terminator v3.1 (Ambion) and 2.5µl of 
2µM either forward or reverse primer (Table 6-1). Cycle settings included an 
initial denaturation at 95°C for 5 mins, followed by 26 cycles of 95°C for 30 secs, 
50°C for 10 secs, and 60°C for 4 mins, and finally a 7 min elongation at 60°C.  
Unincorporated dye was removed using the Qiagen DyeEx 2.0 Spin kit.  Half to 
all of the sequencing reaction was analyzed on a polyacrylamide gel on an ABI 
Prism 377 DNA sequencing machine. 
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Gene Forward primer Reverse primer Product size (bp) 
CALM2 5’-GCTGCAGAACTTCGTCATGT-3’ 5’-CAGTAAGGGAAAAACCTTTTACAGA-3’ 240 
OSR1 5’-CATCCAGCCCAAGCAAGAG-3’ 5’-TGGCATATGTCGCATGTGTA-3’ 327 
SATB2 5’-CGGGATCGAATCTATCAGGA-3’ 5’-TTGGCAAACAGAGCTTGAGA-3’ 236 
TCEA2 5’-ACCCGCATTGGTATGTCAGT-3’ 5’-TGCAGAGCTGTTGTCAGCAT-3’ 320 
TGFB2 5’-AGAAGCGTGCTCTAGATGCTG-3’ 5’-GCACGGAGAGGCAGAAGC-3’ 239 
Table 6-1: Primers used to amplify cDNA regions that bind to microarray probes. 
 
In situ hybridization 
PCR primers (Table 6-2) were used to amplify DNA products from highly 
conserved regions of chicken; all products were sequence verified. A T7 viral 
promoter (5’-CTCTAATACGACTCACTATAGGG-3’) was added to the 5’ end of 
either the sense (negative control) or antisense (experimental) strand using PCR. 
Digoxigenin (DIG)-labeled RNA probes were generated from the cDNA 
fragments using Ambion MEGAscript T7 transcription kits (Ambion) per 
manufacturers protocols.  Approximately 1.0µg of cDNA was incubated at 37° for 
6hrs in a 20µl reaction with 7.5mM ATP, CTP, and GTP, 3.75mM UTP, 0.5mM 
Digoxigenin-11-UTP (Roche) and 2µl T7 enzyme mix in 1x reaction buffer 
(Ambion).  RNA probes were DNase treated, LiCl precipitated, analyzed by gel 
electrophoresis as described above, and resuspended in 1ml in situ hybridization 
buffer (Ambion). 
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Probe 
Name Forward primer Reverse primer 
Probe 
size (bp) 
CALM2 
(coding) 5’-AGGAGTTGGGGACTGTGATG-3’ 5’-CATGGAGGAATGGCCTTCTA-3’ 501 
CALM1 
UTR 5’-GAACTCGAAAGTTCCATTTGCT-3’ 5’-GTTGTGCTGAAGTCCACAGG-3’ 535 
CALM2 
UTR 5’-TAGGGTCAGCATCTCGCTTT-3’ 5’-CAGCGAAGTGAAGACGTTGT-3’ 419 
PHF16 5’-GAACTGGGCCTCCCTAAACT-3’ 5’-AAATGGCTCCTTTGACATCG-3’ 504 
SATB2 5’-GGAAAGAGTGGAAAGAGAAAACC-3’ 5’-TGTGCGGTTGAATGCTACTC-3’ 469 
TBX20 5’-TCAGCTTTTACAACATCTGATAACC-3’ 5’-ATTACTGCGGAGGAGTGACG-3’ 323 
WNT1 5’-ACGTCCTCAAAGACCGCTTC-3’ 5’-AGTTGAGGCAGCTGACGTG-3’ 348 
Table 6-2: Primers used to amplify in situ hybridization probes.   
 
HH25 chicken (Gallus domesticus, Ideal Poultry, Cameron, TX) and duck 
(Anas platyrhynchos, Metzer Farms, Gonzales, CA) embryo heads were 
dissected in cold 1xPBS and fixed in 4% paraformaldehyde in 1xPBS at 4°C 
overnight.  Embryos were serially dehydrated to 100% methanol for storage, and 
serially rehydrated to PBS before in situ hybridization.  Whole-mount RNA in situ 
hybridizations were then performed on stage-matched embryos as previously 
described (http://genepath.med.harvard.edu/~cepko/protocol/ctlab/ish.ct.htm).  
Duck and chicken hybridizations were conducted in parallel to ensure appropriate 
comparisons.  All steps below were conducted at room temperature on an orbital 
shaker unless otherwise noted, allowing embryos to equilibrate for each step (i.e. 
samples do not float in the solution).  Embryos were first bleached with 6% 
hydrogen peroxide in PBT (1xPBS with 0.1% Tween-20) for 1 hr, and then 
washed 3 times for 5 mins each with PBT.  Samples were permeated by treating 
with 25µg/ml Proteinase K (Ambion) in PBT for 30 mins, then the enzyme was 
deactivated with a 10 min wash in 2mg/ml glycine in PBT.  Embryos were 
washed twice for 5 mins each with PBT, post-fixed with 4% paraformaldehyde 
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and 0.2% glutaraldehyde (v/v) in PBS for 20 mins, and washed twice for 5 mins 
each with PBT.  Embryos were serially equilibrated with 10-20 min washes in 
25% hybridization buffer (Ambion)/75% PBT, 50% hybridization buffer/50% PBT, 
75% hybridization buffer/25% PBT, and 100% hybridization buffer.  Samples 
were pre-hybridized in 100% hybridization buffer at hybridization temperature 
(50-55°C for all samples but CALM1 and CALM2, which were conducted at 
70°C).  Embryos were incubated in hybridization buffer (Ambion) containing DIG-
labeled riboprobe at 1µg/ml for mRNA transcripts and 40nM of 5’ DIG-labeled 
miRCURY LNA probe (Exiqon) for microRNA samples at hybridization 
temperature for 12-16 hrs.  Non-specifically bound probe was removed by 
washing three times per solution in solution I (50% formamide, 5x SSC, 1% SDS) 
and solution II (50% formamide, 2x SSC, 0.1% Tween-20) at hybridization 
temperature for 30 mins per wash. 
Hybridized probe was visualized using an antibody against DIG, followed 
by a color reaction.  Embryos were washed 3 times in TBST (1xTBS with 1% 
Tween-20) for 5 minutes each, then blocked for 1 hr in 1% BMB (Boerhinger 
Mannheim blocking reagent [Roche] dissolved in 1x maleic acid buffer [100mM 
maleic acid, 150mM NaCl, pH 7.5]) and 1% mixed heat-inactivated sera 
(generally 25% goat serum, 25% sheep serum, 50% bovine serum) in TBST.  
Samples were incubated for 4 hrs in antibody solution (1% BMB, 0.1% mixed 
heat-inactivated sera, 1:5000 anti-digoxigenin-AP, Fab fragments [Roche]) that 
was pre-absorbed by incubating with shaking at 4°C for 1 hr (during block step).  
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Embryos were washed in TBST overnight at 4°C, then 5 times at room 
temperature for 10 minutes each in TBST in the morning.  Prior to the color 
reaction, pH was equilibrated by incubating samples 3 times for 10 minutes each 
in NTMT (100mM NaCl, 100mM Tris-HCl pH 9.5, 50mM MgCl2, 1% Tween-20).  
Signal is developed by providing substrates that produce a purple product when 
cleaved by the alkaline phosphatase conjugated to the anti-DIG antibody.  
Embryos were incubated in the color reaction mix (175 µg/ml 5-bromo-4-chloro-
3-indolyl phosphate [BCIP, Roche] and 450 µg/mL nitro blue tetrazolium 
choloride [NBT, Roche] in NTMT) in the dark until the reaction is judged 
complete.  Samples were washed in PBS for 5 mins, fixed in 4% 
paraformaldehyde in 1xPBS for 20 mins, PBS for 5 mins, then serially 
dehydrated to 100% methanol for storage and visualization. 
 
Reverse transcription PCR (RT-PCR) 
FNPs and hearts were collected from 2-3 embryos per stage from HH17-
27 chickens and ducks, staged according to Hamburger-Hamilton criteria 
(Hamburger and Hamilton 1951).  Total RNA was isolated as above, and the 
entire RNA sample was DNase treated in a 10µl reaction (1U DNase [Invitrogen] 
in 20mM Tris-HCl pH 8.4, 2mM MgCl2, 50mM KCl) at room temperature for 15 
mins.  The reaction was stopped by adding 1µl of 25mM EDTA pH 8.0.  cDNA 
was produced with the High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems). 1µg oligo(dT)20 primer (Invitrogen), 0.5mM each dNTP, 50U 
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MultiScribe Reverse Transcriptase (Applied Biosystems), and 1x RT buffer 
(Applied Biosystems) were added to the unpurified DNase-treated sample to a 
final volume of 20µl and samples were incubated at 25°C for 10 mins, 37°C for 2 
hrs, and then 85°C for 1 min.  RNA was degraded by adding 3.5µl of 0.5M 
NaOH/50mM EDTA and incubating at 65°C for 10 mins.  cDNA samples were 
neutralized by adding 5µl of 1M Tris-HCl pH 7.4 and introduced directly into a 
PCR reaction.  RT primers (Table 6-3) were designed with Primer3 
(http://frodo.wi.mit.edu/primer3/) to 3’ end of coding region, preferably crossing 
an intron.  PCR was conducted on 1-2µl of cDNA in a 20µl reaction with 0.2mM 
each dNTP, 0.5uM each forward and reverse primer (Table 6-3), 1.5mM MgCl2, 
and 0.075 U Taq DNA polymerase (Invitrogen) in 1x PCR buffer (20mM Tris-Hcl 
pH 8.4, 50mM KCl).  Cycle settings included an initial denaturation at 95°C for 2 
mins, followed by the cycles indicated (Table 6-3) of 95°C for 30 secs, specified 
annealing temperature (Table 6-3) for 30 secs, and 72°C for 30 secs, and finally 
a 7 min elongation at 72°C.  To amplify TBX20 in FNP samples, two sets of PCR 
were necessary; after 30 initial cycles, 5µl of the completed reaction was used as 
template for a further 30 PCR cycles. 
Gene Forward primer Reverse primer 
Anneal 
temp 
(°C) 
Cycles Product size (bp) 
GAPDH 5’- CGTCAAGCTTGTTTCCTGGT-3’ 5’- CTGCAGGATGCAGAACTGAG-3’ 50 18-20 179 
TBX20  5’-ATTGACAGCAACCCTTTTGC-3’ 5’-CCTGGCTGTCATCTCCAAGA-3’ 50 30 157 
FZD1 5’- CCTGCAGAGGAAAAGTCAGG-3’ 5’- TCTGCAAACGGGTTAAAAATG-3’ 50 25 237 
p27KIP1 5’-AACGTCCGCATTTCTAATGG-3’ 5’-GGCTTGTGGTTCTGGAAATC-3’ 50 30 200 
Table 6-3: Primer sequences and reaction conditions for RT-PCRs in frontonasal 
prominences and hearts. 
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Wing and heart microarray comparisons 
Hearts and wing buds were collected from 2-3 HH23 chicken and duck 
embryos, staged according to Hamburger-Hamilton criteria (Hamburger and 
Hamilton 1951). Total RNA extraction, cDNA amplification, in vitro transcription, 
microarray target preparation, microarray hybridization, and microarray data 
processing were conducted as described above. 
 
MicroRNA isolation and processing 
Tissue and total RNA were isolated from the frontonasal mesenchyme of 
ducks, chickens and quails as described above for 40 or 5 embryos for the first 
and second biological samples, respectively.  Note that the first biological 
samples are the same total RNA samples used for microarray analysis.  
microRNA sequencing samples were prepared by a fellow graduate student, 
Yuan-Chieh Ku, who ligated adapters to mature miRNAs using the Illumina Small 
RNA Sequencing kit per manufacturers instructions (v1.5 sRNA 3’ Adapter).  1µg 
of total RNA was incubated with 1µl of 0.5µM v1.5 sRNA 3’ adapter (5’-P-
AUCUCGUAUGCCGUCUUCUGCUUGUidT-3’) in a 5µl reaction at 70°C for 2 
minutes, then on ice for 2 minutes. The 3’ adapter was ligated to RNAs in a 10µl 
reaction volume containing the total RNA, 3’ adapter, 1.5µl T4 RNA Ligase 2 
truncated (200U/µl, New England BioLabs), 0.5µl RNaseOUT (Illumina), and 
1.6µl of 50mM MgCl2 in 1x T4 RNA ligase reaction buffer (50mM Tris-HCl pH 7.5, 
10mM MgCl2, 1mM DTT) by incubating at 22°C for 1 hr. This 3’ adapter is 
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specifically modified to target microRNAs and other small RNAs that have a 3’ 
hydroxyl group resulting from enzymatic cleavage by DICER.  The reaction was 
then supplemented with 1µl of 5µM SRA 5’ adapter (5' 
GUUCAGAGUUCUACAGUCCGACGAUC-3’; previously incubated at 70°C for 2 
minutes, then on ice for 2 minutes), 1µl of 10mM ATP, and 1µl of T4 RNA ligase 
(Illumina) and incubated at 20°C for 1 hr.  To the 12µl ligation reaction, 3µl of 
20µM SRA RT primer (5'-CAAGCAGAAGACGGCATACGA-3’) was added and 
incubated at 65°C for 10mins, before snap cooling on ice for 2 mins.  The 
RNA/primer sample was supplemented to a total reaction volume of 27µl with 
1.5µl RNase OUT (Illumina), 1.5µl of 12.5mM dNTP mix, and 10mM dithiothreitol 
(DTT) in 1x RT buffer (50mM Tris-HCl pH 8.3, 75mM KCl, 3mM MgCl2) and 
incubated at 48°C for 3 mins.  After adding 3µl (200U/µl) SuperScript II Reverse 
Transcriptase (Invitrogen), the reaction was incubated at 44°C for 1 hr to perform 
reverse transcription on the 5’ and 3’ adapter-ligated RNAs. 
  The cDNAs were then amplified by PCR.  The 30µl RT reaction was 
supplemented with 0.25mM each dTNP, 0.5uM GX1 primer (5'-
CAAGCAGAAGACGGCATACGA-3’), 0.5uM GX2 primer (5'-
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA-3’), and 
0.02U Phusion DNA polymerase (Finnzymese) in 1x Phusion HF PCR buffer 
(Finnzymes) to a final volume of 50µl.  DNA was amplified with an initial 
denaturation at 98°C for 30 secs, followed by 15 cycles of 98°C for 10 secs, 60°C 
for 30 secs, and 72°C for 15 secs, and finally a 10 min elongation at 72°C.   
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The entire PCR reaction was loaded on a 6% Novex Tris-borate-EDTA 
(TBE) polyacrylamide gel (Invitrogen).  cDNAs corresponding to 20-40bp RNA 
species (90-110bp on the gel) were gel extracted. The gel slice was dissolved in 
200µl of 1x gel elution buffer (Illumina) by incubating with gentle rotation at room 
temperature for 2 hrs.  Any remaining gel debris was removed using a Spin-X 
cellulose acetate filter (Illumina) and spinning at 14000 rpm for 2 mins.  DNA was 
precipitated by adding 1µl of 20mg/ml glycogen, 20 µl of 3M NaOAc, and 650 µl 
of cold 100% ethanol.  The sample was spun at 14000 rpm for 20 mins and 
supernatant was discarded.  The remaining pellet was washed in 500µl of room 
temperature 70% ethanol by spinning at 14000 rpm for 5 mins. After removing 
the supernatant, the pellet was air dried and resuspended in 10µl of 
resuspension buffer (Illumina). 
 
MicroRNA sequencing and analysis 
 Size-selected RNA samples were sequenced on a GAIIX platform 
(Illumina) by the Genome Technology Access Center (GTAC) core at 
Washington University in St. Louis.  Raw reads were first processed using a 
custom Perl script to remove any adapter sequences and count the abundance 
of each read.  Reads were then mapped to known chicken and human mature 
miRNAs, allowing zero to two mismatches, using the miRanalyzer program 
(version 2, parameters: mismatch for libraries [mRNA transcripts]=1, mismatches 
to genome=2, threshold of the posterior probability=0.9, minimum number of 
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models which predict the microRNA=3) (Hackenberg et al. 2009), which includes 
all microRNAs submitted to miRBase (http://mirbase.org/, release version 16) 
(Griffiths-Jones et al. 2008).  For one sample, the second biological sample of 
HH25 chicken neural crest (Chick_HH25_BS2), data from two replicate 
sequencing runs was combined after verifying that runs correlated >95% (data 
not shown). 
 
Quantitative real-time PCR (qRT-PCR) 
In order to confirm differential expression of individual microRNAs 
between chicken and duck, I performed quantitative real-time polymerase chain 
(qRT-PCR) with TaqMan MicroRNA assays (Applied Biosystems), designed to 
the mature human microRNA sequence.  First, a reverse transcription 
(International Chicken Genome Sequencing Consortium) reaction was performed 
on total RNA using a primer to a specific microRNA. 25ng of total RNA, 1mM 
each dNTP, 1µl MultiScribe reverse transcriptase (Applied Biosystems), 0.2µl of 
20U/µl RNase inhibitor, 3µl TaqMan RT primer (Applied Biosystems), and 1x 
Reverse Transcription buffer (Applied Biosystems) were combined in a 15µl RT 
synthesis reaction and incubated on ice for 5 mins, 16°C for 30 mins, 42°C for 30 
mins, and then 85°C for 5 mins.  For the real time step, a total reaction of 20µl 
with 2µl of the RT reaction and 1µl TaqMan real-time primer (Applied 
Biosystems) in 1x TaqMan Universal PCR master mix, no AmpErase UNG 
(Applied Biosystems) was prepared.  Real-time reactions and detection were 
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carried out using the Applied Biosystems Prism 7500 machine, with cycle 
settings of an initial denaturation at 95°C for 10 mins, followed by 40 cycles of 
95°C for 15 secs and 60°C for 1 min.  The levels of microRNA gene expression 
were determined by normalizing to the spliceosomal RNA RNU6B. All reactions 
were performed in triplicate. 
 
RCAS production and infection 
Our collaborators Samantha Brugmann and Jill Helms (Stanford 
University) prepared and injected replication competent retrovirus (RCAS) 
(Hughes 2004).  Virus was produced, concentrated, and titered in DF-1 cells 
(American Type Culture Collection) as previously described (Logan and Tabin 
1998). DF-1 cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and 1x L-glutamine to 
approximately 70-80% confluency in a 10-cm dish, and transfected with a 
plasmid encoding RCAS virus with a WNT2B transgene.  10µg of plasmid was 
diluted with water to 450µl, mixed with 50µl of 2.5M CaCl2 and 500µl of 2x BES 
(50mM N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid, 280mM NaCl, 
1.5mM Na2HPO4, pH 6.95), incubated at room temperature for 20-30 mins, and 
added to the medium in the plate.  Cells were repeatedly grown until confluent 
and split until cells reached confluency on each of six 15-cm plates.  Cells were 
grown for an additional 36-48 hrs until they became superconfluent.  For each 
plate, medium was replaced with 10ml of DMEM with 1% FBS.  Supernatant was 
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harvested every 24hrs for 3 days, stored at -80°C, and replaced with a fresh 
10ml of DMEM with 1% FBS. 
Viral supernatants were thawed, passed through a 0.45-µm filter, and 
spun in a Beckman Coulter ultracentrifuge at 21000 rpm at 4°C for 3hrs.  
Supernatant was carefully decanted, and the viral pellet was resuspended in the 
remaining media by shaking tubes on ice for 15 mins.  In order to determine the 
titer of the concentrated virus, DF-1 cells were infected for 48hrs with viral stocks 
at a series of dilutions from 10-3 to 10-7.  Infected cells were detected with 
immunohistochemistry.  Cells were washed twice in PBS, and fixed in 4% 
paraformaldehyde in 1xPBS for 15 mins.  After three PBS washes, cells were 
blocked for 30 mins in MST (DMEM with 10% chicken serum and 0.2% Triton X-
100), and incubated for 30 min with AMV-3C2 monoclonal antibody 
(Developmental Studies Hybridoma Bank, University of Iowa) against the gag 
protein of the virus, diluted 1:5 in MST.  Cells were washed three times for 5-10 
mins each in MST, and incubated in 1:400 goat α-mouse peroxidase conjugated 
secondary antibody (Sigma) in MST for 30 mins.  Cells were washed three times 
for 5-10 mins each in PBT (PBS + 0.1% Tween-20).  During these washes, one 
10mg tablet of 3,3’-Diaminobenzidine (DAB, Sigma) was dissolved in 33ml PBT.  
Cells were incubated with DAB solution for 20 mins, and supplemented with 
0.03% hydrogen peroxide.  Cells positive for the 3C2 epitope (and therefore 
infected with the RCAS virus) develop a brown stain within 5-10 mins of 
hydrogen peroxide addition.  Cells were washed with PBT and infected clones 
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were counted to determine viral titer. 
For virus delivery, 2µl of viral supernatant (10^9 pfu/ml) was injected to the 
facial tissue of HH20 chickens. Transgene expression was assayed after 
injection by in situ hybridization with probes against WNT2B or the RCAS virus 
(Suzuki et al.).  Phenotypic effects of transgene expression were analyzed by 
gross inspection and tissue sectioning. 
 
Wnt reporter activity in the face 
Our collaborators Samantha Brugmann and Jill Helms (Stanford 
University) constructed a Wnt reporter virus where enhanced green fluorescent 
protein (eGFP) expression was driven by seven Tcf binding sites (Veeman et al. 
2003). This DNA construct (7xTcf-eGFP) was cloned into the RCAN vector and 
virions were produced by combining the construct with the VSV-G envelope 
plasmid and the packaging plasmid (Dull et al. 1998) then transiently transfecting 
293T cells. The DNA was introduced into cells via calcium phosphate 
precipitation. Media was collected, pooled, filtered, and concentrated by ultra-
centrifugation. The resulting viral pellet was resuspended in PBS then titered on 
chick embryonic fibroblasts. A control retrovirus expressing eGFP under a strong 
constitutive reporter was employed for all assays (Brugmann et al. 2007). HH13 
embryos were infected with 1.0µl of a 106 virions/µl solution and incubated until 
they reached HH25 or HH28. The pattern of eGFP activity was determined by 
examination of whole embryos under fluorescent light, and by immunostaining of 
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tissue sections. 
 
Western blotting 
For Western blotting, FNPs were isolated in cold PBS.  To lyse, tissues 
were incubated in 1x Radio Immuno Precipitation Assay (RIPA) buffer (150mM 
NaCl, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50mM Tris-HCl 
pH 8.0) supplemented with Complete Mini Protease Inhibitor Cocktail (Roche, 1 
tablet per 1mL RIPA) and maintained with constant agitation at 4°C for 30 mins.  
Samples were then centrifuged at 13000 x g at 4°C for 20 mins to pellet cell 
debris.  Supernatant (lysate) was transferred to a fresh tube and the pellet was 
discarded.  Samples were harvested at a concentration of 2-3 FNPs per 10µl 
RIPA plus Protease Inhibitor Cocktail, yielding approximately 1-2µg/µl.  Lysates 
were combined with equal volumes of 2x Laemmli buffer (4% SDS, 10% 2-
mercaptoethanol, 20% glycerol, 0.004% bromophenol blue, 0.125M Tris-Hcl, pH 
6.8), denatured by incubating at 95°C for 5 mins, snap-cooled on ice for 3 mins, 
and loaded at 10-20µg per lane. 
Samples were resolved by 10% SDS/PAGE (5% stacking gel) and 
transferred to nitrocellulose membrane.  Membranes were blocked for 1hr with 
agitation in 5% non-fat milk w/v in TBST (5% milk), and probed with primary 
antibodies diluted in 5% milk as indicated in Table 6-4.  Membranes were 
washed 3 times for 5 mins each in TBST to remove residual primary antibody, 
then probed with secondary antibodies in 5% milk (Table 6-4).  After secondary 
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antibody incubation, membranes were washed twice each for 10 mins and 5 
mins in TBST, and proteins were visualized by enhanced chemiluminescence 
(ECL) substrate kits (Pierce).  The α-alpha-tubulin antibody was used as a 
loading control. 
Antibody Supplier Dilution Incubation conditions 
Protein 
size 
Primary Antibodies 
mouse α-alpha-tubulin 
monoclonal 
Santa Cruz 
Biotechnology 1:25000 
room temperature, 
35-45 mins 55kDa 
mouse α-p27KIP1 
monoclonal 
BD Transduction 
Laboratories 
1:1000-
1:2000 4°C overnight 27kDa 
rabbit α-CULLIN3 
polyclonal Abcam 1:666 4°C overnight 85kDa 
rabbit α-SPRY2 
polyclonal 
Millipore/Upstate 
Cell Signaling 1:2000 4°C overnight 
35-
40kDa 
Secondary Antibodies 
goat α-mouse 
peroxidase conjugate Sigma 1:10000 
room temperature, 
90 mins N/A 
goat α-rabbit  
peroxidase conjugate KPL 
1:10000-
1:20000 
room temperature, 
90 mins N/A 
Table 6-4: Details for antibodies used for Western blotting. 
 
 
Whole-mount immunohistochemistry 
HH25 chicken (Gallus domesticus, Ideal Poultry, Cameron, TX) and duck 
(Anas platyrhynchos, Metzer Farms, Gonzales, CA) embryos were staged 
according to Hamburger-Hamilton criteria (Hamburger and Hamilton 1951).  
Heads were dissected in cold 1xPBS, fixed in 4% paraformaldehyde in 1xPBS at 
4°C overnight, and serially dehydrated to 100% methanol for storage.  Whole-
mount immunohistochemistry was then performed on stage-matched embryos as 
previously described (http://graeflab.stanford.edu/pdf/Whole-
mount_immunohistochemistry.pdf).  Duck and chicken processing were 
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conducted in parallel to ensure appropriate comparisons.  All steps below were 
conducted at room temperature on an orbital shaker unless otherwise noted, 
allowing embryos to equilibrate for each step (i.e. samples do not float in the 
solution).   
Embryos were first bleached with 5% hydrogen peroxide in methanol for 4 
hrs, washed twice for 5 mins each with methanol, and then serially rehydrated to 
PBS.  Embryos were blocked in 5% non-fat milk w/v and 0.1% TritonX-100 v/v in 
1x PBS (PBSMT) with two washed of 1 hr each, then incubated in 1:25 rabbit α-
p27 polyclonal antibody (Santa Cruz Biotechnology) in PBSMT at 4°C overnight.  
Samples were washed five times in PBSMT at 4°C for 1 hr each wash, then 
incubated in 1:500 goat α-rabbit peroxidase conjugate (Sigma) in PBSMT at 4°C 
overnight.  Embryos were washed five times in PBSMT at 4°C for 1 hr each 
wash, then once in PBS for 20 mins.  During the PBS wash, one 10mg tablet of 
3,3’-Diaminobenzidine (DAB, Sigma) was dissolved in 33ml PBS.  Embryos were 
incubated with DAB solution for 20 mins, and supplemented with 0.03% 
hydrogen peroxide for 5-10 mins.  Once the reaction was judged complete, 
samples were washed in PBS for 5 mins and post-fixed in 2% paraformaldehyde, 
0.1% glutaraldehyde in PBS at 4°C overnight.  Embryo heads were washed in 
PBS twice for 5 mins each before being serially dehydrated to methanol for 
imaging and storage. 
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Compilation of genes and loci associated with human craniofacial 
disorders 
 The Online Mendelian Inheritance in Man (OMIM) database 
(http://www.ncbi.nlm.nih.gov/omim/) was interrogated to compile a list of genes 
and genomic loci previously associated with syndromic and non-syndromic 
human disorders with a variety of craniofacial defects.  OMIM was searched with 
the terms “craniofacial,” “cleft,” “microcephaly,” and “craniostynostosis.” Results 
were individually verified to include craniofacial defects and manually compiled.  
OMIM entries fell into three classes: known genes, known loci, and unknown loci.  
For instance, Apert syndrome (MIM ID #101200) is caused by mutations in the 
fibroblast growth factor receptor-2 gene (FGFR2) and was classified as a “known 
gene” (Table 6-5).  Seckel syndrome type 3 (MIM ID %606744) is linked to the 
chromosomal region 14q21-q22, but a causative gene or mutation has yet to be 
identified, and was therefore classified as a “known loci” (Table 6-6)  A third 
group of disorders (“unknown loci”) have yet to linked a specific chromosomal 
interval.  The list of known genes (Table 6-5) was supplemented with additional 
genes from a recent review on the genetic causes of cleft lip and/or palate (Dixon 
et al. 2011).   
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ACAN DLX1 FREM2 MID1 RAB23 SOX9 
ACTB DLX2 FRZB MSX1 RAI1 STAT3 
ADAMTS2 DLX5 FTO MSX2 RECQL4 STRA6 
AHR DNMT3B GABRB3 MYCN RELN SUMO1 
ALK5 E2F4 GDF5 MYH3 ROR2 TBCE 
ANKH EBP GJA1 NDN RPL11 TBX1 
ARX EFNB1 GLI2 NEB RPL5 TBX15 
ATP6V0A2 EPHB3 GLI3 NIPBL RPS17 TBX5 
ATPAF2 ERBB3 GLIS1 NSD1 RPS19 TCF3 
ATR ERCC5 GNAS1 OSR2 RPS7 TCOF1 
ATRX ESCO2 GPC3 p57(KIP2) RUNX2 TERT 
B3GALTL EVC1 H19 PAX3 SATB2 TFAP2A 
BARX2 EVC2 HCCS PAX6 SC5DL TFAP2B 
BCOR EXT1 HOXA2 PAX9 SEC23A TGFA 
BMP2 EXT2 HSD17B4 PEX1 SEMA3E TGFB3 
BMP4 EYA1 HSPG2 PEX14 SHH TGFBR1 
BMPR1A EYA4 HYLS1 PEX26 SHOX TGFBR2 
BRAF FAM20C ICK PEX3 SIL1 TGIF 
CASK FBN1 IGF2 PEX5 SIX3 TMEM70 
CD96 FGD1 IRF6 PHF8 SKI TNNT2 
CDKN1C FGF10 JAG1 PITX2 SLC26A2 TNNT3 
CHD7 FGF8 JAG2 PLOD3 SLC35D1 TP63 
CHX10 FGF9 KCNJ2 PQBP1 SLC3A1 TPM2 
COH1 FGFR1 KCNK9 PREPL SLC9A6 TRIM37 
COL11A1 FGFR2 KIAA1279 PROK2 SMAD2 TRPS1 
COL11A2 FGFR3 KRAS PROKR2 SMS TWIST1 
COL1A1 FKHL15 LHX8 PTCH1 SNAI1 TBX22 
COL1A2 FLNA LIT1 PTEN SNRPN UBR1 
COL2A1 FLNB MED12 PTHR1 SNX3 WNT3 
CXORF5 FOXC1 MEK1 PTPN11 SOX2 WTX 
DHCR24 FOXC2 MEK2 PVRL1 SOX3 ZEB2 
DHCR7 FRAS1 MEOX2 PYCR1 SOX6 ZIC2 
Table 6-5: Genes previously correlated with a variety of mammalian 
craniofacial defects.  See text for details. 
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Loci MIM ID# Region size (Mb)  Loci MIM ID# 
Region 
size (Mb) 
10p14-p13 %601362 10.7  2p13 %602966 6.4 
10q23.31 %176920 3.4  2p15 #202370 2.8 
10q24 %600095 8.8  2p15 #214100 2.8 
11p11.2 #601224 5.3  2p16.1-p15 #612513 9.1 
11q23-q24 %225000 20.4  2q14.2-q14.3 %210710 11.1 
12p13.3 #214100 10.1  2q31 %183600 13.3 
13q12.2-q13 %157900 12.3  2q31 %606708 13.3 
13q14 %601499 15.2  2q32-q33 #612313 26 
13q31.1-q34 %610361 36.2  2q34-q36 %185900 22 
14q13 %609408 4.5  2q37.1-q37.3 %236100 12.2 
14q21-q22 %608664 20.3  2q37.1-q37.3 %605934 12.2 
14q32 %164210 17.5  3q29 %609425 5.7 
15q26.1 #612813   4p16 %600593 11.3 
17p11.2 #610883 6.2  4p16.3 #194190 4.5 
17p11.2 %604547 6.2  4q21-q31 %608371 79.3 
17p12-p11.1 #119540 13.3  4q33-qter %607258 21.1 
17p13.3 #247200 3.3  5q23 #225410  
17q24.3-q25.1 %261800 7.7  6p24.3 %119530 3.5 
18p #146390 17.2  6p25 %608545 7.1 
18p11.31-q11.2 %606744 22.1  6q21-q22 %218400 24.8 
18q #601808 60.9  7p11.2 #180860 4 
19q13 %600757 26.7  7p13 241800 2.1 
1p34 %606713 12.2  7p22-p21 #607371  
1p36 #607872 28  7q11 #214100 17.6 
1p36.3 %119530 7.2  7q11.23 #194050 5.3 
1p36.32 #202370 3.1  7q11.2-q21.3 %129900 36.3 
1p36.32 #214100 3.1  7q11-q21 %608027 38.1 
1q21.1 #274000 4.4  7q21.2-q21.3 %183600 6.9 
1q21.1 #612474 4.4  7q21.2-q21.3 %220600 6.9 
1q22 #214100 1.5  7q36 #120200 11.2 
1q4 %119530 34.8  8p23.3 #105650 2.2 
1q42.2-q43 %119100 13  8q24.3 %612858 6.5 
1q42-q44 #612337 25.2  9q32 %154400 2.8 
21q22.3 %236100 5.5  Xp11.23-q13.3 %311900 29.6 
22q11 #115470 11.2  Xp22 #300209 24.9 
22q11.2 #145410 8  Xq24-q27.3 #300243 30.6 
22q11.2 #608363 8  Xq25-q26.1 %313850 9.5 
22q11.2 #611867 8  Xq26-q27 %300238 18.4 
22q11.2 #192430 8  Xq26-q27 %300712 18.4 
22q12-q13 %603116 25.4  Xq28 %300261 8.2 
Table 6-6: Genomic loci previously correlated with a variety of mammalian 
craniofacial defects.  See text for details. 
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Avian-specific microRNAs 
 The annotated microRNAs in miRBase (http://mirbase.org/, release 
version 16) (Griffiths-Jones et al. 2008) were compared across species by name 
and sequence.  A list was compiled of those mature miRNAs only annotated in 
chicken (Gallus gallus, WASHUC2 genome build) and/or zebrafinch (Taeniopygia 
guttata, taeGut3.2.4 genome build), the only two avians with their genomes 
sequenced.  Sequence reads for these miRNAs was assessed in the chicken, 
duck, and quail FNP mesenchyme libraries.  miRNAs annotated in the chicken 
and/or zebrafinch and expressed in all three species in my miRNA libraries were 
further analyzed.  Potential specificity to the avian lineage was assessed by 
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis, the current standard for 
assessing linage-specific microRNAs (Bentwich et al. 2005, Berezikov et al. 
2006, Brameier 2010, Li J. et al. 2010, Li S. et al. 2009, Yuan et al. 2010), 
against genomic sequences of zebrafish (Danio rerio, danRer 7 genome build), 
ilzard (Anolis carolinensis, anoCar1 genome build), frog (Xenopus tropicalis, 
xenTro2 genome build), Caenorhabditis elegans (ce6 genome build), Drosophila 
melanogaster (dm3 genome build), platypus, (Ornithorhynchus anatinus, 
ornAna1 genome build), cow (Bos Taurus, bosTau4 genome build), dog (Canis 
lupus familiaris, canFam2 genome build), mouse (Mus musculus, mm9 genome 
build), and human (Homo sapiens, hg19 genome build).  PCR to amplify the miR-
2954 hairpin precursor was conducted on DNA from birds that span the avian 
lineage (Table 6-7 and Figure 4-5) (Sibley and Ahlquist 1990) using primers 
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designed against the zebrafinch reference (5’- CCAAATCGGTGTTTCTTGGT-3’ 
and 5’-GTTCCCTAGCTCAGCCACAC-3’). 
 
Common name Scientific name Sample ID Source 
Black-footed 
Albatross Phoebastria nigripes UAMX789 UAM 
Common Loon Gavia immer UAMX2231 UAM 
Common 
Nighthawk Chordeiles minor JMM075 UAM 
Gray-chested 
Dove Leptotila cassini KSW4287 UAM 
Great Blue Heron Ardea herodias UAMX1947 UAM 
Greater Flamingo Phoenicopterus ruber KSW3611 UAM 
Green Warbler 
Finch Certhidea olivacea 1801 UC 
Ostrich Struthio camelus B-29767 LSUMNS 
Spotted Northura 
(tinamou) Nothura maculosa KGM252 UAM 
Table 6-7: Bird species used to assess avian-specific microRNAs.  LSUMNS, Louisiana 
State University Museum of Natural Sciences; UAM, University of Alaska Museum, UC, Kenneth 
Petren (University of Cincinnati). 
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